Matthew Todd Roe
Professor of Medicine
My clinical activities focus upon general, preventive, and acute care cardiology. I round regularly on the inpatient general cardiology and coronary care unit (CCU) services and i have a particular interest in the treatment and management of patients with acute myocardial infarction and cardiogenic shock. In my outpatient clinic, I care for patients with a variety of cardiovascular conditions include chronic coronary artery disease, hypertension, hyperlipidemia, atrial fibrillation, congestive heart failure, aortic aneurysms, and peripheral arterial disease. In this setting, I have a particular interest in cardiovascular risk factor modification and long-term treatment strategies to mitigate the risk of future cardiovascular events.
My research activities at the Duke Clinical Research Institute focus upon the coordination and leadership of randomized clinical trials evaluating new therapies for a variety of cardiovascular conditions (acute myocardial infarction, hyperlipidemia, coronary stent placement, peripheral arterial disease, and coronary artery disease) as well as observational registries that evaluate the same disease conditions.
My research activities at the Duke Clinical Research Institute focus upon the coordination and leadership of randomized clinical trials evaluating new therapies for a variety of cardiovascular conditions (acute myocardial infarction, hyperlipidemia, coronary stent placement, peripheral arterial disease, and coronary artery disease) as well as observational registries that evaluate the same disease conditions.
Current Appointments & Affiliations
- Professor of Medicine, Medicine, Cardiology, Medicine 2016
- Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 1999
Contact Information
- 2400 Pratt St, Durham, NC 27705
- Duke Box 3850, Durham, NC 27710
-
roe00001@mc.duke.edu
(919) 668-8959
-
Department of Medicine Profile
-
Roe CV - February 2017
- Background
-
Education, Training, & Certifications
- Cardiology Fellow, Cardiology, Case Western Reserve University 1996 - 1999
- Medical Resident, Medicine, Duke University 1993 - 1996
- M.D., Duke University 1993
-
Duke Appointment History
- Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 1999 - 2017
- Associate Professor of Medicine, Medicine, Cardiology, Medicine 2011 - 2015
- Associate Professor of Medicine, Medicine, Cardiology, Medicine 2007 - 2010
- Assistant Professor of Medicine, Medicine, Cardiology, Medicine 2001 - 2007
- Associate in the Department of Medicine, Medicine, Cardiology, Medicine 1999 - 2001
- Instructor, Temporary in the Department of Medicine, Medicine, Cardiology, Medicine 1999
- Recognition
-
In the News
- Research
-
Selected Grants
- Postdoctoral Training in Cardiovascular Clinical Research awarded by National Institutes of Health 2003 - 2024
- HiLo awarded by National Institutes of Health 2018 - 2023
- Evaluating fitness-for-use of Electronic Health Records in Clinical Research awarded by Food and Drug Administration 2019 - 2022
- ADAPTABLE awarded by Patient Centered Outcomes Research Institute 2015 - 2020
- ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment with Alirocumab 2018 - 2020
- Vesalius Real Registry 2019
- CASCADE Registry 2013 - 2019
- HiLo awarded by National Institutes of Health 2018 - 2019
- Core Clinical Centers for the CTSN awarded by National Institutes of Health 2007 - 2018
- MYK-461-004: Phase 2a and 2b Program 2016 - 2018
- NCDR-ACTION 2016 - 2017
- Mission Lifeline Texas State System Report 2015
- NCDR-ACTION 2008 - 2015
- Mission Lifeline Texas State System Report 2014
- FDA Crusade Database Query awarded by Food and Drug Administration 2006 - 2008
- Safer Antithrombotic Therapy for Elderly ACS Patients awarded by National Institutes of Health 2005 - 2008
-
Industry Relationships
- Amgen, Inc.
- Astra Zeneca
- CME Education Resources
- Eli Lilly & Co.
- Elsevier
- Genetech
- Janssen Pharmaceuticals (Johnson & Johnson)
- Novo Nordisk
- Pfizer Inc.
- Regeneron Pharmaceuticals
- Sanofi-Aventis
- Signal Path, LLC
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Fordyce, Christopher B., Kaitlin Malone, Annemarie Forrest, Terri Hinkley, Amy Corneli, James Topping, and Matthew T. Roe. “Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative..” Contemp Clin Trials Commun 16 (December 2019). https://doi.org/10.1016/j.conctc.2019.100462.Full Text Link to Item
-
Sinnaeve, Peter R., Gregory G. Schwartz, Daniel M. Wojdyla, Marco Alings, Deepak L. Bhatt, Vera A. Bittner, Chern-En Chiang, et al. “Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis..” Eur Heart J, November 16, 2019. https://doi.org/10.1093/eurheartj/ehz809.Full Text Link to Item
-
Jukema, J Wouter, Laurien E. Zijlstra, Deepak L. Bhatt, Vera A. Bittner, Rafael Diaz, Heinz Drexel, Shaun G. Goodman, et al. “Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES..” Circulation, November 11, 2019. https://doi.org/10.1161/CIRCULATIONAHA.119.043826.Full Text Link to Item
-
Roe, Matthew T., Qian H. Li, Deepak L. Bhatt, Vera A. Bittner, Rafael Diaz, Shaun G. Goodman, Robert A. Harrington, et al. “Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes..” Circulation 140, no. 19 (November 5, 2019): 1578–89. https://doi.org/10.1161/CIRCULATIONAHA.119.042551.Full Text Link to Item
-
Szarek, Michael, Ph Gabriel Steg, Dina DiCenso, Deepak L. Bhatt, Vera A. Bittner, Andrzej Budaj, Rafael Diaz, et al. “Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial..” Circ Cardiovasc Qual Outcomes 12, no. 11 (November 2019). https://doi.org/10.1161/CIRCOUTCOMES.119.005858.Full Text Link to Item
-
Roe, Matthew T., and John Strickler. “Addressing the Conundrum of Bleeding and Cancer Detection With Antithrombotic Therapies for Chronic Atherosclerotic Cardiovascular Disease..” Circulation 140, no. 18 (October 29, 2019): 1460–62. https://doi.org/10.1161/CIRCULATIONAHA.119.042875.Full Text Link to Item
-
Marquis-Gravel, Guillaume, Matthew T. Roe, Mintu P. Turakhia, William Boden, Robert Temple, Abhinav Sharma, Boaz Hirshberg, et al. “Technology-Enabled Clinical Trials: Transforming Medical Evidence Generation..” Circulation 140, no. 17 (October 22, 2019): 1426–36. https://doi.org/10.1161/CIRCULATIONAHA.119.040798.Full Text Link to Item
-
Duell, P Barton, Samuel S. Gidding, Rolf L. Andersen, Thomas Knickelbine, Lars Anderson, Eugenia Gianos, Peter Shrader, et al. “Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry..” Atherosclerosis 289 (October 2019): 85–93. https://doi.org/10.1016/j.atherosclerosis.2019.08.007.Full Text Link to Item
-
Kwee, Lydia Coulter, Megan L. Neely, Elizabeth Grass, Simon G. Gregory, Matthew T. Roe, E Magnus Ohman, Keith A. A. Fox, et al. “Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome..” Physiol Genomics 51, no. 10 (October 1, 2019): 506–15. https://doi.org/10.1152/physiolgenomics.00033.2019.Full Text Link to Item
-
Marquis-Gravel, Guillaume, Matthew T. Roe, Robert A. Harrington, Daniel Muñoz, Adrian F. Hernandez, and W Schuyler Jones. “Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease..” Circulation 140, no. 13 (September 24, 2019): 1115–24. https://doi.org/10.1161/CIRCULATIONAHA.119.040205.Full Text Link to Item
-
Roe, Matthew T., and Guillaume Marquis-Gravel. “Overcoming the Risk-Treatment Paradox for Non-ST-Segment Elevation Acute Coronary Syndromes..” J Am Coll Cardiol 74, no. 11 (September 17, 2019): 1462–64. https://doi.org/10.1016/j.jacc.2019.07.031.Full Text Link to Item
-
Brennan, J Matthew, Lisa Wruck, Michael J. Pencina, Robert M. Clare, Renato D. Lopes, John H. Alexander, Sean O’Brien, et al. “Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials..” Am Heart J 218 (September 12, 2019): 110–22. https://doi.org/10.1016/j.ahj.2019.09.002.Full Text Link to Item
-
Bagai, Akshay, Anita Y. Chen, Jacob A. Udell, John A. Dodson, David D. McManus, Mathew S. Maurer, Jonathan R. Enriquez, et al. “Association of Cognitive Impairment With Treatment and Outcomes in Older Myocardial Infarction Patients: A Report From the NCDR Chest Pain-MI Registry..” J Am Heart Assoc 8, no. 17 (September 3, 2019). https://doi.org/10.1161/JAHA.119.012929.Full Text Link to Item
-
Goodman, Shaun G., Philip E. Aylward, Michael Szarek, Vakhtang Chumburidze, Deepak L. Bhatt, Vera A. Bittner, Rafael Diaz, et al. “Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery..” J Am Coll Cardiol 74, no. 9 (September 3, 2019): 1177–86. https://doi.org/10.1016/j.jacc.2019.07.015.Full Text Link to Item
-
Jukema, J Wouter, Michael Szarek, Laurien E. Zijlstra, H Asita de Silva, Deepak L. Bhatt, Vera A. Bittner, Rafael Diaz, et al. “Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial..” J Am Coll Cardiol 74, no. 9 (September 3, 2019): 1167–76. https://doi.org/10.1016/j.jacc.2019.03.013.Full Text Link to Item
-
Fordyce, Christopher B., Matthew T. Roe, Christine Pierre, Terri Hinkley, Gerrit Hamre, Pamela Tenaerts, Jonathan McCall, and James D. Topping. “Trends in clinical trial investigator workforce and turnover: An analysis of the U.S. FDA 1572 BMIS database..” Contemp Clin Trials Commun 15 (September 2019). https://doi.org/10.1016/j.conctc.2019.100380.Full Text Link to Item
-
White, Harvey D., Ph Gabriel Steg, Michael Szarek, Deepak L. Bhatt, Vera A. Bittner, Rafael Diaz, Jay M. Edelberg, et al. “Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial..” Eur Heart J 40, no. 33 (September 1, 2019): 2801–9. https://doi.org/10.1093/eurheartj/ehz299.Full Text Link to Item
-
Fanaroff, Alexander C., Amit N. Vora, Anita Y. Chen, Robin Mathews, Jacob A. Udell, Matthew T. Roe, Laine E. Thomas, and Tracy Y. Wang. “Hospital participation in clinical trials for patients with acute myocardial infarction: Results from the National Cardiovascular Data Registry..” Am Heart J 214 (August 2019): 184–93. https://doi.org/10.1016/j.ahj.2019.05.011.Full Text Link to Item
-
Ma, Qinli, Haechung Chung, Sonali Shambhu, Matthew Roe, Mark Cziraky, W Schuyler Jones, and Kevin Haynes. “Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health..” Clin Trials 16, no. 4 (August 2019): 419–30. https://doi.org/10.1177/1740774519846853.Full Text Link to Item
-
Ray, Kausik K., Helen M. Colhoun, Michael Szarek, Marie Baccara-Dinet, Deepak L. Bhatt, Vera A. Bittner, Andrzej J. Budaj, et al. “Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial..” Lancet Diabetes Endocrinol 7, no. 8 (August 2019): 618–28. https://doi.org/10.1016/S2213-8587(19)30158-5.Full Text Link to Item
-
Steg, Philippe Gabriel, Michael Szarek, Deepak L. Bhatt, Vera A. Bittner, Marie-France Brégeault, Anthony J. Dalby, Rafael Diaz, et al. “Effect of Alirocumab on Mortality After Acute Coronary Syndromes..” Circulation 140, no. 2 (July 9, 2019): 103–12. https://doi.org/10.1161/CIRCULATIONAHA.118.038840.Full Text Link to Item
-
Shavadia, Jay S., DaJuanicia N. Holmes, Laine Thomas, Eric D. Peterson, Christopher B. Granger, Matthew T. Roe, and Tracy Y. Wang. “Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients..” Circ Cardiovasc Qual Outcomes 12, no. 7 (July 2019). https://doi.org/10.1161/CIRCOUTCOMES.118.005103.Full Text Link to Item
-
Sharma, Abhinav, Jie-Lena Sun, Yuliya Lokhnygina, Matthew T. Roe, Tariq Ahmad, Nihar R. Desai, and Michael A. Blazing. “Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)..” Am J Cardiol 123, no. 8 (April 15, 2019): 1193–1201. https://doi.org/10.1016/j.amjcard.2019.01.034.Full Text Link to Item
-
Kaul, Padma, Karen P. Alexander, E Magnus Ohman, Anamaria Savu, Matthew T. Roe, Shaun G. Goodman, Keith A. Fox, et al. “Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial..” Can J Cardiol 35, no. 4 (April 2019): 430–37. https://doi.org/10.1016/j.cjca.2018.12.035.Full Text Link to Item
-
Melloni, Chiara, and Matthew T. Roe. “Androgen deprivation therapy and cardiovascular disease..” Urol Oncol, March 14, 2019. https://doi.org/10.1016/j.urolonc.2019.02.010.Full Text Link to Item
-
Kontos, Michael C., Christopher B. Fordyce, Anita Y. Chen, Karen Chiswell, Jonathan R. Enriquez, James de Lemos, and Matthew T. Roe. “Association of acute myocardial infarction cardiac arrest patient volume and in-hospital mortality in the United States: Insights from the National Cardiovascular Data Registry Acute Coronary Treatment And Intervention Outcomes Network Registry..” Clin Cardiol 42, no. 3 (March 2019): 352–57. https://doi.org/10.1002/clc.23146.Full Text Link to Item
-
Fanaroff, Alexander C., Robert Clare, Karen S. Pieper, Kenneth W. Mahaffey, Chiara Melloni, Jennifer B. Green, John H. Alexander, et al. “Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials..” Circulation 139, no. 7 (February 12, 2019): 863–73. https://doi.org/10.1161/CIRCULATIONAHA.118.037202.Full Text Link to Item
-
Szarek, Michael, Harvey D. White, Gregory G. Schwartz, Marco Alings, Deepak L. Bhatt, Vera A. Bittner, Chern-En Chiang, et al. “Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial..” J Am Coll Cardiol 73, no. 4 (February 5, 2019): 387–96. https://doi.org/10.1016/j.jacc.2018.10.039.Full Text Link to Item
-
Fanaroff, Alexander C., Pearl Zakroysky, Daniel Wojdyla, Lisa A. Kaltenbach, Matthew W. Sherwood, Matthew T. Roe, Tracy Y. Wang, et al. “Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention..” Circulation 139, no. 4 (January 22, 2019): 458–72. https://doi.org/10.1161/CIRCULATIONAHA.117.033325.Full Text Link to Item
-
Bulluck, Heerajnarain, Mervyn H. H. Chan, Jennifer A. Bryant, Ping Chai, Ashish Chawla, Terrance S. Chua, Yiu-Cho Chung, et al. “Platelet inhibition to target reperfusion injury trial: Rationale and study design..” Clin Cardiol 42, no. 1 (January 2019): 5–12. https://doi.org/10.1002/clc.23110.Full Text Link to Item
-
Mahajan, Asha M., Himali Gandhi, Nathaniel R. Smilowitz, Matthew T. Roe, Anne S. Hellkamp, Karen Chiswell, Martha Gulati, and Harmony R. Reynolds. “Seasonal and circadian patterns of myocardial infarction by coronary artery disease status and sex in the ACTION Registry-GWTG..” Int J Cardiol 274 (January 1, 2019): 16–20. https://doi.org/10.1016/j.ijcard.2018.08.103.Full Text Link to Item
-
Navar, Ann Marie, Matthew T. Roe, Jennifer A. White, Christopher P. Cannon, Yuliya Lokhnygina, L Kristin Newby, Robert P. Giugliano, et al. “Medication Discontinuation in the IMPROVE-IT Trial..” Circ Cardiovasc Qual Outcomes 12, no. 1 (January 2019). https://doi.org/10.1161/CIRCOUTCOMES.118.005041.Full Text Link to Item
-
Bagai, Akshay, Di Lu, Joseph Lucas, Abhinav Goyal, Charles A. Herzog, Tracy Y. Wang, Shaun G. Goodman, and Matthew T. Roe. “Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry..” J Am Heart Assoc 7, no. 24 (December 18, 2018). https://doi.org/10.1161/JAHA.118.010394.Full Text Link to Item
-
Fanaroff, Alexander C., Derek Cyr, Megan L. Neely, Jeffery Bakal, Harvey D. White, Keith A. A. Fox, Paul W. Armstrong, Renato D. Lopes, E Magnus Ohman, and Matthew T. Roe. “Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes..” Circ Cardiovasc Qual Outcomes 11, no. 12 (December 2018). https://doi.org/10.1161/CIRCOUTCOMES.118.004755.Full Text Link to Item
-
Fordyce, Christopher B., Anita Y. Chen, Tracy Y. Wang, Joseph Lucas, Abhinav Goyal, Graham C. Wong, Sean van Diepen, et al. “Patterns of use of targeted temperature management for acute myocardial infarction patients following out-of-hospital cardiac arrest: Insights from the National Cardiovascular Data Registry..” Am Heart J 206 (December 2018): 131–33. https://doi.org/10.1016/j.ahj.2018.08.013.Full Text Link to Item
-
Schwartz, Gregory G., P Gabriel Steg, Michael Szarek, Deepak L. Bhatt, Vera A. Bittner, Rafael Diaz, Jay M. Edelberg, et al. “Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome..” N Engl J Med 379, no. 22 (November 29, 2018): 2097–2107. https://doi.org/10.1056/NEJMoa1801174.Full Text Link to Item
-
Dodson, John A., Judith S. Hochman, Matthew T. Roe, Anita Y. Chen, Sarwat I. Chaudhry, Stuart Katz, Hua Zhong, et al. “The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction: Insights From the ACTION Registry..” Jacc Cardiovasc Interv 11, no. 22 (November 26, 2018): 2287–96. https://doi.org/10.1016/j.jcin.2018.08.028.Full Text Link to Item
-
Ambrosy, Andrew P., Lukasz P. Cerbin, Marat Fudim, Robert M. Clare, Yuliya Lokhnygina, Eugene Braunwald, Robert M. Califf, et al. “Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status..” Am J Cardiol 122, no. 9 (November 1, 2018): 1451–58. https://doi.org/10.1016/j.amjcard.2018.07.034.Full Text Link to Item
-
Hinohara, Tomoya T., Matthew T. Roe, Harvey D. White, Keith A. A. Fox, Deepak L. Bhatt, Christian Hamm, Paul A. Gurbel, et al. “Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial)..” Am J Cardiol 122, no. 8 (October 15, 2018): 1322–29. https://doi.org/10.1016/j.amjcard.2018.06.052.Full Text Link to Item
-
Shavadia, Jay S., Matthew T. Roe, Anita Y. Chen, Joseph Lucas, Alexander C. Fanaroff, Ajar Kochar, Christopher B. Fordyce, et al. “Association Between Cardiac Catheterization Laboratory Pre-Activation and Reperfusion Timing Metrics and Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Report From the ACTION Registry..” Jacc Cardiovasc Interv 11, no. 18 (September 24, 2018): 1837–47. https://doi.org/10.1016/j.jcin.2018.07.020.Full Text Link to Item
-
O’Brien, Emily C., Shuang Li, Laine Thomas, Tracy Y. Wang, Matthew T. Roe, and Eric D. Peterson. “The impact of clinical vs administrative claims coding on hospital risk-adjusted outcomes..” Clin Cardiol 41, no. 9 (September 2018): 1225–31. https://doi.org/10.1002/clc.23059.Full Text Link to Item
-
Yan, Andrew T., Matthew T. Roe, Megan Neely, Derek D. Cyr, Harvey White, Keith A. A. Fox, Dorairaj Prabhakaran, Paul W. Armstrong, Erik M. Ohman, and Shaun G. Goodman. “Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes: insights from the TRILOGY ACS trial..” Coron Artery Dis 29, no. 6 (September 2018): 469–76. https://doi.org/10.1097/MCA.0000000000000623.Full Text Link to Item
-
Pagidipati, Neha J., Robert M. Clare, Robert T. Keenan, Karen Chiswell, Matthew T. Roe, and Connie N. Hess. “Association of Gout With Long-Term Cardiovascular Outcomes Among Patients With Obstructive Coronary Artery Disease..” J Am Heart Assoc 7, no. 16 (August 21, 2018). https://doi.org/10.1161/JAHA.118.009328.Full Text Link to Item
-
Inohara, Taku, Karen Pieper, Daniel M. Wojdyla, Manesh R. Patel, William Schuyler Jones, Pierluigi Tricoci, Kenneth W. Mahaffey, et al. “Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome..” Am Heart J 201 (July 2018): 25–32. https://doi.org/10.1016/j.ahj.2018.03.013.Full Text Link to Item
-
Kochar, Ajar, Anita Y. Chen, Puza P. Sharma, Neha J. Pagidipati, Gregg C. Fonarow, Patricia A. Cowper, Matthew T. Roe, Eric D. Peterson, and Tracy Y. Wang. “Long-Term Mortality of Older Patients With Acute Myocardial Infarction Treated in US Clinical Practice..” J Am Heart Assoc 7, no. 13 (June 30, 2018). https://doi.org/10.1161/JAHA.117.007230.Full Text Link to Item
-
Sharma, Abhinav, Robert A. Harrington, Mark B. McClellan, Mintu P. Turakhia, Zubin J. Eapen, Steven Steinhubl, James R. Mault, et al. “Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care..” J Am Coll Cardiol 71, no. 23 (June 12, 2018): 2680–90. https://doi.org/10.1016/j.jacc.2018.03.523.Full Text Link to Item
-
Udell, Jacob A., Nihar R. Desai, Shuang Li, Laine Thomas, James A. de Lemos, Phyllis Wright-Slaughter, Wenying Zhang, Matthew T. Roe, and Deepak L. Bhatt. “Neighborhood Socioeconomic Disadvantage and Care After Myocardial Infarction in the National Cardiovascular Data Registry..” Circ Cardiovasc Qual Outcomes 11, no. 6 (June 2018). https://doi.org/10.1161/CIRCOUTCOMES.117.004054.Full Text Link to Item
-
Bellemain-Appaix, A., C. Bégué, D. L. Bhatt, K. Ducci, R. A. Harrington, M. Roe, S. D. Wiviott, et al. “The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: A systematic review and meta-analysis.” Eurointervention 14, no. 1 (May 1, 2018): 78–85. https://doi.org/10.4244/EIJ-D-17-00852.Full Text
-
Green, Jacqueline L., Alice K. Jacobs, DaJuanicia Holmes, Karen Chiswell, Rosalia Blanco, Eric R. Bates, William French, et al. “Taking the Reins on Systems of Care for ST-Segment-Elevation Myocardial Infarction Patients: A Report From the American Heart Association Mission: Lifeline Program..” Circ Cardiovasc Interv 11, no. 5 (May 2018). https://doi.org/10.1161/CIRCINTERVENTIONS.117.005706.Full Text Link to Item
-
Shavadia, Jay S., William French, Anne S. Hellkamp, Laine Thomas, Eric R. Bates, Steven V. Manoukian, Michael C. Kontos, et al. “Comprehensive electrocardiogram-to-device time for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A report from the American Heart Association mission: Lifeline program..” Am Heart J 197 (March 2018): 9–17. https://doi.org/10.1016/j.ahj.2017.10.017.Full Text Link to Item
-
Malta Hansen, Carolina, Tracy Y. Wang, Anita Y. Chen, Karen Chiswell, Deepak L. Bhatt, Jonathan R. Enriquez, Timothy Henry, and Matthew T. Roe. “Contemporary Patterns of Early Coronary Angiography Use in Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry..” Jacc Cardiovasc Interv 11, no. 4 (February 26, 2018): 369–80. https://doi.org/10.1016/j.jcin.2017.12.016.Full Text Link to Item
- Hansen, CM, Wang, TY, Chen, AY, Chiswell, K, Bhatt, DL, Enriquez, JR, Henry, T, and Roe, MT. "Contemporary Patterns of Early Coronary Angiography Use in Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry." JACC-CARDIOVASCULAR INTERVENTIONS 11, no. 4 (February 26, 2018): 369-380. Full Text Link to Item
-
Doll, Jacob A., Shuang Li, Karen Chiswell, Matthew T. Roe, Mikhail Kosiborod, Benjamin M. Scirica, and Tracy Y. Wang. “Clopidogrel reloading for patients with acute myocardial infarction already on clopidogrel therapy..” Eur Heart J 39, no. 3 (January 14, 2018): 193–200. https://doi.org/10.1093/eurheartj/ehx255.Full Text Link to Item
-
Mody, Purav, Tracy Wang, Robert McNamara, Sandeep Das, Shuang Li, Karen Chiswell, Thomas Tsai, et al. “Association of acute kidney injury and chronic kidney disease with processes of care and long-term outcomes in patients with acute myocardial infarction..” Eur Heart J Qual Care Clin Outcomes 4, no. 1 (January 1, 2018): 43–50. https://doi.org/10.1093/ehjqcco/qcx020.Full Text Link to Item
-
Amrock, Stephen M., P Barton Duell, Thomas Knickelbine, Seth S. Martin, Emily C. O’Brien, Karol E. Watson, Joanna Mitri, et al. “Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry..” Atherosclerosis 267 (December 2017): 19–26. https://doi.org/10.1016/j.atherosclerosis.2017.10.006.Full Text Link to Item
-
Smilowitz, Nathaniel R., Asha M. Mahajan, Matthew T. Roe, Anne S. Hellkamp, Karen Chiswell, Martha Gulati, and Harmony R. Reynolds. “Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines)..” Circ Cardiovasc Qual Outcomes 10, no. 12 (December 2017). https://doi.org/10.1161/CIRCOUTCOMES.116.003443.Full Text Link to Item
-
Kuijt, Wichert J., Cindy L. Green, Niels J. W. Verouden, Joost D. E. Haeck, Dan Tzivoni, Karel T. Koch, Gregg W. Stone, et al. “What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction..” J Electrocardiol 50, no. 6 (November 2017): 952–59. https://doi.org/10.1016/j.jelectrocard.2017.04.009.Full Text Link to Item
-
Kragholm, Kristian, Di Lu, Karen Chiswell, Hussein R. Al-Khalidi, Mayme L. Roettig, Matthew Roe, James Jollis, and Christopher B. Granger. “Improvement in Care and Outcomes for Emergency Medical Service-Transported Patients With ST-Elevation Myocardial Infarction (STEMI) With and Without Prehospital Cardiac Arrest: A Mission: Lifeline STEMI Accelerator Study..” J Am Heart Assoc 6, no. 10 (October 11, 2017). https://doi.org/10.1161/JAHA.117.005717.Full Text Link to Item
-
Kittle, Jessie, Renato D. Lopes, Mingyan Huang, Marsha L. Marquess, Matthew D. Wilson, John Ascher, Alok Krishen, et al. “Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort..” Clin Cardiol 40, no. 10 (October 2017): 899–906. https://doi.org/10.1002/clc.22744.Full Text Link to Item
-
Stanifer, John W., David M. Charytan, Jennifer White, Yuliya Lokhnygina, Christopher P. Cannon, Matthew T. Roe, and Michael A. Blazing. “Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function..” J Am Soc Nephrol 28, no. 10 (October 2017): 3034–43. https://doi.org/10.1681/ASN.2016090957.Full Text Open Access Copy Link to Item
-
Fanaroff, Alexander C., Matthew T. Roe, Robert M. Clare, Yuliya Lokhnygina, Ann Marie Navar, Robert P. Giugliano, Stephen D. Wiviott, Andrew M. Tershakovec, Eugene Braunwald, and Michael A. Blazing. “Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long-Term Follow-Up After Acute Coronary Syndromes..” J Am Heart Assoc 6, no. 9 (September 18, 2017). https://doi.org/10.1161/JAHA.117.005840.Full Text Link to Item
-
Secemsky, Eric A., Ajay Kirtane, Sripal Bangalore, Ion S. Jovin, Dhavalkumar Patel, Enrico G. Ferro, Neil J. Wimmer, et al. “Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States..” Circ Cardiovasc Qual Outcomes 10, no. 9 (September 2017). https://doi.org/10.1161/CIRCOUTCOMES.117.003741.Full Text Link to Item
-
Fanaroff, Alexander C., Vic Hasselblad, Matthew T. Roe, Deepak L. Bhatt, Stefan K. James, Ph Gabriel Steg, C Michael Gibson, and E Magnus Ohman. “Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis..” Int J Cardiol 241 (August 15, 2017): 87–96. https://doi.org/10.1016/j.ijcard.2017.03.046.Full Text Link to Item
-
Alfredsson, Joakim, Benjamin Neely, Megan L. Neely, Deepak L. Bhatt, Shaun G. Goodman, Pierluigi Tricoci, Kenneth W. Mahaffey, et al. “Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes..” Heart 103, no. 15 (August 2017): 1168–76. https://doi.org/10.1136/heartjnl-2016-310090.Full Text Link to Item
-
Pi, Yi, Matthew T. Roe, DaJuanicia N. Holmes, Karen Chiswell, J Lee Garvey, Gregg C. Fonarow, James A. de Lemos, Kirk N. Garratt, and Ying Xian. “Utilization, Characteristics, and In-Hospital Outcomes of Coronary Artery Bypass Grafting in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines..” Circ Cardiovasc Qual Outcomes 10, no. 8 (August 2017). https://doi.org/10.1161/CIRCOUTCOMES.116.003490.Full Text Link to Item
-
Povsic, Thomas J., Rob Scott, Kenneth W. Mahaffey, Robert Blaustein, Jay M. Edelberg, Martin P. Lefkowitz, Scott D. Solomon, et al. “Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference..” Cardiovasc Drugs Ther 31, no. 4 (August 2017): 445–58. https://doi.org/10.1007/s10557-017-6739-9.Full Text Link to Item
-
Chan, Mark Y., Megan L. Neely, Matthew T. Roe, Shaun G. Goodman, David Erlinge, Jan H. Cornel, Kenneth J. Winters, et al. “Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome..” Clin Chem 63, no. 7 (July 2017): 1214–26. https://doi.org/10.1373/clinchem.2016.265272.Full Text Link to Item
-
Fanaroff, Alexander C., Pearl Zakroysky, David Dai, Daniel Wojdyla, Matthew W. Sherwood, Matthew T. Roe, Tracy Y. Wang, et al. “Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States..” J Am Coll Cardiol 69, no. 24 (June 20, 2017): 2913–24. https://doi.org/10.1016/j.jacc.2017.04.032.Full Text Link to Item
-
Corneli, Amy, Christine Pierre, Terri Hinkley, Li Lin, Christopher B. Fordyce, Gerrit Hamre, and Matthew T. Roe. “One and done: Reasons principal investigators conduct only one FDA-regulated drug trial..” Contemp Clin Trials Commun 6 (June 2017): 31–38. https://doi.org/10.1016/j.conctc.2017.02.009.Full Text Link to Item
-
Dalby, Anthony J., Shmuel Gottlieb, Derek D. Cyr, Erik Magnus Ohman, Darren K. McGuire, Witold Ruzyllo, Deepak L. Bhatt, et al. “Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization..” Am Heart J 188 (June 2017): 156–66. https://doi.org/10.1016/j.ahj.2017.03.015.Full Text Link to Item
-
Wang, Alice, Lydia Coulter Kwee, Elizabeth Grass, Megan L. Neely, Simon G. Gregory, Keith A. A. Fox, Paul W. Armstrong, et al. “Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome..” Atherosclerosis 261 (June 2017): 19–25. https://doi.org/10.1016/j.atherosclerosis.2017.03.041.Full Text Link to Item
-
Ohman, E Magnus, Matthew T. Roe, P Gabriel Steg, Stefan K. James, Thomas J. Povsic, Jennifer White, Frank Rockhold, et al. “Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial..” Lancet 389, no. 10081 (May 6, 2017): 1799–1808. https://doi.org/10.1016/S0140-6736(17)30751-1.Full Text Open Access Copy Link to Item
-
Hess, Connie N., Robert M. Clare, Megan L. Neely, Pierluigi Tricoci, Kenneth W. Mahaffey, Stefan K. James, John H. Alexander, et al. “Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome..” Am Heart J 187 (May 2017): 194–203. https://doi.org/10.1016/j.ahj.2017.01.016.Full Text Link to Item
-
Pagidipati, Neha J., Connie N. Hess, Robert M. Clare, Axel Akerblom, Pierluigi Tricoci, Daniel Wojdyla, Robert T. Keenan, et al. “An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome..” Am Heart J 187 (May 2017): 53–61. https://doi.org/10.1016/j.ahj.2017.02.023.Full Text Link to Item
-
Miller, Amy Leigh, DaJuanicia Simon, Matthew T. Roe, Michael C. Kontos, Deborah Diercks, Ezra Amsterdam, and Deepak L. Bhatt. “Comparison of Delay Times from Symptom Onset to Medical Contact in Blacks Versus Whites With Acute Myocardial Infarction..” Am J Cardiol 119, no. 8 (April 15, 2017): 1127–34. https://doi.org/10.1016/j.amjcard.2016.12.021.Full Text Link to Item
-
Goldstein, Sarah A., L Kristin Newby, Derek D. Cyr, Megan Neely, Thomas F. Lüscher, Eileen B. Brown, Harvey D. White, E Magnus Ohman, Matthew T. Roe, and Christian W. Hamm. “Relationship Between Peak Troponin Values and Long-Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes..” J Am Heart Assoc 6, no. 4 (April 11, 2017). https://doi.org/10.1161/JAHA.116.005334.Full Text Link to Item
-
Doll, Jacob A., Dadi Dai, Matthew T. Roe, John C. Messenger, Matthew W. Sherwood, Abhiram Prasad, Ehtisham Mahmud, et al. “Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary Intervention: A Report From the NCDR..” Jacc Cardiovasc Interv 10, no. 7 (April 10, 2017): 672–82. https://doi.org/10.1016/j.jcin.2016.12.019.Full Text Link to Item
-
Fleming, Thomas R., David L. DeMets, Matthew T. Roe, Janet Wittes, Karim A. Calis, Amit N. Vora, Alan Meisel, et al. “Rejoinder..” Clin Trials 14, no. 2 (April 2017): 126–27. https://doi.org/10.1177/1740774516688917.Full Text Link to Item
-
Fleming, Thomas R., David L. DeMets, Matthew T. Roe, Janet Wittes, Karim A. Calis, Amit N. Vora, Alan Meisel, et al. “Data monitoring committees: Promoting best practices to address emerging challenges..” Clin Trials 14, no. 2 (April 2017): 115–23. https://doi.org/10.1177/1740774516688915.Full Text Link to Item
-
Valle, Javier A., Lisa A. McCoy, Thomas M. Maddox, John S. Rumsfeld, P Michael Ho, Ivan P. Casserly, Brahmajee K. Nallamothu, Matthew T. Roe, Thomas T. Tsai, and John C. Messenger. “Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry..” Circ Cardiovasc Interv 10, no. 4 (April 2017). https://doi.org/10.1161/CIRCINTERVENTIONS.116.004439.Full Text Link to Item
-
Lau, Emily S., Eugene Braunwald, Sabina A. Murphy, Stephen D. Wiviott, Marc P. Bonaca, Steen Husted, Stefan K. James, et al. “Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials..” J Am Coll Cardiol 69, no. 12 (March 28, 2017): 1549–59. https://doi.org/10.1016/j.jacc.2017.01.028.Full Text Link to Item
-
Masoudi, Frederick A., Angelo Ponirakis, James A. de Lemos, James G. Jollis, Mark Kremers, John C. Messenger, John W. M. Moore, et al. “Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries..” J Am Coll Cardiol 69, no. 11 (March 21, 2017): 1427–50. https://doi.org/10.1016/j.jacc.2016.12.005.Full Text Link to Item
-
Masoudi, Frederick A., Angelo Ponirakis, James A. de Lemos, James G. Jollis, Mark Kremers, John C. Messenger, John W. M. Moore, et al. “Executive Summary: Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries..” J Am Coll Cardiol 69, no. 11 (March 21, 2017): 1424–26. https://doi.org/10.1016/j.jacc.2016.12.004.Full Text Link to Item
-
Fordyce, Christopher B., Matthew T. Roe, and Neal W. Dickert. “Maximizing value and minimizing barriers: Patient-centered community consultation for research in emergency settings..” Clin Trials 14, no. 1 (February 2017): 88–93. https://doi.org/10.1177/1740774516676084.Full Text Link to Item
-
Welsh, Robert C., Matthew T. Roe, Philippe Gabriel Steg, Stefan James, Thomas J. Povsic, Christoph Bode, Charles Michael Gibson, and Erik Magnus Ohman. “Corrigendum to "A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease" [Am Heart J 181 (2016) 92-100]..” Am Heart J 184 (February 2017). https://doi.org/10.1016/j.ahj.2017.01.004.Full Text Link to Item
-
Roswell, Robert O., Jordan Kunkes, Anita Y. Chen, Karen Chiswell, Sohah Iqbal, Matthew T. Roe, and Sripal Bangalore. “Impact of Sex and Contact-to-Device Time on Clinical Outcomes in Acute ST-Segment Elevation Myocardial Infarction-Findings From the National Cardiovascular Data Registry..” J Am Heart Assoc 6, no. 1 (January 11, 2017). https://doi.org/10.1161/JAHA.116.004521.Full Text Link to Item
-
Hess, Connie N., and Matthew T. Roe. “Treatment of coronary artery disease in cancer survivors: an emerging challenge..” Coron Artery Dis 28, no. 1 (January 2017): 1–2. https://doi.org/10.1097/MCA.0000000000000444.Full Text Link to Item
-
Ostergaard, Lauge, Emil L. Fosbol, and Matthew T. Roe. “The Role of Antiplatelet Therapy in Primary Prevention. A Review..” Curr Pharm Des 23, no. 9 (2017): 1294–1306. https://doi.org/10.2174/1381612822666161205115540.Full Text Link to Item
-
Motivala, Apurva A., Valay Parikh, Matthew Roe, David Dai, J Dawn Abbott, Abhiram Prasad, and Debabrata Mukherjee. “Reply: Effect of Pre-Procedural β-Blocker in Patients Undergoing Percutaneous Coronary Intervention..” Jacc Cardiovasc Interv 9, no. 23 (December 12, 2016): 2459–60. https://doi.org/10.1016/j.jcin.2016.10.014.Full Text Link to Item
-
Secemsky, Eric A., Ajay Kirtane, Sripal Bangalore, Ion S. Jovin, Rachit M. Shah, Enrico G. Ferro, Neil J. Wimmer, et al. “Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States..” Jacc Cardiovasc Interv 9, no. 23 (December 12, 2016): 2376–86. https://doi.org/10.1016/j.jcin.2016.09.020.Full Text Link to Item
-
Cornel, Jan H., E Magnus Ohman, Benjamin Neely, Joseph A. Jakubowski, Deepak L. Bhatt, Harvey D. White, Diego Ardissino, et al. “Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes..” J Am Heart Assoc 5, no. 11 (November 4, 2016). https://doi.org/10.1161/JAHA.116.003977.Full Text Link to Item
-
Welsh, Robert C., Matthew T. Roe, Philippe Gabriel Steg, Stefan James, Thomas J. Povsic, Christoph Bode, Charles Michael Gibson, and Erik Magnus Ohman. “A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease..” Am Heart J 181 (November 2016): 92–100. https://doi.org/10.1016/j.ahj.2016.08.008.Full Text Link to Item
-
Jones, W Schuyler, Matthew T. Roe, Elliott M. Antman, Mark J. Pletcher, Robert A. Harrington, Russell L. Rothman, William J. Oetgen, et al. “The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease..” J Am Coll Cardiol 68, no. 17 (October 25, 2016): 1898–1907. https://doi.org/10.1016/j.jacc.2016.07.781.Full Text Link to Item
-
Kontos, Michael C., Tracy Y. Wang, Anita Y. Chen, Eric R. Bates, Harold L. Dauerman, Timothy D. Henry, Steven V. Manoukian, et al. “The effect of high-risk ST elevation myocardial infarction transfer patients on risk-adjusted in-hospital mortality: A report from the American Heart Association Mission: Lifeline program..” Am Heart J 180 (October 2016): 74–81. https://doi.org/10.1016/j.ahj.2016.07.010.Full Text Link to Item
-
Rymer, Jennifer A., Robert W. Harrison, David Dai, Matthew T. Roe, John C. Messenger, H Vernon Anderson, Eric D. Peterson, and Tracy Y. Wang. “Trends in Bare-Metal Stent Use in the United States in Patients Aged ≥65 Years (from the CathPCI Registry)..” Am J Cardiol 118, no. 7 (October 1, 2016): 959–66. https://doi.org/10.1016/j.amjcard.2016.06.061.Full Text Link to Item
-
Stroes, Erik, John R. Guyton, Norman Lepor, Fernando Civeira, Daniel Gaudet, Gerald F. Watts, Marie T. Baccara-Dinet, et al. “Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study..” J Am Heart Assoc 5, no. 9 (September 13, 2016). https://doi.org/10.1161/JAHA.116.003421.Full Text Link to Item
-
Ahmad, Zahid S., Rolf L. Andersen, Lars H. Andersen, Emily C. O’Brien, Iris Kindt, Peter Shrader, Chandna Vasandani, et al. “US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry..” J Clin Lipidol 10, no. 5 (September 2016): 1223–29. https://doi.org/10.1016/j.jacl.2016.07.011.Full Text Link to Item
-
Jackson, Larry R., Jonathan P. Piccini, Derek D. Cyr, Matthew T. Roe, Megan L. Neely, Felipe Martinez, Thomas F. Lüscher, et al. “Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial..” Clin Cardiol 39, no. 9 (September 2016): 497–506. https://doi.org/10.1002/clc.22562.Full Text Link to Item
-
Vora, Amit N., Tracy Y. Wang, Anne S. Hellkamp, Laine Thomas, Timothy D. Henry, Abhinav Goyal, and Matthew T. Roe. “Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease..” Circ Cardiovasc Qual Outcomes 9, no. 5 (September 2016): 513–22. https://doi.org/10.1161/CIRCOUTCOMES.115.002312.Full Text Link to Item
-
Motivala, Apurva A., Valay Parikh, Matthew Roe, David Dai, J Dawn Abbott, Abhiram Prasad, and Debabrata Mukherjee. “Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry..” Jacc Cardiovasc Interv 9, no. 16 (August 22, 2016): 1639–48. https://doi.org/10.1016/j.jcin.2016.05.048.Full Text Link to Item
-
Academic Research Organization Consortium for Continuing Evaluation of Scientific Studies--Cardiovascular (ACCESS CV), Michael, Manesh R. Patel, Paul W. Armstrong, Deepak L. Bhatt, Eugene Braunwald, A John Camm, Keith A. A. Fox, et al. “Sharing Data from Cardiovascular Clinical Trials--A Proposal..” N Engl J Med 375, no. 5 (August 4, 2016): 407–9. https://doi.org/10.1056/NEJMp1605260.Full Text Link to Item
-
Chin, Chee Tang, William E. Boden, Matthew T. Roe, Benjamin Neely, Megan L. Neely, Jose L. Leiva-Pons, Ramón Corbalán, et al. “Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients..” Heart 102, no. 15 (August 1, 2016): 1221–29. https://doi.org/10.1136/heartjnl-2015-308840.Full Text Link to Item
-
Fanaroff, Alexander C., and Matthew T. Roe. “Contemporary Reflections on the Safety of Long-Term Aspirin Treatment for the Secondary Prevention of Cardiovascular Disease..” Drug Saf 39, no. 8 (August 2016): 715–27. https://doi.org/10.1007/s40264-016-0421-1.Full Text Link to Item
-
Jing, Mingxue, Fei Gao, Qifeng Chen, Leonardo P. de Carvalho, Ling-Ling Sim, Tian-Hai Koh, David Foo, et al. “Comparison of Long-Term Mortality of Patients Aged ≤40 Versus >40 Years With Acute Myocardial Infarction..” Am J Cardiol 118, no. 3 (August 1, 2016): 319–25. https://doi.org/10.1016/j.amjcard.2016.05.002.Full Text Link to Item
-
Kaul, Padma, E Magnus Ohman, J David Knight, Kevin J. Anstrom, Matthew T. Roe, William E. Boden, Judith S. Hochman, et al. “Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial..” Am Heart J 178 (August 2016): 55–64. https://doi.org/10.1016/j.ahj.2016.03.017.Full Text Link to Item
-
Wayangankar, S. A., M. T. Roe, A. Y. Chen, R. S. Gupta, R. P. Giugliano, L. K. Newby, J. A. de Lemos, K. P. Alexander, T. A. Sanborn, and J. F. Saucedo. “Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy..” Indian Heart J 68, no. 4 (July 2016): 464–72. https://doi.org/10.1016/j.ihj.2015.09.036.Full Text Link to Item
-
Anderson, Lindsay L., David Dai, Amy Leigh Miller, Matthew T. Roe, John C. Messenger, and Tracy Y. Wang. “Percutaneous coronary intervention for older adults who present with syncope and coronary artery disease? Insights from the National Cardiovascular Data Registry..” Am Heart J 176 (June 2016): 1–9. https://doi.org/10.1016/j.ahj.2016.02.017.Full Text Link to Item
-
Hagström, Emil, Matthew T. Roe, Gail Hafley, Megan L. Neely, Mandeep S. Sidhu, Kenneth J. Winters, Dorairaj Prabhakaran, et al. “Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial..” Clin Cardiol 39, no. 6 (June 2016): 329–37. https://doi.org/10.1002/clc.22533.Full Text Link to Item
-
White, Harvey D., Cynthia M. Westerhout, Karen P. Alexander, Matthew T. Roe, Kenneth J. Winters, Derek D. Cyr, Keith Aa Fox, et al. “Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial..” Eur Heart J Acute Cardiovasc Care 5, no. 3 (June 2016): 231–42. https://doi.org/10.1177/2048872615581502.Full Text Link to Item
-
Yerokun, Babatunde A., Judson B. Williams, Jeffrey Gaca, Peter K. Smith, and Matthew T. Roe. “Indications, algorithms, and outcomes for coronary artery bypass surgery in patients with acute coronary syndromes..” Coron Artery Dis 27, no. 4 (June 2016): 319–26. https://doi.org/10.1097/MCA.0000000000000364.Full Text Link to Item
-
deGoma, Emil M., Zahid S. Ahmad, Emily C. O’Brien, Iris Kindt, Peter Shrader, Connie B. Newman, Yashashwi Pokharel, et al. “Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry..” Circ Cardiovasc Genet 9, no. 3 (June 2016): 240–49. https://doi.org/10.1161/CIRCGENETICS.116.001381.Full Text Link to Item
-
Mathews, Robin, Gregg C. Fonarow, Shuang Li, Eric D. Peterson, John S. Rumsfeld, Paul A. Heidenreich, Matthew T. Roe, et al. “Comparison of performance on Hospital Compare process measures and patient outcomes between hospitals that do and do not participate in Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines..” Am Heart J 175 (May 2016): 1–8. https://doi.org/10.1016/j.ahj.2016.01.008.Full Text Link to Item
-
Pandey, Ambarish, Darren K. McGuire, James A. de Lemos, Sandeep R. Das, Jarett D. Berry, Emmanouil S. Brilakis, Subhash Banerjee, et al. “Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG)..” Circ Cardiovasc Qual Outcomes 9, no. 3 (May 2016): 197–205. https://doi.org/10.1161/CIRCOUTCOMES.115.002084.Full Text Link to Item
-
Xu, Haiyan, Wei Li, Jingang Yang, Stephen D. Wiviott, Marc S. Sabatine, Eric D. Peterson, Ying Xian, et al. “The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China..” Am Heart J 175 (May 2016): 193-201.e3. https://doi.org/10.1016/j.ahj.2015.04.014.Full Text Link to Item
-
Vora, Amit N., Eric D. Peterson, Lisa A. McCoy, Kirk N. Garratt, Michael A. Kutcher, Steven P. Marso, Matthew T. Roe, John C. Messenger, and Sunil V. Rao. “The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry..” Jacc Cardiovasc Interv 9, no. 8 (April 25, 2016): 771–79. https://doi.org/10.1016/j.jcin.2016.01.033.Full Text Link to Item
-
Chin, Chee Tang, Benjamin Neely, E. Magnus Ohman, Paul W. Armstrong, Ramón Corbalán, Harvey D. White, Dorairaj Prabhakaran, et al. “Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial..” Stroke 47, no. 4 (April 2016): 1135–39. https://doi.org/10.1161/STROKEAHA.115.012454.Full Text Link to Item
-
Hess, Paul L., Daniel M. Wojdyla, Sana M. Al-Khatib, Yuliya Lokhnygina, Lars Wallentin, Paul W. Armstrong, Matthew T. Roe, et al. “Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome..” Jama Cardiol 1, no. 1 (April 1, 2016): 73–79. https://doi.org/10.1001/jamacardio.2015.0359.Full Text Link to Item
-
Povsic, Thomas J., Matthew T. Roe, Erik Magnus Ohman, Philippe Gabriel Steg, Stefan James, Alexei Plotnikov, Hardi Mundl, Robert Welsh, Christoph Bode, and Charles Michael Gibson. “A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study..” Am Heart J 174 (April 2016): 120–28. https://doi.org/10.1016/j.ahj.2016.01.004.Full Text Link to Item
-
Wimmer, Neil J., Eric A. Secemsky, Laura Mauri, Matthew T. Roe, Paramita Saha-Chaudhuri, David Dai, James M. McCabe, Frederic S. Resnic, Hitinder S. Gurm, and Robert W. Yeh. “Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis..” Circ Cardiovasc Interv 9, no. 4 (April 2016). https://doi.org/10.1161/CIRCINTERVENTIONS.115.003464.Full Text Link to Item
-
Zimerman, André, Renato D. Lopes, Amanda L. Stebbins, Patrícia O. Guimarães, Ghazala Haque, Chiara Melloni, Kathleen Trollinger, et al. “Pooled analysis of adverse event collection from 4 acute coronary syndrome trials..” Am Heart J 174 (April 2016): 60–67. https://doi.org/10.1016/j.ahj.2016.01.003.Full Text Link to Item
-
Lopes, Renato D., Sergio Leonardi, Benjamin Neely, Megan L. Neely, E Magnus Ohman, Diego Ardissino, Christian W. Hamm, et al. “Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial..” J Am Coll Cardiol 67, no. 11 (March 22, 2016): 1289–97. https://doi.org/10.1016/j.jacc.2016.01.034.Full Text Link to Item
-
Hess, Connie N., Anne S. Hellkamp, Matthew T. Roe, Laine Thomas, Benjamin M. Scirica, S Andrew Peng, Eric D. Peterson, and Tracy Y. Wang. “Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital Revascularization..” J Am Heart Assoc 5, no. 3 (March 14, 2016). https://doi.org/10.1161/JAHA.115.002784.Full Text Open Access Copy Link to Item
-
Doll, Jacob A., Megan L. Neely, Matthew T. Roe, Paul W. Armstrong, Harvey D. White, Dorairaj Prabhakaran, Kenneth J. Winters, et al. “Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel..” J Am Coll Cardiol 67, no. 8 (March 1, 2016): 936–47. https://doi.org/10.1016/j.jacc.2015.12.036.Full Text Link to Item
-
Vora, Amit N., Dadi Dai, Hitinder Gurm, Amit P. Amin, John C. Messenger, Ehtisham Mahmud, Laura Mauri, et al. “Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry's CathPCI Registry..” Circ Cardiovasc Interv 9, no. 3 (March 2016). https://doi.org/10.1161/CIRCINTERVENTIONS.115.003070.Full Text Link to Item
-
Wayangankar, Siddharth A., Sripal Bangalore, Lisa A. McCoy, Hani Jneid, Faisal Latif, Wassef Karrowni, Konstantinos Charitakis, et al. “Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry..” Jacc Cardiovasc Interv 9, no. 4 (February 22, 2016): 341–51. https://doi.org/10.1016/j.jcin.2015.10.039.Full Text Link to Item
-
Wang, Tracy Y., Lisa A. McCoy, Deepak L. Bhatt, Sunil V. Rao, Matthew T. Roe, Frederic S. Resnic, Matthew A. Cavender, John C. Messenger, and Eric D. Peterson. “Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction..” Am Heart J 172 (February 2016): 9–18. https://doi.org/10.1016/j.ahj.2015.10.017.Full Text Link to Item
-
Roe, Matthew T., Derek D. Cyr, Debra Eckart, Phillip J. Schulte, Michael A. Morse, Kimberly L. Blackwell, Neal E. Ready, et al. “Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome..” Eur Heart J 37, no. 4 (January 21, 2016): 412–22. https://doi.org/10.1093/eurheartj/ehv611.Full Text Link to Item
-
Ohman, E Magnus, and Matthew T. Roe. “Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook..” Am J Ther 23, no. 1 (January 2016): e243–44. https://doi.org/10.1097/MJT.0b013e31824ea5f9.Full Text Link to Item
-
Kang, Hyun-Jae, Dajuanicia Simon, Tracy Y. Wang, Karen P. Alexander, Myung Ho Jeong, Hyo-Soo Kim, Eric R. Bates, et al. “The Contemporary Use of Angiography and Revascularization Among Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States Compared With South Korea..” Clin Cardiol 38, no. 12 (December 2015): 708–14. https://doi.org/10.1002/clc.22475.Full Text Link to Item
-
Kohsaka, Shun, Hiroaki Miyata, Ikuko Ueda, Frederick A. Masoudi, Eric D. Peterson, Yuichiro Maekawa, Akio Kawamura, et al. “An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database-Keio interhospital Cardiovascular Studies (JCD-KiCS)..” Am Heart J 170, no. 6 (December 2015): 1077–85. https://doi.org/10.1016/j.ahj.2015.09.017.Full Text Link to Item
-
Shen, Lan, Bimal R. Shah, Shuang Li, Laine Thomas, Tracy Y. Wang, Karen P. Alexander, Eric D. Peterson, Ben He, and Matthew T. Roe. “The Association of Transfer Rate From Hospitals Without Revascularization Capabilities and Mortality Risk for Older Non-ST-Segment Elevation Myocardial Infarction Patients..” Clin Cardiol 38, no. 12 (December 2015): 733–39. https://doi.org/10.1002/clc.22480.Full Text Link to Item
-
Clemmensen, Peter, Matthew T. Roe, Judith S. Hochman, Derek D. Cyr, Megan L. Neely, Darren K. McGuire, Jan H. Cornel, et al. “Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial..” Am Heart J 170, no. 4 (October 2015): 695-705.e5. https://doi.org/10.1016/j.ahj.2015.06.011.Full Text Link to Item
-
Nicolau, Jose Carlos, Deepak L. Bhatt, Matthew T. Roe, Yuliya Lokhnygina, Benjamin Neely, Ramón Corbalán, José L. Leiva-Pons, et al. “Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial..” Am Heart J 170, no. 4 (October 2015): 683-694.e3. https://doi.org/10.1016/j.ahj.2015.05.017.Full Text Link to Item
-
Anderson, Lindsay L., William J. French, S Andrew Peng, Amit N. Vora, Timothy D. Henry, Matthew T. Roe, Michael C. Kontos, et al. “Direct Transfer From the Referring Hospitals to the Catheterization Laboratory to Minimize Reperfusion Delays for Primary Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry..” Circ Cardiovasc Interv 8, no. 9 (September 2015). https://doi.org/10.1161/CIRCINTERVENTIONS.114.002477.Full Text Link to Item
-
Melloni, Chiara, and Matthew T. Roe. “Cardiac Troponin and Risk Stratification in Ischemic Heart Disease..” N Engl J Med 373, no. 7 (August 13, 2015): 672–74. https://doi.org/10.1056/NEJMe1506298.Full Text Link to Item
-
Shah, Bimal R., Emily C. O’Brien, Matthew T. Roe, Anita Y. Chen, and Eric D. Peterson. “The association of in-hospital guideline adherence and longitudinal postdischarge mortality in older patients with non-ST-segment elevation myocardial infarction..” Am Heart J 170, no. 2 (August 2015): 273-280.e1. https://doi.org/10.1016/j.ahj.2015.05.007.Full Text Link to Item
-
Hess, Connie N., Matthew T. Roe, Robert M. Clare, Karen Chiswell, Joseph Kelly, James E. Tcheng, Emil Hagstrom, et al. “Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention..” J Am Heart Assoc 4, no. 7 (July 6, 2015). https://doi.org/10.1161/JAHA.115.001779.Full Text Open Access Copy Link to Item
-
Mahaffey, Kenneth W., Rebecca Hager, Daniel Wojdyla, Harvey D. White, Paul W. Armstrong, John H. Alexander, Pierluigi Tricoci, et al. “Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes..” J Am Heart Assoc 4, no. 6 (June 18, 2015). https://doi.org/10.1161/JAHA.114.001512.Full Text Link to Item
-
O’Brien, Emily C., DaJuanicia N. Simon, Matthew T. Roe, Tracy Y. Wang, Eric D. Peterson, and Karen P. Alexander. “Statin Treatment by Low-Density Lipoprotein Cholesterol Levels in Patients With Non-ST-Segment Elevation Myocardial Infarction/Unstable Angina Pectoris (from the CRUSADE Registry)..” Am J Cardiol 115, no. 12 (June 15, 2015): 1655–60. https://doi.org/10.1016/j.amjcard.2015.03.007.Full Text Link to Item
-
Lopes, Renato D., S Michael Gharacholou, DaJuanicia N. Holmes, Laine Thomas, Tracy Y. Wang, Matthew T. Roe, Eric D. Peterson, and Karen P. Alexander. “Cumulative incidence of death and rehospitalization among the elderly in the first year after NSTEMI..” Am J Med 128, no. 6 (June 2015): 582–90. https://doi.org/10.1016/j.amjmed.2014.12.032.Full Text Link to Item
-
Roe, Matthew T., Kenneth W. Mahaffey, Justin A. Ezekowitz, John H. Alexander, Shaun G. Goodman, Adrian Hernandez, Tracy Temple, et al. “The future of cardiovascular clinical research in North America and beyond-addressing challenges and leveraging opportunities through unique academic and grassroots collaborations..” Am Heart J 169, no. 6 (June 2015): 743–50. https://doi.org/10.1016/j.ahj.2015.03.002.Full Text Link to Item
-
Aragam, Krishna G., Dadi Dai, Megan L. Neely, Deepak L. Bhatt, Matthew T. Roe, John S. Rumsfeld, and Hitinder S. Gurm. “Gaps in referral to cardiac rehabilitation of patients undergoing percutaneous coronary intervention in the United States..” J Am Coll Cardiol 65, no. 19 (May 19, 2015): 2079–88. https://doi.org/10.1016/j.jacc.2015.02.063.Full Text Link to Item
-
Alfredsson, Joakim, and Matthew T. Roe. “Risks and benefits of triple oral anti-thrombotic therapies after acute coronary syndromes and percutaneous coronary intervention..” Drug Saf 38, no. 5 (May 2015): 481–91. https://doi.org/10.1007/s40264-015-0286-8.Full Text Link to Item
-
Dauerman, Harold L., Eric R. Bates, Michael C. Kontos, Shuang Li, J Lee Garvey, Timothy D. Henry, Steven V. Manoukian, and Matthew T. Roe. “Nationwide Analysis of Patients With ST-Segment-Elevation Myocardial Infarction Transferred for Primary Percutaneous Intervention: Findings From the American Heart Association Mission: Lifeline Program..” Circ Cardiovasc Interv 8, no. 5 (May 2015). https://doi.org/10.1161/CIRCINTERVENTIONS.114.002450.Full Text Link to Item
-
Fordyce, Christopher B., Matthew T. Roe, Tariq Ahmad, Peter Libby, Jeffrey S. Borer, William R. Hiatt, Michael R. Bristow, et al. “Cardiovascular drug development: is it dead or just hibernating?.” J Am Coll Cardiol 65, no. 15 (April 21, 2015): 1567–82. https://doi.org/10.1016/j.jacc.2015.03.016.Full Text Link to Item
-
Kontos, Michael C., Benjamin M. Scirica, Anita Y. Chen, Laine Thomas, Monique L. Anderson, Deborah B. Diercks, James G. Jollis, Matthew T. Roe, and Matthew T. NCDR. “Cardiac arrest and clinical characteristics, treatments and outcomes among patients hospitalized with ST-elevation myocardial infarction in contemporary practice: A report from the National Cardiovascular Data Registry..” Am Heart J 169, no. 4 (April 2015): 515-22.e1. https://doi.org/10.1016/j.ahj.2015.01.010.Full Text Link to Item
-
Doll, Jacob A., and Matthew T. Roe. “Time to treatment as a quality metric for acute STEMI care..” Lancet 385, no. 9973 (March 21, 2015): 1056–57. https://doi.org/10.1016/S0140-6736(14)62051-1.Full Text Link to Item
-
Alfredsson, Joakim, and Matthew T. Roe. “Balancing the risks and benefits of long-term antiplatelet therapies for cardiovascular disease: clinical, research, and regulatory implications..” J Am Heart Assoc 4, no. 3 (March 19, 2015). https://doi.org/10.1161/JAHA.115.001897.Full Text Link to Item
-
Mehta, Rajendra H., Anita Y. Chen, Karen P. Alexander, E Magnus Ohman, Matthew T. Roe, and Eric D. Peterson. “Doing the right things and doing them the right way: association between hospital guideline adherence, dosing safety, and outcomes among patients with acute coronary syndrome..” Circulation 131, no. 11 (March 17, 2015): 980–87. https://doi.org/10.1161/CIRCULATIONAHA.114.013451.Full Text Link to Item
-
Bakal, Jeffrey A., Matthew T. Roe, E Magnus Ohman, Shaun G. Goodman, Keith A. A. Fox, Yinggan Zheng, Cynthia M. Westerhout, et al. “Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial..” Eur Heart J 36, no. 6 (February 7, 2015): 385-92a. https://doi.org/10.1093/eurheartj/ehu262.Full Text Link to Item
-
Roy, Ambuj, Matthew T. Roe, Megan L. Neely, Derek D. Cyr, Dmitry Zamoryakhin, Keith A. A. Fox, Harvey D. White, Paul W. Armstrong, E Magnus Ohman, and Dorairaj Prabhakaran. “Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome..” Heart 101, no. 4 (February 2015): 279–86. https://doi.org/10.1136/heartjnl-2014-306389.Full Text Link to Item
-
Vora, Amit N., DaJuanicia N. Holmes, Ivan Rokos, Matthew T. Roe, Christopher B. Granger, William J. French, Elliott Antman, et al. “Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry..” Jama Intern Med 175, no. 2 (February 2015): 207–15. https://doi.org/10.1001/jamainternmed.2014.6573.Full Text Link to Item
-
Udell, Jacob A., Matthew T. Roe, and Stephen D. Wiviott. “Risk profile of clinical trial participants--reply..” Jama 313, no. 1 (January 6, 2015): 94–95. https://doi.org/10.1001/jama.2014.15633.Full Text Link to Item
-
Yeh, Robert W., Matthew J. Czarny, Sharon-Lise T. Normand, Dean J. Kereiakes, David R. Holmes, Ralph G. Brindis, W Douglas Weaver, et al. “Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry..” Circ Cardiovasc Qual Outcomes 8, no. 1 (January 2015): 96–102. https://doi.org/10.1161/CIRCOUTCOMES.114.001239.Full Text Link to Item
-
Nicholson, Benjamin D., Harinder S. Dhindsa, Matthew T. Roe, Anita Y. Chen, James G. Jollis, and Michael C. Kontos. “Relationship of the distance between non-PCI hospitals and primary PCI centers, mode of transport, and reperfusion time among ground and air interhospital transfers using NCDR's ACTION Registry-GWTG: a report from the American Heart Association Mission: Lifeline Program..” Circ Cardiovasc Interv 7, no. 6 (December 2014): 797–805. https://doi.org/10.1161/CIRCINTERVENTIONS.113.001307.Full Text Link to Item
-
Kontos, Michael C., Stephen L. Rennyson, Anita Y. Chen, Karen P. Alexander, Eric D. Peterson, and Matthew T. Roe. “The association of myocardial infarction process of care measures and in-hospital mortality: a report from the NCDR®..” Am Heart J 168, no. 5 (November 2014): 766–75. https://doi.org/10.1016/j.ahj.2014.07.005.Full Text Link to Item
-
Schwartz, Gregory G., Laurence Bessac, Lisa G. Berdan, Deepak L. Bhatt, Vera Bittner, Rafael Diaz, Shaun G. Goodman, et al. “Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial..” Am Heart J 168, no. 5 (November 2014): 682–89. https://doi.org/10.1016/j.ahj.2014.07.028.Full Text Link to Item
-
Harskamp, Ralf E., and Matthew T. Roe. “Soluble urokinase-type plasminogen activator receptor: a useful biomarker for coronary artery disease and clinical outcomes?.” J Am Heart Assoc 3, no. 5 (October 23, 2014). https://doi.org/10.1161/JAHA.114.001431.Full Text Link to Item
-
Rousan, Talla A., Reji M. Pappy, Anita Y. Chen, Matthew T. Roe, and Jorge F. Saucedo. “Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR)..” Am J Cardiol 114, no. 8 (October 15, 2014): 1136–44. https://doi.org/10.1016/j.amjcard.2014.07.031.Full Text Link to Item
-
Bagai, Akshay, Phillip J. Schulte, Christopher B. Granger, Kenneth W. Mahaffey, Robert H. Christenson, Gregory Bell, Renato D. Lopes, et al. “Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention..” Am Heart J 168, no. 4 (October 2014): 503-511.e2. https://doi.org/10.1016/j.ahj.2014.06.008.Full Text Link to Item
-
Lincoff, A Michael, Matthew Roe, Philip Aylward, John Galla, Andrzej Rynkiewicz, Victor Guetta, Michael Zelizko, et al. “Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial..” Eur Heart J 35, no. 37 (October 1, 2014): 2516–23. https://doi.org/10.1093/eurheartj/ehu177.Full Text Link to Item
-
Dasari, Tarun W., Matthew T. Roe, Anita Y. Chen, Eric D. Peterson, Robert P. Giugliano, Gregg C. Fonarow, and Jorge F. Saucedo. “Impact of time of presentation on process performance and outcomes in ST-segment-elevation myocardial infarction: a report from the American Heart Association: Mission Lifeline program..” Circ Cardiovasc Qual Outcomes 7, no. 5 (September 2014): 656–63. https://doi.org/10.1161/CIRCOUTCOMES.113.000740.Full Text Link to Item
-
Hall, Hurst M., James A. de Lemos, Jonathan R. Enriquez, Darren K. McGuire, S Andrew Peng, Karen P. Alexander, Matthew T. Roe, Nihar Desai, Stephen D. Wiviott, and Sandeep R. Das. “Contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States: results from the National Cardiovascular Data Registry (NCDR)..” Circ Cardiovasc Qual Outcomes 7, no. 5 (September 2014): 701–7. https://doi.org/10.1161/CIRCOUTCOMES.113.000822.Full Text Link to Item
-
Udell, Jacob A., Tracy Y. Wang, Shuang Li, Payal Kohli, Matthew T. Roe, James A. de Lemos, and Stephen D. Wiviott. “Clinical trial participation after myocardial infarction in a national cardiovascular data registry..” Jama 312, no. 8 (August 27, 2014): 841–43. https://doi.org/10.1001/jama.2014.6217.Full Text Link to Item
-
Mathews, Robin, Anita Y. Chen, Laine Thomas, Tracy Y. Wang, Chee Tang Chin, Kevin L. Thomas, Matthew T. Roe, and Eric D. Peterson. “Differences in short-term versus long-term outcomes of older black versus white patients with myocardial infarction: findings from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of American College of Cardiology/American Heart Association Guidelines (CRUSADE)..” Circulation 130, no. 8 (August 19, 2014): 659–67. https://doi.org/10.1161/CIRCULATIONAHA.113.008370.Full Text Link to Item
-
Ahmad, Tariq, and Matthew T. Roe. “Acute coronary syndromes: Treatment for low-risk patients with STEMI--challenges remain..” Nat Rev Cardiol 11, no. 8 (August 2014): 440–42. https://doi.org/10.1038/nrcardio.2014.89.Full Text Link to Item
-
Bagai, Akshay, Yongfei Wang, Tracy Y. Wang, Jeptha P. Curtis, Hitinder S. Gurm, Binita Shah, Asim N. Cheema, et al. “In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry..” Circ Cardiovasc Interv 7, no. 4 (August 2014): 585–93. https://doi.org/10.1161/CIRCINTERVENTIONS.114.001555.Full Text Link to Item
-
Hess, Connie N., Matthew T. Roe, C Michael Gibson, Robert J. Temple, Michael J. Pencina, Deborah A. Zarin, Kevin J. Anstrom, et al. “Independent data monitoring committees: preparing a path for the future..” Am Heart J 168, no. 2 (August 2014): 135-41.e1. https://doi.org/10.1016/j.ahj.2014.05.003.Full Text Link to Item
-
McNamara, R. L., S. C. Chung, T. Jernberg, D. Holmes, M. Roe, A. Timmis, S. James, et al. “International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries..” Int J Cardiol 175, no. 2 (August 1, 2014): 240–47. https://doi.org/10.1016/j.ijcard.2014.04.270.Full Text Open Access Copy Link to Item
-
McNamara, R. L., S. C. Chung, T. Jernberg, D. Holmes, M. Roe, A. Timmis, S. James, et al. “International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries.” International Journal of Cardiology 175, no. 2 (August 1, 2014): 240–47. https://doi.org/10.1016/j.ijcard.2014.04.270.Full Text
-
Cotoni, David A., Matthew T. Roe, Shuang Li, and Michael C. Kontos. “Frequency of nonsystem delays in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention and implications for door-to-balloon time reporting (from the American Heart Association Mission: Lifeline program)..” Am J Cardiol 114, no. 1 (July 1, 2014): 24–28. https://doi.org/10.1016/j.amjcard.2014.04.003.Full Text Link to Item
-
Patel, Manesh R., David Dai, Adrian F. Hernandez, Pamela S. Douglas, John Messenger, Kirk N. Garratt, Thomas M. Maddox, Eric D. Peterson, and Matthew T. Roe. “Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice..” Am Heart J 167, no. 6 (June 2014): 846-52.e2. https://doi.org/10.1016/j.ahj.2014.03.001.Full Text Link to Item
-
Roe, Matthew T., and Matthew W. Sherwood. “Uncovering the shroud on antiplatelet therapy for patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention..” Jacc Cardiovasc Interv 7, no. 6 (June 2014): 613–14. https://doi.org/10.1016/j.jcin.2014.02.008.Full Text Link to Item
-
Shen, Lan, Bimal R. Shah, Aro Nam, DaJuanicia Holmes, Karen P. Alexander, Deepak L. Bhatt, P Michael Ho, Eric D. Peterson, Ben He, and Matthew T. Roe. “Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction..” Am Heart J 167, no. 6 (June 2014): 840–45. https://doi.org/10.1016/j.ahj.2014.03.009.Full Text Link to Item
-
Wang, Tracy Y., David J. Magid, Henry H. Ting, Shuang Li, Karen P. Alexander, Matthew T. Roe, and Eric D. Peterson. “The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary intervention..” Am Heart J 167, no. 6 (June 2014): 833–39. https://doi.org/10.1016/j.ahj.2014.03.002.Full Text Link to Item
-
O’Brien, Emily, Sumeet Subherwal, Matthew T. Roe, DaJuanicia N. Holmes, Laine Thomas, Karen P. Alexander, Tracy Y. Wang, and Eric D. Peterson. “Do patients treated at academic hospitals have better longitudinal outcomes after admission for non-ST-elevation myocardial infarction?.” Am Heart J 167, no. 5 (May 2014): 762–69. https://doi.org/10.1016/j.ahj.2014.01.009.Full Text Link to Item
-
Sherwood, Matthew W., Stephen D. Wiviott, S Andrew Peng, Matthew T. Roe, James Delemos, Eric D. Peterson, and Tracy Y. Wang. “Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry..” J Am Heart Assoc 3, no. 2 (April 14, 2014). https://doi.org/10.1161/JAHA.114.000849.Full Text Open Access Copy Link to Item
-
Gupta, Navdeep, Michael C. Kontos, Aditi Gupta, David Dai, George W. Vetrovec, Matthew T. Roe, and John Messenger. “Characteristics and outcomes in patients undergoing percutaneous coronary intervention following cardiac arrest (from the NCDR)..” Am J Cardiol 113, no. 7 (April 1, 2014): 1087–92. https://doi.org/10.1016/j.amjcard.2013.12.014.Full Text Link to Item
-
Bagai, Akshay, James G. Jollis, Harold L. Dauerman, S Andrew Peng, Ivan C. Rokos, Eric R. Bates, William J. French, Christopher B. Granger, and Matthew T. Roe. “Response to letter regarding article, "Emergency department bypass for ST-segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline Program"..” Circulation 129, no. 9 (March 4, 2014). https://doi.org/10.1161/CIRCULATIONAHA.113.008027.Full Text Link to Item
-
Chin, Chee Tang, John C. Messenger, David Dai, Lisa A. McCoy, Michael A. Kutcher, H Vernon Anderson, Matthew T. Roe, and Tracy Y. Wang. “Comparison of percutaneous coronary intervention for previously treated versus de novo culprit lesions in acute myocardial infarction patients: insights from the National Cardiovascular Data Registry..” Am Heart J 167, no. 3 (March 2014): 393-400.e1. https://doi.org/10.1016/j.ahj.2013.12.005.Full Text Link to Item
-
Gupta, Navdeep, Jeffrey B. Washam, Stavros E. Mountantonakis, Shuang Li, Matthew T. Roe, James A. de Lemos, and Rohit Arora. “Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry)..” Am J Cardiol 113, no. 5 (March 1, 2014): 749–56. https://doi.org/10.1016/j.amjcard.2013.11.023.Full Text Link to Item
-
Harskamp, Ralf E., Tracy Y. Wang, Deepak L. Bhatt, Stephen D. Wiviott, Ezra A. Amsterdam, Shuang Li, Laine Thomas, Robbert J. de Winter, and Matthew T. Roe. “Hospital patterns of medical management strategy use for patients with non-ST-elevation myocardial infarction and 3-vessel or left main coronary artery disease..” Am Heart J 167, no. 3 (March 2014): 355-362.e3. https://doi.org/10.1016/j.ahj.2013.12.004.Full Text Link to Item
-
O’Brien, Emily C., Matthew T. Roe, Elizabeth S. Fraulo, Eric D. Peterson, Christie M. Ballantyne, Jacques Genest, Samuel S. Gidding, et al. “Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry..” Am Heart J 167, no. 3 (March 2014): 342-349.e17. https://doi.org/10.1016/j.ahj.2013.12.008.Full Text Link to Item
-
Shavelle, David M., Anita Y. Chen, Ray V. Matthews, Matthew T. Roe, James A. de Lemos, James Jollis, Joseph L. Thomas, William J. French, and William J. ACTION-GWTG Investigators. “Predictors of reperfusion delay in patients with ST elevation myocardial infarction self-transported to the hospital (from the American Heart Association's Mission: Lifeline Program)..” Am J Cardiol 113, no. 5 (March 1, 2014): 798–802. https://doi.org/10.1016/j.amjcard.2013.11.036.Full Text Link to Item
-
Xian, Ying, Anita Y. Chen, Laine Thomas, Matthew T. Roe, Sumeet Subherwal, Christopher P. Cannon, Charles V. Pollack, et al. “Sources of hospital-level variation in major bleeding among patients with non-st-segment elevation myocardial infarction: a report from the National Cardiovascular Data Registry (NCDR)..” Circ Cardiovasc Qual Outcomes 7, no. 2 (March 2014): 236–43. https://doi.org/10.1161/CIRCOUTCOMES.113.000715.Full Text Link to Item
-
Diepen, Sean van, Anita Y. Chen, Tracy Y. Wang, Karen P. Alexander, Justin A. Ezekowitz, Eric D. Peterson, and Matthew T. Roe. “Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction..” Am Heart J 167, no. 2 (February 2014): 267-273.e1. https://doi.org/10.1016/j.ahj.2013.11.005.Full Text Link to Item
-
Kang, Hyun-Jae, and Matthew T. Roe. “Lessons learned from negative clinical trials evaluating antithrombotic therapy for ischemic heart disease..” J Cardiovasc Transl Res 7, no. 1 (February 2014): 112–25. https://doi.org/10.1007/s12265-013-9532-6.Full Text Link to Item
-
Patel, Jigar H., Raghav Gupta, Matthew T. Roe, S Andrew Peng, Stephen D. Wiviott, and Jorge F. Saucedo. “Influence of presenting electrocardiographic findings on the treatment and outcomes of patients with non-ST-segment elevation myocardial infarction..” Am J Cardiol 113, no. 2 (January 15, 2014): 256–61. https://doi.org/10.1016/j.amjcard.2013.09.009.Full Text Link to Item
-
Chin, Chee Tang, Tracy Y. Wang, Anita Y. Chen, Robin Mathews, Karen P. Alexander, Matthew T. Roe, and Eric D. Peterson. “Trends in outcomes among older patients with non-ST-segment elevation myocardial infarction..” Am Heart J 167, no. 1 (January 2014): 36-42.e1. https://doi.org/10.1016/j.ahj.2013.10.008.Full Text Link to Item
-
Harskamp, R. E., T. Y. Wang, D. L. Bhatt, S. D. Wiviott, E. A. Amsterdam, S. Li, L. Thomas, R. J. De Winter, and M. T. Roe. “Hospital patterns of medical management strategy use for patients with non-ST-elevation myocardial infarction and 3-vessel or left main coronary artery disease.” American Heart Journal 167, no. 3 (2014): 355-362.e3.
-
Kang, H. -. J., and M. T. Roe. “Lessons learned from negative clinical trials evaluating antithrombotic therapy for ischemic heart disease.” Journal of Cardiovascular Translational Research 7, no. 1 (2014): 112–25.
-
O’Brien, E. C., M. T. Roe, E. S. Fraulo, E. D. Peterson, C. M. Ballantyne, J. Genest, S. S. Gidding, et al. “Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.” American Heart Journal 167, no. 3 (2014): 342-349.e17.
-
O’Brien, Emily C., Emil L. Fosbol, S Andrew Peng, Karen P. Alexander, Matthew T. Roe, and Eric D. Peterson. “Association of body mass index and long-term outcomes in older patients with non-ST-segment-elevation myocardial infarction: results from the CRUSADE Registry..” Circ Cardiovasc Qual Outcomes 7, no. 1 (January 2014): 102–9. https://doi.org/10.1161/CIRCOUTCOMES.113.000421.Full Text Link to Item
-
Desai, Nihar R., Eric D. Peterson, Anita Y. Chen, Stephen D. Wiviott, Marc S. Sabatine, Karen P. Alexander, Matthew T. Roe, and Bimal R. Shah. “Balancing the risk of mortality and major bleeding in the treatment of NSTEMI patients - a report from the National Cardiovascular Data Registry..” Am Heart J 166, no. 6 (December 2013): 1043-1049.e1. https://doi.org/10.1016/j.ahj.2013.09.004.Full Text Link to Item
-
Shen, Lan, Eric D. Peterson, Shuang Li, Laine Thomas, Karen Alexander, Ying Xian, Tracy Y. Wang, Matthew T. Roe, Ben He, and Bimal R. Shah. “The association between smoking and long-term outcomes after non-ST-segment elevation myocardial infarction in older patients..” Am Heart J 166, no. 6 (December 2013): 1056–62. https://doi.org/10.1016/j.ahj.2013.09.011.Full Text Link to Item
-
Xu, Weixian, Dajuanicia N. Holmes, Richard C. Becker, Matthew T. Roe, Eric D. Peterson, and Tracy Y. Wang. “Comparison of long-term outcomes between older Asian and white patients with non-ST-segment elevation myocardial infarction: findings from CRUSADE-CMS database..” Am Heart J 166, no. 6 (December 2013): 1050–55. https://doi.org/10.1016/j.ahj.2013.10.001.Full Text Link to Item
-
Masoudi, Frederick A., Angelo Ponirakis, Robert W. Yeh, Thomas M. Maddox, Jim Beachy, Paul N. Casale, Jeptha P. Curtis, et al. “Cardiovascular care facts: a report from the national cardiovascular data registry: 2011..” J Am Coll Cardiol 62, no. 21 (November 19, 2013): 1931–47. https://doi.org/10.1016/j.jacc.2013.05.099.Full Text Link to Item
-
Anderson, Monique L., Eric D. Peterson, S Andrew Peng, Tracy Y. Wang, E Magnus Ohman, Deepak L. Bhatt, Jorge F. Saucedo, and Matthew T. Roe. “Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDR..” Circ Cardiovasc Qual Outcomes 6, no. 6 (November 2013): 708–15. https://doi.org/10.1161/CIRCOUTCOMES.113.000262.Full Text Link to Item
-
Fosbol, Emil L., Tracy Y. Wang, Shuang Li, Jonathan Piccini, Renato D. Lopes, Roger M. Mills, Winslow Klaskala, Laine Thomas, Matthew T. Roe, and Eric D. Peterson. “Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy..” Am Heart J 166, no. 5 (November 2013): 864–70. https://doi.org/10.1016/j.ahj.2013.08.005.Full Text Link to Item
-
Wang, Tracy Y., Lisa A. McCoy, John C. Messenger, Megan L. Neely, Kalon K. L. Ho, Matthew T. Roe, and H Vernon Anderson. “Cardiac biomarker measurement after elective percutaneous coronary interventions in older patients: insights from the National Cardiovascular Data Registry..” Am Heart J 166, no. 5 (November 2013): 927–34. https://doi.org/10.1016/j.ahj.2013.09.007.Full Text Link to Item
-
Acharjee, Subroto, Matthew T. Roe, Ezra A. Amsterdam, DaJuanicia N. Holmes, and William E. Boden. “Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry)..” Am J Cardiol 112, no. 8 (October 15, 2013): 1057–62. https://doi.org/10.1016/j.amjcard.2013.05.050.Full Text Link to Item
-
Diepen, Sean van, L Kristin Newby, Renato D. Lopes, Amanda Stebbins, Vic Hasselblad, Stefan James, Matthew T. Roe, et al. “Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy..” Int J Cardiol 168, no. 3 (October 3, 2013): 2127–33. https://doi.org/10.1016/j.ijcard.2013.01.004.Full Text Link to Item
-
Hess, Connie N., Bimal R. Shah, S Andrew Peng, Laine Thomas, Matthew T. Roe, and Eric D. Peterson. “Association of early physician follow-up and 30-day readmission after non-ST-segment-elevation myocardial infarction among older patients..” Circulation 128, no. 11 (September 10, 2013): 1206–13. https://doi.org/10.1161/CIRCULATIONAHA.113.004569.Full Text Link to Item
-
Peacock, W Frank, Michael C. Kontos, Ezra Amsterdam, Christopher P. Cannon, Deborah Diercks, Lee Garvey, Louis Graff, et al. “Impact of Society of Cardiovascular Patient Care accreditation on quality: an ACTION Registry®-Get With The Guidelines™ analysis..” Crit Pathw Cardiol 12, no. 3 (September 2013): 116–20. https://doi.org/10.1097/HPC.0b013e31828940e3.Full Text Link to Item
-
Roe, Matthew T., Shaun G. Goodman, E Magnus Ohman, Susanna R. Stevens, Judith S. Hochman, Shmuel Gottlieb, Felipe Martinez, et al. “Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel..” Circulation 128, no. 8 (August 20, 2013): 823–33. https://doi.org/10.1161/CIRCULATIONAHA.113.002303.Full Text Link to Item
-
Wiviott, Stephen D., Harvey D. White, E Magnus Ohman, Keith A. A. Fox, Paul W. Armstrong, Dorairaj Prabhakaran, Gail Hafley, et al. “Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial..” Lancet 382, no. 9892 (August 17, 2013): 605–13. https://doi.org/10.1016/S0140-6736(13)61451-8.Full Text Link to Item
-
Bagai, Akshay, Anita Y. Chen, Tracy Y. Wang, Karen P. Alexander, Laine Thomas, E Magnus Ohman, Judith S. Hochman, Eric D. Peterson, and Matthew T. Roe. “Long-term outcomes among older patients with non-ST-segment elevation myocardial infarction complicated by cardiogenic shock..” Am Heart J 166, no. 2 (August 2013): 298–305. https://doi.org/10.1016/j.ahj.2013.05.003.Full Text Link to Item
-
Borden, William B., John A. Spertus, Alvin I. Mushlin, Matthew T. Roe, Lisa A. McCoy, and Rita F. Redberg. “Antianginal therapy before percutaneous coronary intervention..” Circ Cardiovasc Interv 6, no. 4 (August 2013): 436–43. https://doi.org/10.1161/CIRCINTERVENTIONS.112.000215.Full Text Link to Item
-
Scirica, Benjamin M., Mitul B. Kadakia, James A. de Lemos, Matthew T. Roe, David A. Morrow, Shuang Li, Stephen D. Wiviott, Michael C. Kontos, and Michael C. National Cardiovascular Data Registry. “Association between natriuretic peptides and mortality among patients admitted with myocardial infarction: a report from the ACTION Registry(R)-GWTG™..” Clin Chem 59, no. 8 (August 2013): 1205–14. https://doi.org/10.1373/clinchem.2012.198556.Full Text Link to Item
-
Bagai, Akshay, James G. Jollis, Harold L. Dauerman, S Andrew Peng, Ivan C. Rokos, Eric R. Bates, William J. French, Christopher B. Granger, and Matthew T. Roe. “Emergency department bypass for ST-Segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline program..” Circulation 128, no. 4 (July 23, 2013): 352–59. https://doi.org/10.1161/CIRCULATIONAHA.113.002339.Full Text Link to Item
-
Cannon, Christopher P., Ralph G. Brindis, Bernard R. Chaitman, David J. Cohen, J Thomas Cross, Joseph P. Drozda, Francis M. Fesmire, et al. “2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards)..” Crit Pathw Cardiol 12, no. 2 (June 2013): 65–105. https://doi.org/10.1097/HPC.0b013e3182846e16.Full Text Link to Item
-
Anderson, H Vernon, William S. Weintraub, Martha J. Radford, Mark S. Kremers, Matthew T. Roe, Richard E. Shaw, Dana M. Pinchotti, and James E. Tcheng. “Standardized cardiovascular data for clinical research, registries, and patient care: a report from the Data Standards Workgroup of the National Cardiovascular Research Infrastructure project..” J Am Coll Cardiol 61, no. 18 (May 7, 2013): 1835–46. https://doi.org/10.1016/j.jacc.2012.12.047.Full Text Link to Item
-
Roe, Matthew T., Shuang Li, Laine Thomas, Tracy Y. Wang, Karen P. Alexander, E Magnus Ohman, and Eric D. Peterson. “Long-term outcomes after invasive management for older patients with non-ST-segment elevation myocardial infarction..” Circ Cardiovasc Qual Outcomes 6, no. 3 (May 1, 2013): 323–32. https://doi.org/10.1161/CIRCOUTCOMES.113.000120.Full Text Link to Item
-
Subherwal, Sumeet, E Magnus Ohman, Kenneth W. Mahaffey, Sunil V. Rao, John H. Alexander, Tracy Y. Wang, Karen P. Alexander, Vic Hasselblad, and Matthew T. Roe. “Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches..” Am Heart J 165, no. 5 (May 2013): 644-654.e1. https://doi.org/10.1016/j.ahj.2012.11.012.Full Text Link to Item
-
Hanna, Elias B., Karen P. Alexander, Anita Y. Chen, Matthew T. Roe, Marjorie Funk, and Jorge F. Saucedo. “Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction undergoing an invasive strategy according to hemoglobin levels..” Am J Cardiol 111, no. 8 (April 15, 2013): 1099–1103. https://doi.org/10.1016/j.amjcard.2012.12.041.Full Text Link to Item
-
Cannon, Christopher P., Ralph G. Brindis, Bernard R. Chaitman, David J. Cohen, J Thomas Cross, Joseph P. Drozda, Francis M. Fesmire, et al. “2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on clinical data standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards)..” J Am Coll Cardiol 61, no. 9 (March 5, 2013): 992–1025. https://doi.org/10.1016/j.jacc.2012.10.005.Full Text Link to Item
-
Cannon, Christopher P., Ralph G. Brindis, Bernard R. Chaitman, David J. Cohen, J Thomas Cross, Joseph P. Drozda, Francis M. Fesmire, et al. “2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards)..” Circulation 127, no. 9 (March 5, 2013): 1052–89. https://doi.org/10.1161/CIR.0b013e3182831a11.Full Text Link to Item
-
Harrison, Robert W., Atul Aggarwal, Fang-shu Ou, Lloyd W. Klein, John S. Rumsfeld, Matthew T. Roe, Tracy Y. Wang, and Tracy Y. American College of Cardiology National Cardiovascular Data Registry. “Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction..” Am J Cardiol 111, no. 2 (January 15, 2013): 178–84. https://doi.org/10.1016/j.amjcard.2012.09.015.Full Text Link to Item
-
Roe, Matthew T., E Magnus Ohman, and E Magnus TRILOGY ACS Investigators. “Prasugrel versus clopidogrel for acute coronary syndromes..” N Engl J Med 368, no. 2 (January 10, 2013): 188–89. https://doi.org/10.1056/NEJMc1213509.Full Text Link to Item
-
Enriquez, Jonathan R., James A. de Lemos, Shailja V. Parikh, S Andrew Peng, John A. Spertus, Elizabeth M. Holper, Matthew T. Roe, Anand Rohatgi, and Sandeep R. Das. “Association of chronic lung disease with treatments and outcomes patients with acute myocardial infarction..” Am Heart J 165, no. 1 (January 2013): 43–49. https://doi.org/10.1016/j.ahj.2012.09.010.Full Text Link to Item
-
Riley, Robert F., L Kristin Newby, Creighton W. Don, Matthew T. Roe, DaJuanicia N. Holmes, Sanjay K. Gandhi, Michael A. Kutcher, and David M. Herrington. “Diagnostic time course, treatment, and in-hospital outcomes for patients with ST-segment elevation myocardial infarction presenting with nondiagnostic initial electrocardiogram: a report from the American Heart Association Mission: Lifeline program..” Am Heart J 165, no. 1 (January 2013): 50–56. https://doi.org/10.1016/j.ahj.2012.10.027.Full Text Link to Item
-
Dehmer, G. J., D. Weaver, M. T. Roe, S. Milford-Beland, S. Fitzgerald, A. Hermann, J. Messenger, et al. “Erratum: A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the united states: A report from the cathpci registry of the national cardiovascular data registry, 2010 through june 2011 (Journal of the American College of Cardiology (2012) 60 (2017-31)).” Journal of the American College of Cardiology 60, no. 24 (December 18, 2012): 2605–6. https://doi.org/10.1016/j.jacc.2012.10.014.Full Text
-
Owan, Theophilus E., Matthew T. Roe, John C. Messenger, David Dai, and Andrew D. Michaels. “Contemporary use of adjunctive thrombectomy during primary percutaneous coronary intervention for ST-elevation myocardial infarction in the United States..” Catheter Cardiovasc Interv 80, no. 7 (December 1, 2012): 1173–80. https://doi.org/10.1002/ccd.24306.Full Text Link to Item
-
Bagai, Akshay, James G. Iollis, Harold L. Dauerman, S Andrew Peng, Eric R. Bates, William J. French, Christopher B. Granger, and Matthew T. Roe. “Bypassing the Emergency Department is Associated with Faster Reperfusion in Patients with Pre-Hospital ST-Segment Elevation: Findings from the ACTION Registry (R)-GWTG (TM).” Circulation 126, no. 21 (November 20, 2012).Link to Item
-
Hall, Hurst M., Jonathan R. Enriquez, James A. de Lemos, Nihar Desai, S Andrew Peng, Karen P. Alexander, Matthew T. Roe, Darren K. McGuire, Stephen D. Wiviott, and Sandeep R. Das. “Patterns of Discharge Aspirin Dosing in 213,344 US Patients after Acute Myocardial Infarction: Results from the NCDR.” Circulation 126, no. 21 (November 20, 2012).Link to Item
-
Hess, Connie N., S Andrew Peng, Laine Thomas, Matthew T. Roe, Bimal R. Shah, and Eric D. Peterson. “Relationship of Early Physician Follow-Up and 30-Day Readmission after Non-ST-Segment Elevation Myocardial Infarction Among Older Patients.” Circulation 126, no. 21 (November 20, 2012).Link to Item
-
Miller, Amy L., DaJuanicia Holmes, Matthew T. Roe, Michael C. Kontos, Deborah B. Diercks, Ezra Amsterdam, Deepak L. Bhatt, and Tracy Y. Wang. “Patient and Neighborhood Factors Associated with Presentation Delay in ST-Elevation Myocardial Infarction: Insights from the NCDR (R).” Circulation 126, no. 21 (November 20, 2012).Link to Item
-
Nicholson, Benjamin D., Harinder S. Dhindsa, Matthew T. Roe, Anita Y. Chen, James G. Jollis, and Michael C. Kontos. “Distance, Treatment Strategy, and Mode of Transfer for Primary PCI in Patients Presenting to a Hospital Without PCI Capability: A Report from ACTION Registry (R)-GWTG (TM) and The AHA Mission: Lifeline Program.” Circulation 126, no. 21 (November 20, 2012).Link to Item
-
Pappy, Reji M., Anita Y. Chen, Talla A. Rousan, Matthew T. Roe, and Jorge F. Saucedo. “Impact of Diabetes on Clinical Findings, Management, and In-Hospital Outcomes in Non ST Elevation and ST Elevation Myocardial Infarction: An Analysis from the NCDR (R).” Circulation 126, no. 21 (November 20, 2012).Link to Item
-
Patel, Jigar H., Raghav Gupta, Matthew T. Roe, S. A. Peng, and Jorge F. Saucedo. “The Influence of Presenting Electrocardiographic Findings on the Treatment and Outcomes of Patients With Non-ST-elevation Myocardial Infarction (NSTEMI).” Circulation 126, no. 21 (November 20, 2012).Link to Item
-
Rousan, Talla A., Anita Y. Chen, Reji M. Pappy, Matthew T. Roe, and Jorge F. Saucedo. “Clinical Characteristics and Outcomes of Patients With Insulin Receiving and Non-Insulin Receiving Diabetes Mellitus Presenting With Myocardial Infarction: An Analysis From The NCDR.” Circulation 126, no. 21 (November 20, 2012).Link to Item
-
Shen, Lan, Shuang Li, Laine Thomas, Tracy Y. Wang, Karen Alexander, Eric Peterson, Matthew T. Roe, and Bimal Shah. “The Impact of Smoking on Short- and Long-Term Outcomes in NSTEMI Results from 38,628 Patients from the CRUSADE Registry.” Circulation 126, no. 21 (November 20, 2012).Link to Item
-
Dehmer, Gregory J., Douglas Weaver, Matthew T. Roe, Sarah Milford-Beland, Susan Fitzgerald, Anthony Hermann, John Messenger, et al. “A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011..” J Am Coll Cardiol 60, no. 20 (November 13, 2012): 2017–31. https://doi.org/10.1016/j.jacc.2012.08.966.Full Text Link to Item
-
Gurbel, P. A., D. Erlinge, E. M. Ohman, B. Neely, M. Neely, S. G. Goodman, K. Huber, et al. “Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization: The TRILOGY ACS Platelet Function Substudy..” Jama, November 4, 2012, 1–10. https://doi.org/10.1001/jama.2012.17312.Full Text Link to Item
-
Li, Yiding, Bee-Choo Tai, Winnie Sia, Qian-Hui Phua, Mark A. Richards, Adrian Low, Koo-Hui Chan, et al. “Angiographic and platelet reactivity outcomes with prasugrel 60 mg pretreatment and clopidogrel 600 mg pretreatment in primary percutaneous coronary intervention..” J Thromb Thrombolysis 34, no. 4 (November 2012): 499–505. https://doi.org/10.1007/s11239-012-0782-y.Full Text Link to Item
-
Parikh, Nisha I., Emily F. Honeycutt, Matthew T. Roe, Megan Neely, Eric J. Rosenthal, Murray A. Mittleman, Joseph P. Carrozza, and Kalon K. L. Ho. “Left and codominant coronary artery circulations are associated with higher in-hospital mortality among patients undergoing percutaneous coronary intervention for acute coronary syndromes: report From the National Cardiovascular Database Cath Percutaneous Coronary Intervention (CathPCI) Registry..” Circulation. Cardiovascular Quality and Outcomes 5, no. 6 (November 2012): 775–82. https://doi.org/10.1161/circoutcomes.111.964593.Full Text
-
Vavalle, John P., Renato D. Lopes, Anita Y. Chen, L Kristin Newby, Tracy Y. Wang, Bimal R. Shah, P Michael Ho, et al. “Hospital length of stay in patients with non-ST-segment elevation myocardial infarction..” Am J Med 125, no. 11 (November 2012): 1085–94. https://doi.org/10.1016/j.amjmed.2012.04.038.Full Text Link to Item
-
Roe, Matthew T., Paul W. Armstrong, Keith A. A. Fox, Harvey D. White, Dorairaj Prabhakaran, Shaun G. Goodman, Jan H. Cornel, et al. “Prasugrel versus clopidogrel for acute coronary syndromes without revascularization..” N Engl J Med 367, no. 14 (October 4, 2012): 1297–1309. https://doi.org/10.1056/NEJMoa1205512.Full Text Link to Item
-
Leonardi, Sergio, Anita Y. Chen, S Michael Gharacholou, Tracy Y. Wang, James A. de Lemos, Jorge F. Saucedo, Eric D. Peterson, and Matthew T. Roe. “Limitations of using cardiac catheterization rates to assess the quality of care for patients with non-ST-segment elevation myocardial infarction..” Am Heart J 164, no. 4 (October 2012): 502–8. https://doi.org/10.1016/j.ahj.2012.07.005.Full Text Link to Item
-
Lopes, Renato D., Sumeet Subherwal, Dajuanicia N. Holmes, Laine Thomas, Tracy Y. Wang, Sunil V. Rao, Erik Magnus Ohman, Matthew T. Roe, Eric D. Peterson, and Karen P. Alexander. “The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction..” Eur Heart J 33, no. 16 (August 2012): 2044–53. https://doi.org/10.1093/eurheartj/ehs012.Full Text Link to Item
-
Diepen, Sean van, Matthew T. Roe, Renato D. Lopes, Amanda Stebbins, Stefan James, L Kristin Newby, David J. Moliterno, et al. “Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial..” J Thromb Thrombolysis 34, no. 1 (July 2012): 106–13. https://doi.org/10.1007/s11239-012-0691-0.Full Text Link to Item
-
Eapen, Zubin J., WH Wilson Tang, G Michael Felker, Adrian F. Hernandez, Kenneth W. Mahaffey, A Michael Lincoff, and Matthew T. Roe. “Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward..” Circ Cardiovasc Qual Outcomes 5, no. 4 (July 1, 2012): 594–600. https://doi.org/10.1161/CIRCOUTCOMES.112.966150.Full Text Link to Item
-
Gurbel, Paul A., Matthew T. Roe, Joseph A. Jakubowski, Svathi Shah, David Erlinge, Shaun G. Goodman, Kurt Huber, et al. “Translational platelet research in patients with coronary artery disease: what are the major knowledge gaps?.” Thromb Haemost 108, no. 1 (July 2012): 12–20. https://doi.org/10.1160/TH12-01-0039.Full Text Link to Item
-
Hanna, Elias B., Anita Y. Chen, Matthew T. Roe, and Jorge F. Saucedo. “Characteristics and in-hospital outcomes of patients presenting with non-ST-segment elevation myocardial infarction found to have significant coronary artery disease on coronary angiography and managed medically: stratification according to renal function..” American Heart Journal 164, no. 1 (July 2012): 52-7.e1. https://doi.org/10.1016/j.ahj.2012.04.009.Full Text
-
Subherwal, Sumeet, Deepak L. Bhatt, Shuang Li, Tracy Y. Wang, Laine Thomas, Karen P. Alexander, Manesh R. Patel, et al. “Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction..” Circ Cardiovasc Qual Outcomes 5, no. 4 (July 1, 2012): 541–49. https://doi.org/10.1161/CIRCOUTCOMES.111.964379.Full Text Link to Item
-
Subherwal, Sumeet, Eric D. Peterson, David Dai, Laine Thomas, John C. Messenger, Ying Xian, Ralph G. Brindis, et al. “Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry..” J Am Coll Cardiol 59, no. 21 (May 22, 2012): 1861–69. https://doi.org/10.1016/j.jacc.2011.12.045.Full Text Link to Item
-
Duffy, Danielle, Dajuanicia N. Holmes, Matthew T. Roe, and Eric D. Peterson. “The impact of high-density lipoprotein cholesterol levels on long-term outcomes after non-ST-elevation myocardial infarction..” Am Heart J 163, no. 4 (April 2012): 705–13. https://doi.org/10.1016/j.ahj.2012.01.029.Full Text Link to Item
-
Fosbol, Emil L., Tracy Y. Wang, Shuang Li, Jonathan P. Piccini, Renato D. Lopes, Bimal Shah, Roger M. Mills, et al. “Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction..” Am Heart J 163, no. 4 (April 2012): 720–28. https://doi.org/10.1016/j.ahj.2012.01.017.Full Text Link to Item
-
Subherwal, Sumeet, Eric D. Peterson, Anita Y. Chen, Matthew T. Roe, Jeffrey B. Washam, Brian F. Gage, Richard G. Bach, et al. “Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry..” Circulation 125, no. 11 (March 20, 2012): 1414–23. https://doi.org/10.1161/CIRCULATIONAHA.111.059188.Full Text Link to Item
-
Roe, Matthew T., Jennifer A. White, Padma Kaul, Pierluigi Tricoci, Yuliya Lokhnygina, Chadwick D. Miller, Arnoud W. van’t Hof, et al. “Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial..” Circ Cardiovasc Qual Outcomes 5, no. 2 (March 1, 2012): 205–13. https://doi.org/10.1161/CIRCOUTCOMES.111.962332.Full Text Link to Item
-
Yeo, Khung Keong, Shuang Li, Ezra A. Amsterdam, Tracy Y. Wang, Deepak L. Bhatt, Jorge F. Saucedo, Michael C. Kontos, Matthew T. Roe, and William J. French. “Comparison of clinical characteristics, treatments and outcomes of patients with ST-elevation acute myocardial infarction with versus without new or presumed new left bundle branch block (from NCDR®)..” Am J Cardiol 109, no. 4 (February 15, 2012): 497–501. https://doi.org/10.1016/j.amjcard.2011.09.040.Full Text Link to Item
-
Fox, Caroline S., Paul Muntner, Anita Y. Chen, Karen P. Alexander, Matthew T. Roe, and Stephen D. Wiviott. “Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry..” Circulation 125, no. 3 (January 24, 2012): 497–504. https://doi.org/10.1161/CIRCULATIONAHA.111.039909.Full Text Link to Item
-
Roe, Matthew T., and E Magnus Ohman. “A new era in secondary prevention after acute coronary syndrome..” N Engl J Med 366, no. 1 (January 5, 2012): 85–87. https://doi.org/10.1056/NEJMe1112770.Full Text Link to Item
-
Chin, Chee Tang, Tracy Y. Wang, Shuang Li, Stephen D. Wiviott, James A. deLemos, Michael C. Kontos, Eric D. Peterson, and Matthew T. Roe. “Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines..” Clin Cardiol 35, no. 7 (2012): 424–29. https://doi.org/10.1002/clc.21980.Full Text Link to Item
-
Das, Sandeep R., Karen P. Alexander, Anita Y. Chen, Tiffany M. Powell-Wiley, Deborah B. Diercks, Eric D. Peterson, Matthew T. Roe, and James A. de Lemos. “Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry)..” J Am Coll Cardiol 58, no. 25 (December 13, 2011): 2642–50. https://doi.org/10.1016/j.jacc.2011.09.030.Full Text Link to Item
-
Acharjee, Subroto, Matthew T. Roe, Ezra A. Amsterdam, DaJuanicia Holmes, and William E. Boden. “Low Levels of High-Density Lipoprotein Cholesterol (HDL-C) at Presentation in Acute Coronary Syndromes (ACS) and its Relation to Angiographically-Observed Atherosclerotic Burden: Results from the NCDR (R).” Circulation 124, no. 21 (November 22, 2011).Link to Item
-
Acharjee, Subroto, Matthew T. Roe, Ezra A. Amsterdam, DaJuanicia Holmes, and William E. Boden. “Prevalence of Low Levels of High-Density Lipoprotein Cholesterol (HDL-C) at Presentation in Acute Coronary Syndromes (ACS) and its Relation to In-Hospital Mortality: Results from the NCDR (R).” Circulation 124, no. 21 (November 22, 2011).Link to Item
-
Kuijt, Wichert J., Mitchell W. Krucoff, Peter Damman, Renato D. Lopes, Cindy L. Green, Karen S. Pieper, Susanna R. Stevens, et al. “Prediction of Myocardial Infarct Size Using Multiple Concomitant Angiographic, Biochemical and Electrocardiographic Biomarkers in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.” Circulation 124, no. 21 (November 22, 2011).Link to Item
-
Subherwal, Sumeet, Matthew T. Roe, Dajuanicia Holmes, Laine Thomas, Karen P. Alexander, Tracy Y. Wang, and Eric D. Peterson. “Comparison of Non-ST Segment Myocardial Infarction One-Year Outcomes at Academic vs Non-Academic Hospitals.” Circulation 124, no. 21 (November 22, 2011).Link to Item
-
Brilakis, E. S., S. V. Rao, S. Banerjee, S. Goldman, K. A. Shunk, D. R. Holmes, E. Honeycutt, and M. T. Roe. “Reply.” Jacc: Cardiovascular Interventions 4, no. 11 (November 1, 2011). https://doi.org/10.1016/j.jcin.2011.10.001.Full Text
-
Melloni, Chiara, Matthew T. Roe, Anita Y. Chen, Tracy Y. Wang, Stephen D. Wiviott, P Michael Ho, Eric D. Peterson, and Karen P. Alexander. “Use of early clopidogrel by reperfusion strategy among patients presenting with ST-segment elevation myocardial infarction..” Circ Cardiovasc Qual Outcomes 4, no. 6 (November 1, 2011): 603–9. https://doi.org/10.1161/CIRCOUTCOMES.111.961045.Full Text Link to Item
-
Roe, Matthew T., Anita Y. Chen, Laine Thomas, Tracy Y. Wang, Karen P. Alexander, Bradley G. Hammill, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score..” Am Heart J 162, no. 5 (November 2011): 875-883.e1. https://doi.org/10.1016/j.ahj.2011.08.010.Full Text Link to Item
-
Rao, Sunil V., Lisa A. Kaltenbach, William S. Weintraub, Matthew T. Roe, Ralph G. Brindis, John S. Rumsfeld, and Eric D. Peterson. “Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients..” Jama 306, no. 13 (October 5, 2011): 1461–67. https://doi.org/10.1001/jama.2011.1409.Full Text Link to Item
-
Hanna, Elias B., Anita Y. Chen, Matthew T. Roe, Stephen D. Wiviott, Caroline S. Fox, and Jorge F. Saucedo. “Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention..” Jacc Cardiovasc Interv 4, no. 9 (September 2011): 1002–8. https://doi.org/10.1016/j.jcin.2011.05.022.Full Text Link to Item
-
Brilakis, Emmanouil S., Sunil V. Rao, Subhash Banerjee, Steven Goldman, Kendrick A. Shunk, David R. Holmes, Emily Honeycutt, and Matthew T. Roe. “Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry..” Jacc Cardiovasc Interv 4, no. 8 (August 2011): 844–50. https://doi.org/10.1016/j.jcin.2011.03.018.Full Text Link to Item
-
Mathews, Robin, Eric D. Peterson, Shuang Li, Matthew T. Roe, Seth W. Glickman, Stephen D. Wiviott, Jorge F. Saucedo, Elliott M. Antman, Alice K. Jacobs, and Tracy Y. Wang. “Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines..” Circulation 124, no. 2 (July 12, 2011): 154–63. https://doi.org/10.1161/CIRCULATIONAHA.110.002345.Full Text Link to Item
-
Wang, Tracy Y., Brahmajee K. Nallamothu, Harlan M. Krumholz, Shuang Li, Matthew T. Roe, James G. Jollis, Alice K. Jacobs, David R. Holmes, Eric D. Peterson, and Henry H. Ting. “Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention..” Jama 305, no. 24 (June 22, 2011): 2540–47. https://doi.org/10.1001/jama.2011.862.Full Text Link to Item
-
James, Stefan K., Matthew T. Roe, Christopher P. Cannon, Jan H. Cornel, Jay Horrow, Steen Husted, Hugo Katus, et al. “Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial..” Bmj 342 (June 17, 2011). https://doi.org/10.1136/bmj.d3527.Full Text Link to Item
-
Abtahian, Farhad, Benjamin Olenchock, Fang-Shu Ou, Michael C. Kontos, Jorge F. Saucedo, Benjamin M. Scirica, Nihar Desai, et al. “Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry)..” Am J Cardiol 107, no. 10 (May 15, 2011): 1441–46. https://doi.org/10.1016/j.amjcard.2011.01.020.Full Text Link to Item
-
Kontos, Michael C., Debra B. Diercks, P Michael Ho, Tracy Y. Wang, Anita Y. Chen, and Matthew T. Roe. “Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: results from the American College of Cardiology's NCDR(®)..” Am Heart J 161, no. 5 (May 2011): 864–70. https://doi.org/10.1016/j.ahj.2011.01.006.Full Text Link to Item
-
Ohman, E. M., and M. T. Roe. “Explaining the unexpected: insights from the PLATelet inhibition and clinical Outcomes (PLATO) trial comparing ticagrelor and clopidogrel. Editorial on Serebruany "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5)..” Thromb Haemost 105, no. 5 (May 2011): 763–65. https://doi.org/10.1160/TH11-03-0159.Full Text Link to Item
-
Mathews, Robin, Eric D. Peterson, Anita Y. Chen, Tracy Y. Wang, Chee Tang Chin, Gregg C. Fonarow, Christopher P. Cannon, John S. Rumsfeld, Matthew T. Roe, and Karen P. Alexander. “In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™..” Am J Cardiol 107, no. 8 (April 15, 2011): 1136–43. https://doi.org/10.1016/j.amjcard.2010.12.009.Full Text Link to Item
-
Britton, Kathryn A., Vikas Aggarwal, Anita Y. Chen, Karen P. Alexander, Ezra Amsterdam, Elizabeth Fraulo, Paul Muntner, et al. “No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction..” Am Heart J 161, no. 4 (April 2011): 657-663.e1. https://doi.org/10.1016/j.ahj.2010.12.004.Full Text Link to Item
-
Don, Creighton W., Matthew T. Roe, Shuang Li, Elizabeth Fraulo, Eugene Pomerantsev, Igor Palacios, and Stephen D. Wiviott. “Temporal trends and practice variations in clopidogrel loading doses in patients with non-ST-segment elevation myocardial infarction, from the National Cardiovascular Data Registry..” Am Heart J 161, no. 4 (April 2011): 689–97. https://doi.org/10.1016/j.ahj.2010.12.025.Full Text Link to Item
-
Mahaffey, Kenneth W., Karen S. Pieper, Yuliya Lokhnygina, Robert M. Califf, Elliott M. Antman, Neal S. Kleiman, Shaun G. Goodman, et al. “The impact of postrandomization crossover of therapy in acute coronary syndromes care..” Circ Cardiovasc Qual Outcomes 4, no. 2 (March 2011): 211–19. https://doi.org/10.1161/CIRCOUTCOMES.109.853598.Full Text Link to Item
-
Alexander, Karen P., Tracy Y. Wang, Shuang Li, Barbara L. Lytle, Lara E. Slattery, Sarah Calhoun, Jennifer Poteat, et al. “Randomized trial of targeted performance feedback to facilitate quality improvement in acute myocardial infarction care..” Circ Cardiovasc Qual Outcomes 4, no. 1 (January 1, 2011): 129–35. https://doi.org/10.1161/CIRCOUTCOMES.110.958470.Full Text Link to Item
-
Burjonroppa, Sukesh C., Paul D. Varosy, Sunil V. Rao, Fang-Shu Ou, Matthew Roe, Eric Peterson, Mandeep Singh, and Kendrick A. Shunk. “Survival of patients undergoing rescue percutaneous coronary intervention: development and validation of a predictive tool..” Jacc Cardiovasc Interv 4, no. 1 (January 2011): 42–50. https://doi.org/10.1016/j.jcin.2010.09.020.Full Text Link to Item
-
Chin, Chee Tang, Anita Y. Chen, Tracy Y. Wang, Karen P. Alexander, Robin Mathews, John S. Rumsfeld, Christopher P. Cannon, Gregg C. Fonarow, Eric D. Peterson, and Matthew T. Roe. “Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the acute coronary treatment and intervention outcomes network (ACTION) registry-get with the guidelines (GWTG) acute myocardial infarction mortality model and risk score..” Am Heart J 161, no. 1 (January 2011): 113-122.e2. https://doi.org/10.1016/j.ahj.2010.10.004.Full Text Link to Item
-
Wang, Tracy Y., Eric D. Peterson, Fang-Shu Ou, Brahmajee K. Nallamothu, John S. Rumsfeld, and Matthew T. Roe. “Door-to-balloon times for patients with ST-segment elevation myocardial infarction requiring interhospital transfer for primary percutaneous coronary intervention: a report from the national cardiovascular data registry..” Am Heart J 161, no. 1 (January 2011): 76-83.e1. https://doi.org/10.1016/j.ahj.2010.10.001.Full Text Link to Item
-
Melloni, Chiara, Bimal R. Shah, Fang-Shu Ou, Matthew T. Roe, Sidney C. Smith, Charles V. Pollack, Magnus Ohman, W Brian Gibler, Eric D. Peterson, and Karen P. Alexander. “Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registry..” Am Heart J 160, no. 6 (December 2010): 1121-1129.e1. https://doi.org/10.1016/j.ahj.2010.09.008.Full Text Link to Item
-
Mudrick, Daniel W., Anita Y. Chen, Matthew T. Roe, L Kristin Newby, W Brian Gibler, E Magnus Ohman, Eric D. Peterson, and Karen P. Alexander. “Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiative..” Am Heart J 160, no. 6 (December 2010): 1072–78. https://doi.org/10.1016/j.ahj.2010.08.008.Full Text Link to Item
-
Das, Sandeep R., Anita Y. Chen, Karen P. Alexander, Matthew T. Roe, Deborah B. Diercks, Tiffany M. Powell, Eric D. Peterson, and James A. de Lemos. “Impact of Obesity on Presentation, Treatment, and In-Hospital Mortality for 49,329 Patients With ST-Segment Elevation Myocardial Infarction in the ACTION-GWTG Registry.” Circulation 122, no. 21 (November 23, 2010).Link to Item
-
Hanna, Elias B., Karen P. Alexander, Anita Y. Chen, Matthew T. Roe, Marjorie Funk, P. M. Ho, and Jorge F. Saucedo. “In-hospital Outcomes of Anemic Patients Presenting with Non-ST Elevation Myocardial Infarction and Undergoing an Invasive Strategy..” Circulation 122, no. 21 (November 23, 2010).Link to Item
-
Hanna, Elias B., Matthew T. Roe, Stephen D. Wiviott, Caroline S. Fox, Anita Y. Chen, and Jorge F. Saucedo. “Characteristics and In-hospital Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction and Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention.” Circulation 122, no. 21 (November 23, 2010).Link to Item
-
Mathews, Robin, Anita Y. Chen, Chee T. Chin, Tracy Y. Wang, Kevin L. Thomas, Matthew T. Roe, and Eric D. Peterson. “Short- and Long-term Outcomes Among Black vs. White Patients with Non-ST-segment Elevation Myocardial Infarction.” Circulation 122, no. 21 (November 23, 2010).Link to Item
-
Mathews, Robin, Eric D. Peterson, Shuang Li, Matthew T. Roe, Stephen D. Wiviott, Jorge F. Saucedo, Elliott M. Antman, and Tracy Y. Wang. “Under-utilization of Emergency Medical Service Transport Among Contemporary Patients with ST Elevation Myocardial Infarction: Findings from the National Cardiovascular Data Registry ACTION - Get With The Guidelines.” Circulation 122, no. 21 (November 23, 2010).Link to Item
-
Rao, Sunil V., David Dai, John S. Rumsfeld, Tracy Y. Wang, Matthew T. Roe, Steven P. Marso, John Messenger, and Eric D. Peterson. “Association Between Periprocedural Bleeding and Long-term Mortality after Percutaneous Coronary Intervention in the Elderly: A Report from the National Cardiovascular Data Registry (NCDR)(R).” Circulation 122, no. 21 (November 23, 2010).Link to Item
-
Roe, Matthew T., Jennifer A. White, Pierluigi Tricoci, Yuliya Lokhnygina, Chadwick D. Miller, Padma Kaul, Arnoud W. van’t Hof, et al. “Medical Management of Patients with Non-STSegment Elevation Acute Coronary Syndromes Following Coronary Angiography Showing Significant Obstructive Coronary Lesions: Insights from the EARLY ACS Trial.” Circulation 122, no. 21 (November 23, 2010).Link to Item
-
Subherwal, Sumeet, Eric D. Peterson, Anita Y. Chen, Richard G. Bach, Brian F. Gage, Deepak L. Bhatt, Stephen D. Wiviott, et al. “Is Bleeding Risk Augmented With Acute Therapies Across Increasing INR Levels Among NSTEMI Patients on Home Warfarin Therapy?.” Circulation 122, no. 21 (November 23, 2010).Link to Item
-
Ting, Henry H., Anita Y. Chen, Matthew T. Roe, Paul S. Chan, John A. Spertus, Brahmajee K. Nallamothu, Mark D. Sullivan, et al. “Delay from symptom onset to hospital presentation for patients with non-ST-segment elevation myocardial infarction..” Arch Intern Med 170, no. 20 (November 8, 2010): 1834–41. https://doi.org/10.1001/archinternmed.2010.385.Full Text Link to Item
-
Kontos, Michael C., James A. de Lemos, Fang-Shu Ou, Stephan D. Wiviott, Joanne M. Foody, L Kristin Newby, Anita Chen, and Matthew T. Roe. “Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry..” Am Heart J 160, no. 5 (November 2010): 819–25. https://doi.org/10.1016/j.ahj.2010.07.022.Full Text Link to Item
-
Maddox, Thomas M., P Michael Ho, Matthew Roe, David Dai, Thomas T. Tsai, and John S. Rumsfeld. “Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry..” Circ Cardiovasc Qual Outcomes 3, no. 6 (November 2010): 632–41. https://doi.org/10.1161/CIRCOUTCOMES.109.906214.Full Text Link to Item
-
Peterson, Eric D., Matthew T. Roe, Anita Y. Chen, Gregg C. Fonarow, Barbara L. Lytle, Christopher P. Cannon, and John S. Rumsfeld. “The NCDR ACTION Registry-GWTG: transforming contemporary acute myocardial infarction clinical care..” Heart 96, no. 22 (November 2010): 1798–1802. https://doi.org/10.1136/hrt.2010.200261.Full Text Link to Item
-
Brilakis, Emmanouil S., Tracy Y. Wang, Sunil V. Rao, Subhash Banerjee, Steven Goldman, Kendrick Shunk, Biswajit Kar, et al. “Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry..” Jacc Cardiovasc Interv 3, no. 10 (October 2010): 1068–73. https://doi.org/10.1016/j.jcin.2010.07.009.Full Text Link to Item
-
Mehta, Rajendra H., Anita Y. Chen, E Magnus Ohman, W Brian Gibler, Eric D. Peterson, Matthew T. Roe, and Matthew T. CRUSADE National Quality Improvement Initiative Investigators. “Influence of transfer-in rates on quality of care and outcomes at receiving hospitals in patients with non-ST-segment elevation myocardial infarction..” Am Heart J 160, no. 3 (September 2010): 405–11. https://doi.org/10.1016/j.ahj.2010.06.025.Full Text Link to Item
-
Roe, Matthew T., John C. Messenger, William S. Weintraub, Christopher P. Cannon, Gregg C. Fonarow, David Dai, Anita Y. Chen, et al. “Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention..” J Am Coll Cardiol 56, no. 4 (July 20, 2010): 254–63. https://doi.org/10.1016/j.jacc.2010.05.008.Full Text Link to Item
-
Russell, Stuart D., Kimberly L. Blackwell, Julia Lawrence, John E. Pippen, Matthew T. Roe, Freda Wood, Virginia Paton, Eric Holmgren, and Kenneth W. Mahaffey. “Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trials..” J Clin Oncol 28, no. 21 (July 20, 2010): 3416–21. https://doi.org/10.1200/JCO.2009.23.6950.Full Text Link to Item
-
Chin, Chee Tang, Matthew T. Roe, Keith A. A. Fox, Dorairaj Prabhakaran, Debra A. Marshall, Helene Petitjean, Yuliya Lokhnygina, et al. “Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial..” Am Heart J 160, no. 1 (July 2010): 16-22.e1. https://doi.org/10.1016/j.ahj.2010.04.022.Full Text Link to Item
-
Leonardi, Sergio, Sunil V. Rao, Robert A. Harrington, Deepak L. Bhatt, C Michael Gibson, Matthew T. Roe, Janusz Kochman, et al. “Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI)..” Am Heart J 160, no. 1 (July 2010): 65–72. https://doi.org/10.1016/j.ahj.2010.04.008.Full Text Link to Item
-
Glickman, Seth W., Charles B. Cairns, Anita Y. Chen, Eric D. Peterson, and Matthew T. Roe. “Delays in fibrinolysis as primary reperfusion therapy for acute ST-segment elevation myocardial infarction..” Am Heart J 159, no. 6 (June 2010): 998-1004.e2. https://doi.org/10.1016/j.ahj.2010.03.022.Full Text Link to Item
-
Lopes, Renato D., Eric D. Peterson, Anita Y. Chen, Matthew T. Roe, Tracy Y. Wang, E Magnus Ohman, David J. Magid, et al. “Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry..” Jacc Cardiovasc Interv 3, no. 6 (June 2010): 669–77. https://doi.org/10.1016/j.jcin.2010.03.015.Full Text Link to Item
-
Ohman, E Magnus, Matthew T. Roe, Paul W. Armstrong, Keith A. Fox, Dorairaj Prabhakaran, and Harvey D. White. “Public sensationalism and clinical trials: how to address the challenges of science?.” The American Journal of Medicine 123, no. 6 (June 2010): 481–83. https://doi.org/10.1016/j.amjmed.2009.12.012.Full Text
-
Peterson, Eric D., David Dai, Elizabeth R. DeLong, J Matthew Brennan, Mandeep Singh, Sunil V. Rao, Richard E. Shaw, et al. “Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry..” J Am Coll Cardiol 55, no. 18 (May 4, 2010): 1923–32. https://doi.org/10.1016/j.jacc.2010.02.005.Full Text Link to Item
-
Gharacholou, Shahyar Michael, Karen P. Alexander, Anita Y. Chen, Tracy Y. Wang, Chiara Melloni, W Brian Gibler, Charles V. Pollack, E Magnus Ohman, Eric D. Peterson, and Matthew T. Roe. “Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative..” Am Heart J 159, no. 5 (May 2010): 757–63. https://doi.org/10.1016/j.ahj.2010.02.009.Full Text Link to Item
-
Parikh, Shailja V., James A. de Lemos, Michael E. Jessen, Emmanouil S. Brilakis, E Magnus Ohman, Anita Y. Chen, Tracy Y. Wang, et al. “Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines)..” Jacc Cardiovasc Interv 3, no. 4 (April 2010): 419–27. https://doi.org/10.1016/j.jcin.2010.01.012.Full Text Link to Item
-
Bangalore, Sripal, Franz H. Messerli, Fang-Shu Ou, Jacqueline Tamis-Holland, Angela Palazzo, Matthew T. Roe, Mun K. Hong, Eric D. Peterson, and Eric D. CRUSADE Investigators. “The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative..” Eur Heart J 31, no. 5 (March 2010): 552–60. https://doi.org/10.1093/eurheartj/ehp397.Full Text Link to Item
-
Glickman, Seth W., William Boulding, Matthew Manary, Richard Staelin, Matthew T. Roe, Robert J. Wolosin, E Magnus Ohman, Eric D. Peterson, and Kevin A. Schulman. “Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction..” Circ Cardiovasc Qual Outcomes 3, no. 2 (March 2010): 188–95. https://doi.org/10.1161/CIRCOUTCOMES.109.900597.Full Text Link to Item
-
Shah, Bimal R., Eric D. Peterson, Anita Y. Chen, Kenneth W. Mahaffey, Elizabeth R. DeLong, E Magnus Ohman, Charles V. Pollack, W Brian Gibler, and Matthew T. Roe. “Influence of clinical trial participation on subsequent antithrombin use..” Clin Cardiol 33, no. 3 (March 2010): E49–55. https://doi.org/10.1002/clc.20581.Full Text Link to Item
-
Tavris, Dale, Azadeh Shoaibi, Anita Y. Chen, Takahiro Uchida, Matthew T. Roe, and Jiping Chen. “Gender differences in the treatment of non-ST-segment elevation myocardial infarction..” Clin Cardiol 33, no. 2 (February 2010): 99–103. https://doi.org/10.1002/clc.20691.Full Text Link to Item
-
Fox, Caroline S., Paul Muntner, Anita Y. Chen, Karen P. Alexander, Matthew T. Roe, Christopher P. Cannon, Jorge F. Saucedo, Michael C. Kontos, Stephen D. Wiviott, and Stephen D. Acute Coronary Treatment and Intervention Outcomes Network registry. “Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry..” Circulation 121, no. 3 (January 26, 2010): 357–65. https://doi.org/10.1161/CIRCULATIONAHA.109.865352.Full Text Link to Item
-
Atwater, Brett D., Vivian P. Thompson, Richard N. Vest, Linda K. Shaw, Walter R. Mazzei, Sana M. Al-Khatib, Patrick M. Hranitzky, et al. “Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease..” Am J Cardiol 104, no. 12 (December 15, 2009): 1624–30. https://doi.org/10.1016/j.amjcard.2009.07.042.Full Text Link to Item
-
Tsai, Thomas T., Thomas M. Maddox, Matthew T. Roe, David Dai, Karen P. Alexander, P Michael Ho, John C. Messenger, et al. “Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention..” Jama 302, no. 22 (December 9, 2009): 2458–64. https://doi.org/10.1001/jama.2009.1800.Full Text Link to Item
-
Berger, Jeffrey S., Matthew T. Roe, C Michael Gibson, Rakhi Kilaru, Cynthia L. Green, Laura Melton, James D. Blankenship, et al. “Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intravenous Elinogrel before PCI to optimize reperfusion in acute Myocardial Infarction (ERASE MI) pilot trial..” Am Heart J 158, no. 6 (December 2009): 998-1004.e1. https://doi.org/10.1016/j.ahj.2009.10.010.Full Text Link to Item
-
Cudnik, Michael T., W. Frank Peacock, Deborah B. Diercks, Matthew T. Roe, and Anita Y. Chen. “Prehospital electrocardiograms (ECGs) do not improve the process of emergency department care in hospitals with higher usage of ECGs in non-ST-segment elevation myocardial infarction patients..” Clinical Cardiology 32, no. 12 (December 2009): 668–75. https://doi.org/10.1002/clc.20673.Full Text
-
Allen LaPointe, Nancy M., Anita Y. Chen, Matthew T. Roe, David J. Cohen, Deborah B. Diercks, James W. Hoekstra, Francis M. Fesmire, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome..” Am J Cardiol 104, no. 10 (November 15, 2009): 1324–29. https://doi.org/10.1016/j.amjcard.2009.06.054.Full Text Link to Item
-
Linefsky, Jason P., Min Lin, Karen S. Pieper, Craig J. Reist, Lisa G. Berdan, Elliott M. Antman, Shaun G. Goodman, et al. “Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY)..” Am J Cardiol 104, no. 10 (November 15, 2009): 1330–35. https://doi.org/10.1016/j.amjcard.2009.06.056.Full Text Link to Item
-
Ali, Robin C., Chiara Melloni, Fang-Shu Ou, Kenneth Schmader, E Magnus Ohman, Matthew T. Roe, Eric D. Peterson, and Karen P. Alexander. “Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over time..” J Am Geriatr Soc 57, no. 11 (November 2009): 1990–96. https://doi.org/10.1111/j.1532-5415.2009.02483.x.Full Text Link to Item
-
Amsterdam, Ezra A., Eric D. Peterson, Fang-Shu Ou, L Kristin Newby, Charles V. Pollack, W Brian Gibler, E Magnus Ohman, and Matthew T. Roe. “Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiative..” Am Heart J 158, no. 5 (November 2009): 748-754.e1. https://doi.org/10.1016/j.ahj.2009.09.008.Full Text Link to Item
-
Gehrie, Erika R., Harmony R. Reynolds, Anita Y. Chen, Brian H. Neelon, Matthew T. Roe, W Brian Gibler, E Magnus Ohman, L Kristin Newby, Eric D. Peterson, and Judith S. Hochman. “Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative..” Am Heart J 158, no. 4 (October 2009): 688–94. https://doi.org/10.1016/j.ahj.2009.08.004.Full Text Link to Item
-
Fermann, Gregory J., Ali S. Raja, Eric D. Peterson, Matthew T. Roe, James W. Hoekstra, Sarah Milford-Beland, Deborah B. Diercks, et al. “Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge care..” Clin Cardiol 32, no. 9 (September 2009): 519–25. https://doi.org/10.1002/clc.20629.Full Text Link to Item
-
Peterson, Eric D., Matthew T. Roe, John S. Rumsfeld, Richard E. Shaw, Ralph G. Brindis, Gregg C. Fonarow, and Christopher P. Cannon. “A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction..” Circ Cardiovasc Qual Outcomes 2, no. 5 (September 2009): 491–99. https://doi.org/10.1161/CIRCOUTCOMES.108.847145.Full Text Link to Item
-
Roe, Matthew T., Anita Y. Chen, Christopher P. Cannon, Sunil Rao, John Rumsfeld, David J. Magid, Ralph Brindis, et al. “Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries..” Circ Cardiovasc Qual Outcomes 2, no. 5 (September 2009): 414–20. https://doi.org/10.1161/CIRCOUTCOMES.109.850248.Full Text Link to Item
-
Takakuwa, Kevin M., Fang-Shu Ou, Eric D. Peterson, Charles V. Pollack, W Frank Peacock, James W. Hoekstra, E Magnus Ohman, W Brian Gibler, Andra L. Blomkalns, and Matthew T. Roe. “The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADE..” Clin Cardiol 32, no. 9 (September 2009): 498–505. https://doi.org/10.1002/clc.20626.Full Text Link to Item
-
Wang, Tracy Y., L Kristin Newby, Anita Y. Chen, Jyotsna Mulgund, Matthew T. Roe, Ali F. Sonel, Deepak L. Bhatt, et al. “Hypercholesterolemia paradox in relation to mortality in acute coronary syndrome..” Clin Cardiol 32, no. 9 (September 2009): E22–28. https://doi.org/10.1002/clc.20518.Full Text Link to Item
-
Berger, Jeffrey S., Laine Elliott, Dianne Gallup, Matthew Roe, Christopher B. Granger, Paul W. Armstrong, R John Simes, et al. “Sex differences in mortality following acute coronary syndromes..” Jama 302, no. 8 (August 26, 2009): 874–82. https://doi.org/10.1001/jama.2009.1227.Full Text Link to Item
-
Cavender, Matthew A., Sarah Milford-Beland, Matthew T. Roe, Eric D. Peterson, William S. Weintraub, and Sunil V. Rao. “Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)..” Am J Cardiol 104, no. 4 (August 15, 2009): 507–13. https://doi.org/10.1016/j.amjcard.2009.04.016.Full Text Link to Item
-
Aggarwal, Atul, David Dai, John S. Rumsfeld, Lloyd W. Klein, Matthew T. Roe, and Matthew T. American College of Cardiology National Cardiovascular Data Registry. “Incidence and predictors of stroke associated with percutaneous coronary intervention..” The American Journal of Cardiology 104, no. 3 (August 2009): 349–53. https://doi.org/10.1016/j.amjcard.2009.03.046.Full Text
-
Cohen, Mauricio G., Steven J. Filby, Matthew T. Roe, Anita Y. Chen, Venu Menon, George A. Stouffer, W Brian Gibler, et al. “The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative..” Am Heart J 158, no. 2 (August 2009): 263–70. https://doi.org/10.1016/j.ahj.2009.05.016.Full Text Link to Item
-
Melloni, Chiara, Karen P. Alexander, Fang-Shu Ou, Nancy M Allen LaPointe, Matthew T. Roe, L Kristin Newby, Khaula Baloch, P Michael Ho, John S. Rumsfeld, and Eric D. Peterson. “Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome..” Am J Cardiol 104, no. 2 (July 15, 2009): 175–81. https://doi.org/10.1016/j.amjcard.2009.03.013.Full Text Link to Item
-
Chandra, Abhinav, Seth W. Glickman, Fang-Shu Ou, W Frank Peacock, James K. McCord, Charles B. Cairns, Eric D. Peterson, E Magnus Ohman, W Brian Gibler, and Matthew T. Roe. “An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence..” Ann Emerg Med 54, no. 1 (July 2009): 17–25. https://doi.org/10.1016/j.annemergmed.2009.01.025.Full Text Link to Item
-
Chan, Mark Y., Jie L. Sun, L Kristin Newby, Linda K. Shaw, Min Lin, Eric D. Peterson, Robert M. Califf, David F. Kong, and Matthew T. Roe. “Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction..” Circulation 119, no. 24 (June 23, 2009): 3110–17. https://doi.org/10.1161/CIRCULATIONAHA.108.799981.Full Text Link to Item
-
Harrington, Robert A., Robert M. Califf, Patricia K. Hodgson, Eric D. Peterson, Matthew T. Roe, and Daniel B. Mark. “Careers for clinician investigators..” Circulation 119, no. 22 (June 9, 2009): 2945–50. https://doi.org/10.1161/CIRCULATIONAHA.107.752717.Full Text Link to Item
-
Mehta, Sameer K., Andrew D. Frutkin, Jason B. Lindsey, John A. House, John A. Spertus, Sunil V. Rao, Fang-Shu Ou, et al. “Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry..” Circ Cardiovasc Interv 2, no. 3 (June 2009): 222–29. https://doi.org/10.1161/CIRCINTERVENTIONS.108.846741.Full Text Link to Item
-
Spinler, Sarah A., Fang-Shu Ou, Matthew T. Roe, W Brian Gibler, E Magnus Ohman, Charles V. Pollack, Karen P. Alexander, and Eric D. Peterson. “Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative..” Pharmacotherapy 29, no. 6 (June 2009): 631–38. https://doi.org/10.1592/phco.29.6.631.Full Text Link to Item
-
Wang, Tracy Y., Fang-Shu Ou, Matthew T. Roe, Robert A. Harrington, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice..” Circulation 119, no. 18 (May 12, 2009): 2454–62. https://doi.org/10.1161/CIRCULATIONAHA.108.827162.Full Text Link to Item
-
Bhatt, Deepak L., Eric D. Peterson, Robert A. Harrington, Fang-Shu Ou, Christopher P. Cannon, C Michael Gibson, Neal S. Kleiman, et al. “Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes..” Eur Heart J 30, no. 10 (May 2009): 1195–1202. https://doi.org/10.1093/eurheartj/ehp099.Full Text Link to Item
-
Halim, Sharif A., Jyotsna Mulgund, Anita Y. Chen, Matthew T. Roe, Eric D. Peterson, W Brian Gibler, E Magnus Ohman, and L Kristin Newby. “Use of guidelines-recommended management and outcomes among women and men with low-level troponin elevation: insights from CRUSADE..” Circ Cardiovasc Qual Outcomes 2, no. 3 (May 2009): 199–206. https://doi.org/10.1161/CIRCOUTCOMES.108.810127.Full Text Link to Item
-
Subherwal, Sumeet, Richard G. Bach, Anita Y. Chen, Brian F. Gage, Sunil V. Rao, L Kristin Newby, Tracy Y. Wang, et al. “Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score..” Circulation 119, no. 14 (April 14, 2009): 1873–82. https://doi.org/10.1161/CIRCULATIONAHA.108.828541.Full Text Link to Item
-
Smyth, Susan S., Donna S. Woulfe, Jeffrey I. Weitz, Christian Gachet, Pamela B. Conley, Shaun G. Goodman, Matthew T. Roe, et al. “G-protein-coupled receptors as signaling targets for antiplatelet therapy..” Arterioscler Thromb Vasc Biol 29, no. 4 (April 2009): 449–57. https://doi.org/10.1161/ATVBAHA.108.176388.Full Text Link to Item
-
Wang, Tracy Y., Min Zhang, Yuling Fu, Paul W. Armstrong, L Kristin Newby, C Michael Gibson, David J. Moliterno, et al. “Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography..” Am Heart J 157, no. 4 (April 2009): 716–23. https://doi.org/10.1016/j.ahj.2009.01.004.Full Text Link to Item
-
Cardarelli, Francesca, Antonio Bellasi, Fang-Shu Ou, Leslee J. Shaw, Emir Veledar, Matthew T. Roe, Douglas C. Morris, Eric D. Peterson, Lloyd W. Klein, and Paolo Raggi. “Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry)..” Am J Cardiol 103, no. 6 (March 15, 2009): 766–71. https://doi.org/10.1016/j.amjcard.2008.11.033.Full Text Link to Item
-
Alexander, Karen P., Anita Y. Chen, Matthew T. Roe, Tracy Y. Wang, Erik M. Ohman, David J. Magid, Michael P. Ho, Stephen D. Wiviott, Benjamin M. Scirica, and Eric D. Peterson. “Antithrombotic Strategy During Percutaneous Coronary Iintervention in NSTEMI: Update From ACTION Registry-GWTG.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A398–A398.Link to Item
-
Gharacholou, Shahyar M., Anita Y. Chen, Karen P. Alexander, Jorge F. Saucedo, James de Lemos, Michael C. Kontos, Eric D. Peterson, John Rumsfeld, and Matthew T. Roe. “Limitations of Using Cardiac Catheterization Rates as a Quality Measure for Non ST-Segment Elevation Myocardial Infarction.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A370–A370.Link to Item
-
Lindsey, Jason B., Sameer K. Mehta, Andrew D. Frutkin, John A. Spertus, Sunil V. Rao, Fang-Shu Ou, Matthew T. Roe, Eric D. Peterson, and Steven P. Marso. “A Clinical Risk Prediction Tool for Post-PCI Bleeding From the National Cardiovascular Data Registry (R) (NCDR (R)).” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A23–A23.Link to Item
-
Mehta, Rajendra H., Anita Y. Chen, Eric D. Peterson, and Matthew T. Roe. “Influence of Transfer-In Rates on Quality of Care and Outcomes at Receiving Hospitals in Patients With Non-ST-Elevation Acute Coronary Syndromes.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A367–A367.Link to Item
-
Rao, Sunil V., Dadi Dai, Tracy Y. Wang, Matthew T. Roe, Steven P. Marso, John S. Rumsfeld, Ralph Brindis, and Eric D. Peterson. “Annual Case Volume Is Not a Strong Predictor of Bleeding Complications After Percutaneous Coronary Intervention: A Report From the National Cardiovascular Data Registry.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A373–A373.Link to Item
-
Subherwal, Sumeet, Anita Y. Chen, Richard G. Bach, Matthew T. Roe, Eric D. Peterson, and Karen P. Alexander. “Risk of GUSTO Moderate or Severe Bleeding identified by the CRUSADE Bleeding Model.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A384–A384.Link to Item
-
Bangalore, Sripal, Franz H. Messerli, Fang-Shu Ou, Jacqueline Tamis-Holland, Angela Palazzo, Matthew T. Roe, Mun K. Hong, Eric D. Peterson, and Eric D. CRUSADE Investigators. “Blood pressure paradox in patients with non-ST-segment elevation acute coronary syndromes: results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) quality improvement initiative..” Am Heart J 157, no. 3 (March 2009): 525–31. https://doi.org/10.1016/j.ahj.2008.10.025.Full Text Link to Item
-
Patel, Uptal D., Fang-Shu Ou, E Magnus Ohman, W Brian Gibler, Charles V. Pollack, Eric D. Peterson, and Matthew T. Roe. “Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes..” Am J Kidney Dis 53, no. 3 (March 2009): 426–37. https://doi.org/10.1053/j.ajkd.2008.09.024.Full Text Link to Item
-
Pollack, Charles V., Judd E. Hollander, Anita Y. Chen, Eric D. Peterson, Sripal Bangalore, Frank W. Peacock, Christopher P. Cannon, et al. “Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiative..” Crit Pathw Cardiol 8, no. 1 (March 2009): 29–33. https://doi.org/10.1097/HPC.0b013e3181980f9f.Full Text Link to Item
-
Singh, Mandeep, Eric D. Peterson, Matthew T. Roe, Fang-Shu Ou, John A. Spertus, John S. Rumsfeld, H Vernon Anderson, Lloyd W. Klein, Kalon K. L. Ho, and David R. Holmes. “Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience..” Circ Cardiovasc Interv 2, no. 1 (February 2009): 20–26. https://doi.org/10.1161/CIRCINTERVENTIONS.108.826172.Full Text Link to Item
-
Diercks, Deborah B., Michael C. Kontos, Anita Y. Chen, Charles V. Pollack, Stephen D. Wiviott, John S. Rumsfeld, David J. Magid, et al. “Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry..” J Am Coll Cardiol 53, no. 2 (January 13, 2009): 161–66. https://doi.org/10.1016/j.jacc.2008.09.030.Full Text Link to Item
-
Akhter, Nausheen, Sarah Milford-Beland, Matthew T. Roe, Robert N. Piana, John Kao, and Adhir Shroff. “Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR)..” Am Heart J 157, no. 1 (January 2009): 141–48. https://doi.org/10.1016/j.ahj.2008.08.012.Full Text Link to Item
-
Mehta, Rajendra H., Fang-Shu Ou, Eric D. Peterson, Richard E. Shaw, William B. Hillegass, John S. Rumsfeld, Matthew T. Roe, and Matthew T. American College of Cardiology-National Cardiovascular Database Registry Investigators. “Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention..” Jacc Cardiovasc Interv 2, no. 1 (January 2009): 56–64. https://doi.org/10.1016/j.jcin.2008.10.006.Full Text Link to Item
-
Alexander, Deepu, Noelle Mann, Fang-Shu Ou, Eric D. Peterson, E Magnus Ohman, W Brian Gibler, and Matthew T. Roe. “Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative)..” Am J Cardiol 102, no. 10 (November 15, 2008): 1335–40. https://doi.org/10.1016/j.amjcard.2008.06.063.Full Text Link to Item
-
Aggarwal, Atul, David Dai, John S. Rumsfeld, Lloyd W. Klein, and Matthew T. Roe. “Incidence and Predictors of Stroke Associated with Percutaneous Coronary Intervention.” Circulation 118, no. 18 (October 28, 2008): S652–S652.Link to Item
-
Cardarelli, Francesca, Antonio Bellasi, Enrique Rojas-Campos, Fang-Shu Ou, Leslee J. Shaw, Emir Veledar, Matthew T. Roe, Douglas Morris, Lloyd W. Klein, and Paolo Raggi. “The Effect of Age and Estimated Glomerular Filtration Rate on In-Hospital Mortality Following Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Report from the National Cardiovascular Data Registry.” Circulation 118, no. 18 (October 28, 2008): S966–S966.Link to Item
-
Chan, Mark, Lena J. Sun, L. K. Newby, Linda K. Shaw, Eric D. Peterson, David F. Kong, Min Lin, Robert M. Califf, and Matthew T. Roe. “Long-Term Prognostic Impact of ST-elevation vs. Non-ST-elevation Myocardial Infarction.” Circulation 118, no. 18 (October 28, 2008): S1058–S1058.Link to Item
-
Fox, Caroline S., Paul Muntner, Anita Y. Chen, Karen P. Alexander, Matthew T. Roe, Jorge F. Saucedo, and Stephen D. Wiviott. “Short-Term Outcomes of STEMI and NSTEMI in Patients with Chronic Kidney Disease: A Report from the National Cardiovascular Data ACTION Registry.” Circulation 118, no. 18 (October 28, 2008): S966–S966.Link to Item
-
Ting, Henry H., Anita Y. Chen, Matthew T. Roe, Paul S. Chan, John A. Spertus, Brahmajee K. Nallamothu, Mark D. Sullivan, Elizabeth R. DeLong, Harlan M. Krumholz, and Eric D. Peterson. “Factors Associated with Longer Delays to Hospital Presentation for Patients with Non-ST-Elevation Myocardial Infarction.” Circulation 118, no. 18 (October 28, 2008): S1164–S1164.Link to Item
-
Wang, Tracy Y., Anita Y. Chen, Matthew T. Roe, Magnus Ohman, Brian Gibler, and Eric D. Peterson. “Balancing Mortality Benefit vs. Bleeding Risk for Intensive Antiplatelet Therapy among Acute Coronary Syndrome Patients: Insights from the CRUSADE Registry.” Circulation 118, no. 18 (October 28, 2008): S916–S916.Link to Item
-
Wang, Tracy, Eric D. Peterson, Fang-Shu Ou, Brahmajee K. Nallamothu, John S. Rumsfeld, and Matthew T. Roe. “Do Hospitals that Improve "Direct Arrival" Door to Balloon Times for Primary Percutaneous Coronary Intervention Also Improve "Transfer In" Door to Balloon Times?.” Circulation 118, no. 18 (October 28, 2008): S1108–S1108.Link to Item
-
Dixon, William C., Tracy Y. Wang, David Dai, Kendrick A. Shunk, Eric D. Peterson, Matthew T. Roe, and Matthew T. National Cardiovascular Data Registry. “Anatomic distribution of the culprit lesion in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: findings from the National Cardiovascular Data Registry..” J Am Coll Cardiol 52, no. 16 (October 14, 2008): 1347–48. https://doi.org/10.1016/j.jacc.2008.07.029.Full Text Link to Item
-
Roe, Matthew T., Fang-Shu Ou, Karen P. Alexander, Laura Kristin Newby, Joanne M. Foody, W Brian Gibler, William E. Boden, Erik Magnus Ohman, Sidney C. Smith, and Eric D. Peterson. “Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes..” Eur Heart J 29, no. 20 (October 2008): 2480–88. https://doi.org/10.1093/eurheartj/ehn364.Full Text Link to Item
-
Madala, Mohan C., Barry A. Franklin, Anita Y. Chen, Aaron D. Berman, Matthew T. Roe, Eric D. Peterson, E Magnus Ohman, et al. “Obesity and age of first non-ST-segment elevation myocardial infarction..” J Am Coll Cardiol 52, no. 12 (September 16, 2008): 979–85. https://doi.org/10.1016/j.jacc.2008.04.067.Full Text Link to Item
-
Alexander, Deepu, Fang-Shu Ou, Matthew T. Roe, Charles V. Pollack, E Magnus Ohman, Christopher P. Cannon, W Brian Gibler, et al. “Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE)..” Am Heart J 156, no. 3 (September 2008): 606–12. https://doi.org/10.1016/j.ahj.2008.05.012.Full Text Link to Item
-
Roe, M. T. “Multivessel CAD in ACS patients: Four important implications.” Cardiology Review 25, no. 9 (September 1, 2008): 38–39.
-
Wang, Tracy Y., Anita Y. Chen, Karen P. Alexander, E Magnus Ohman, W Brian Gibler, Eric D. Peterson, and Matthew T. Roe. “Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarction..” Am J Med 121, no. 9 (September 2008): 805–10. https://doi.org/10.1016/j.amjmed.2008.04.023.Full Text Link to Item
-
Dunlay, Shannon M., Karen P. Alexander, Chiara Melloni, Jennifer L. Kraschnewski, Li Liang, W Brian Gibler, Matthew T. Roe, E Magnus Ohman, and Eric D. Peterson. “Medical records and quality of care in acute coronary syndromes: results from CRUSADE..” Arch Intern Med 168, no. 15 (August 11, 2008): 1692–98. https://doi.org/10.1001/archinte.168.15.1692.Full Text Link to Item
-
Chan, Mark Y., Kenneth W. Mahaffey, Lena J. Sun, Karen S. Pieper, Harvey D. White, Philip E. Aylward, James J. Ferguson, Robert M. Califf, and Matthew T. Roe. “Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease..” Jacc Cardiovasc Interv 1, no. 4 (August 2008): 369–78. https://doi.org/10.1016/j.jcin.2008.03.019.Full Text Link to Item
-
Melloni, Chiara, Karen P. Alexander, Anita Y. Chen, L Kristin Newby, Matthew T. Roe, Nancy M. Allen LaPointe, Charles V. Pollack, et al. “Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes..” Am Heart J 156, no. 2 (August 2008): 209–15. https://doi.org/10.1016/j.ahj.2008.03.023.Full Text Link to Item
-
Rao, Sunil V., Fang-Shu Ou, Tracy Y. Wang, Matthew T. Roe, Ralph Brindis, John S. Rumsfeld, and Eric D. Peterson. “Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry..” Jacc Cardiovasc Interv 1, no. 4 (August 2008): 379–86. https://doi.org/10.1016/j.jcin.2008.05.007.Full Text Link to Item
-
Peterson, Eric D., David Z. Bynum, and Matthew T. Roe. “Lessons learned from the CRUSADE National Quality Improvement Initiative..” Curr Cardiol Rep 10, no. 4 (July 2008): 285–90. https://doi.org/10.1007/s11886-008-0046-9.Full Text Link to Item
-
Roe, Matthew T., Anita Y. Chen, Elizabeth R. Delong, William E. Boden, James E. Calvin, Charles B. Cairns, Sidney C. Smith, et al. “Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitals..” Am Heart J 156, no. 1 (July 2008): 185–92. https://doi.org/10.1016/j.ahj.2008.01.033.Full Text Link to Item
-
Roe, Matthew T., George Kikano, Chadwick D. Miller, and James W. Hoekstra. “Continuum of care in the treatment of ST-segment elevation myocardial infarction (STEMI): importance of platelet and coagulation inhibition..” Postgraduate Medicine 120, no. 2 (July 2008): 67–78. https://doi.org/10.3810/pgm.2008.07.1793.Full Text
-
Alexander, Karen P., Anita Y. Chen, Tracy Y. Wang, Sunil V. Rao, L Kristin Newby, Nancy M Allen LaPointe, E Magnus Ohman, et al. “Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes..” Am Heart J 155, no. 6 (June 2008): 1047–53. https://doi.org/10.1016/j.ahj.2008.01.009.Full Text Link to Item
-
Wang, Tracy Y., Eric D. Peterson, David Dai, H Vernon Anderson, Sunil V. Rao, Ralph G. Brindis, Matthew T. Roe, and Matthew T. National Cardiovascular Data Registry. “Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR)..” J Am Coll Cardiol 51, no. 21 (May 27, 2008): 2068–74. https://doi.org/10.1016/j.jacc.2008.01.054.Full Text Link to Item
-
Aggarwal, Atul, David Dai, John S. Rumsfeld, Lloyd W. Klein, and Matthew T. Roe. “Impact of home warfarin use on the treatment and outcomes of patients undergoing percutaneous coronary intervention..” Am J Cardiol 101, no. 10 (May 15, 2008): 1413–17. https://doi.org/10.1016/j.amjcard.2008.01.018.Full Text Link to Item
-
Sayah, Assaad J., and Matthew T. Roe. “The role of fibrinolytics in the prehospital treatment of ST-elevation myocardial infarction (STEMI)..” J Emerg Med 34, no. 4 (May 2008): 405–16. https://doi.org/10.1016/j.jemermed.2007.02.068.Full Text Link to Item
-
Wang, Tracy Y., Anita Y. Chen, Eric D. Peterson, Richard C. Becker, W Brian Gibler, E Magnus Ohman, and Matthew T. Roe. “Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative..” Eur Heart J 29, no. 9 (May 2008): 1103–9. https://doi.org/10.1093/eurheartj/ehn126.Full Text Link to Item
-
Majumdar, Sumit R., Matthew T. Roe, Eric D. Peterson, Anita Y. Chen, W Brian Gibler, and Paul W. Armstrong. “Better outcomes for patients treated at hospitals that participate in clinical trials..” Arch Intern Med 168, no. 6 (March 24, 2008): 657–62. https://doi.org/10.1001/archinternmed.2007.124.Full Text Link to Item
-
Melloni, Chiara, Eric D. Peterson, Anita Y. Chen, Lynda A. Szczech, L Kristin Newby, Robert A. Harrington, W Brian Gibler, et al. “Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes..” J Am Coll Cardiol 51, no. 10 (March 11, 2008): 991–96. https://doi.org/10.1016/j.jacc.2007.11.045.Full Text Link to Item
-
Chan, Mark Y., Richard C. Becker, Robert A. Harrington, Eric D. Peterson, Paul W. Armstrong, Harvey White, Keith A. A. Fox, E Magnus Ohman, and Matthew T. Roe. “Noninvasive, medical management for non-ST-elevation acute coronary syndromes..” Am Heart J 155, no. 3 (March 2008): 397–407. https://doi.org/10.1016/j.ahj.2007.11.014.Full Text Link to Item
-
Melloni, Chiara, Karen P. Alexander, Sarah Milford-Beland, L Kristin Newby, Lynda A. Szczech, Charles V. Pollack, J Douglas Kirk, et al. “Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease..” Clin Cardiol 31, no. 3 (March 2008): 125–29. https://doi.org/10.1002/clc.20210.Full Text Link to Item
-
Direct Inhibition of delta-Protein Kinase C Enzyme to Limit Total Infarct Size in Acute Myocardial Infarction (DELTA MI) Investigators, Petr, Eric Bates, Christoph Bode, Marco Costa, C Michael Gibson, Christopher Granger, Cindy Green, et al. “Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction..” Circulation 117, no. 7 (February 19, 2008): 886–96. https://doi.org/10.1161/CIRCULATIONAHA.107.759167.Full Text Link to Item
-
Ting, Henry H., Matthew T. Roe, Bernard J. Gersh, John A. Spertus, John S. Rumsfeld, Fang-Shu Ou, John Kao, et al. “Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarction..” Am J Cardiol 101, no. 3 (February 1, 2008): 286–92. https://doi.org/10.1016/j.amjcard.2007.09.084.Full Text Link to Item
-
Wang, Tracy Y., Lee A. Robinson, Fang-Shu Ou, Matthew T. Roe, E Magnus Ohman, W Brian Gibler, Sidney C. Smith, Eric D. Peterson, and Richard C. Becker. “Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry..” Am Heart J 155, no. 2 (February 2008): 361–68. https://doi.org/10.1016/j.ahj.2007.09.003.Full Text Link to Item
-
Brener, Sorin J., Sarah Milford-Beland, Matthew T. Roe, Deepak L. Bhatt, William S. Weintraub, Ralph G. Brindis, and Ralph G. American College of Cardiology National Cardiovascular Database Registry. “Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report..” Am Heart J 155, no. 1 (January 2008): 140–46. https://doi.org/10.1016/j.ahj.2007.09.007.Full Text Link to Item
-
Peterson, Eric D., David Z. Bynum, and Matthew T. Roe. “Association of evidence-based care processes and outcomes among patients with acute coronary syndromes: performance matters..” J Cardiovasc Nurs 23, no. 1 (January 2008): 50–55. https://doi.org/10.1097/01.JCN.0000305058.03872.f1.Full Text Link to Item
-
Atwater, Brett D., Sarah Milford-Beland, L Kristin Newby, Adrian F. Hernandez, W Frank Peacock, W Brian Gibler, Robert H. Christenson, E Magnus Ohman, Eric D. Peterson, and Matthew T. Roe. “Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromes..” The American Journal of Cardiology 100, no. 12 (December 2007): 1727–33. https://doi.org/10.1016/j.amjcard.2007.07.023.Full Text
-
Glickman, Seth W., William Boulding, Richard Staelin, Jyotsna Mulgund, Matthew T. Roe, Barbara L. Lytle, John S. Rumsfeld, et al. “A framework for quality improvement: an analysis of factors responsible for improvement at hospitals participating in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative..” Am Heart J 154, no. 6 (December 2007): 1206–20. https://doi.org/10.1016/j.ahj.2007.08.001.Full Text Link to Item
-
Lytle, Barbara L., Elizabeth S. Fraulo, Jyotsna Mulgund, Vincent A. Miller, Matthew T. Roe, Sidney C. Smith, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “What aspects of hospital culture influence quality?.” Critical Pathways in Cardiology 6, no. 4 (December 2007): 145–49. https://doi.org/10.1097/hpc.0b013e3181599209.Full Text
-
Steinhubl, S., and M. Roe. “Erratum: Conivaptan: A dual receptor vasopressin V1a/V 2 antagonist (Cardiovascular Drug Reviews (2007) 25, 3, (261-279)).” Cardiovascular Drug Reviews 25, no. 4 (December 1, 2007). https://doi.org/10.1111/j.1527-3466.2007.00033.x.Full Text
-
Blomkalns, Andra L., Matthew T. Roe, Eric D. Peterson, E Magnus Ohman, Elizabeth S. Fraulo, and W Brian Gibler. “Guideline implementation research: exploring the gap between evidence and practice in the CRUSADE Quality Improvement Initiative..” Acad Emerg Med 14, no. 11 (November 2007): 949–54. https://doi.org/10.1197/j.aem.2007.06.017.Full Text Link to Item
-
Diercks, Deborah B., Matthew T. Roe, Anita Y. Chen, W Franklin Peacock, J Douglas Kirk, Charles V. Pollack, W Brian Gibler, Sidney C. Smith, Magnus Ohman, and Eric D. Peterson. “Prolonged emergency department stays of non-ST-segment-elevation myocardial infarction patients are associated with worse adherence to the American College of Cardiology/American Heart Association guidelines for management and increased adverse events..” Ann Emerg Med 50, no. 5 (November 2007): 489–96. https://doi.org/10.1016/j.annemergmed.2007.03.033.Full Text Link to Item
-
Zia, Mohammad I., Shaun G. Goodman, Eric D. Peterson, Jyotsna Mulgund, Anita Y. Chen, Anatoly Langer, Mary Tan, et al. “Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II..” Can J Cardiol 23, no. 13 (November 2007): 1073–79. https://doi.org/10.1016/s0828-282x(07)70876-0.Full Text Link to Item
-
Bhatt, Deepak L., Eric D. Paterson, Robert A. Harrington, Fang-Shu Ou, Christopher P. Cannon, C. M. Gibson, Neal Kleiman, et al. “Polyvascular disease - A novel risk factor for worse ischemic and bleeding outcomes in acute coronary syndromes.” Circulation 116, no. 16 (October 16, 2007): 482–482.Link to Item
-
Chan, Mark Y., Kenneth W. Mahaffey, Je-Lena Sun, Karen S. Pieper, Harvey D. White, Philip E. Aylward, James J. Ferguson, Robert M. Califf, and Matthew T. Roe. “Catheterization without in-hospital revascularization is associated with increased long-term mortality in patients with non-ST elevation myocardial infarction and significant coronary artery disease.” Circulation 116, no. 16 (October 16, 2007): 384–384.Link to Item
-
Melloni, Chiara, Karen P. Alexander, Anita Y. Chen, Matthew T. Roe, L Kristin Newby, Magnus Ohman, W Brian Gibler, Sidney C. Smith, Charles V. Pollak, and Eric D. Peterson. “Unfractionated heparin dosing and major bleeding in non-ST-segment elevation acute coronary syndromes.” Circulation 116, no. 16 (October 16, 2007): 383–383.Link to Item
-
Wang, Tracy Y., Matthew T. Roe, David Dai, Eric D. Peterson, and William C. Dixon. “Anatomic distribution of culprit lesions in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.” Circulation 116, no. 16 (October 16, 2007): 383–84.Link to Item
-
Shah, Bimal R., Seth W. Glickman, Li Liang, W Brian Gibler, E Magnus Ohman, Charles V. Pollack, Matthew T. Roe, and Eric D. Peterson. “The impact of for-profit hospital status on the care and outcomes of patients with non-ST-segment elevation myocardial infarction: results from the CRUSADE Initiative..” Journal of the American College of Cardiology 50, no. 15 (October 2007): 1462–68. https://doi.org/10.1016/j.jacc.2007.07.012.Full Text
-
Roe, Matthew T., Anita Y. Chen, Rajendra H. Mehta, Yun Li, Ralph G. Brindis, Sidney C. Smith, John S. Rumsfeld, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes..” Circulation 116, no. 10 (September 4, 2007): 1153–61. https://doi.org/10.1161/CIRCULATIONAHA.107.697003.Full Text Link to Item
-
Steinhubl, S., and M. Roe. “Erratum: Optimizing platelet P2Y12 inhibition for patients undergoing PCI (Cardiovascular Drug Reviews (2007) 25, 2, (188-203)).” Cardiovascular Drug Reviews 25, no. 3 (September 1, 2007). https://doi.org/10.1111/j.1527-3466.2007.00021.x.Full Text
-
Calvin, J. E., M. T. Roe, and E. D. Peterson. “In response.” Annals of Internal Medicine 147, no. 3 (August 7, 2007).
-
Calvin, James E., Matthew T. Roe, and Eric D. Peterson. “Insurance Coverage and Care of Patients with Non–ST-Segment Elevation Acute Coronary Syndromes.” Annals of Internal Medicine 147, no. 3 (August 7, 2007): 212–212. https://doi.org/10.7326/0003-4819-147-3-200708070-00015.Full Text
-
Miller, Chadwick D., Matthew T. Roe, Jyotsna Mulgund, James W. Hoekstra, Renato Santos, Charles V. Pollack, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction..” Am J Med 120, no. 8 (August 2007): 685–92. https://doi.org/10.1016/j.amjmed.2007.04.016.Full Text Link to Item
-
Wang, Tracy Y., Anita Y. Chen, Matthew T. Roe, Karen P. Alexander, L Kristin Newby, Sidney C. Smith, Sripal Bangalore, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative..” Am J Cardiol 100, no. 3 (August 1, 2007): 391–96. https://doi.org/10.1016/j.amjcard.2007.03.035.Full Text Link to Item
-
LaPointe, Nancy M Allen, Anita Y. Chen, Karen P. Alexander, Matthew T. Roe, Charles V. Pollack, Barbara L. Lytle, Magnus E. Ohman, Brian W. Gibler, and Eric D. Peterson. “Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes..” Arch Intern Med 167, no. 14 (July 23, 2007): 1539–44. https://doi.org/10.1001/archinte.167.14.1539.Full Text Link to Item
-
Nallamothu, Brahmajee K., Harlan M. Krumholz, Dennis T. Ko, Kenneth A. LaBresh, Saif Rathore, Matthew T. Roe, and Lee Schwamm. “Development of systems of care for ST-elevation myocardial infarction patients: gaps, barriers, and implications..” Circulation 116, no. 2 (July 2007): e68–72. https://doi.org/10.1161/circulationaha.107.184052.Full Text
-
Glickman, Seth W., Fang-Shu Ou, Elizabeth R. DeLong, Matthew T. Roe, Barbara L. Lytle, Jyotsna Mulgund, John S. Rumsfeld, et al. “Pay for performance, quality of care, and outcomes in acute myocardial infarction..” Jama 297, no. 21 (June 6, 2007): 2373–80. https://doi.org/10.1001/jama.297.21.2373.Full Text Link to Item
-
Tickoo, Sumit, Matthew T. Roe, Eric D. Peterson, Sarah Milford-Beland, E Magnus Ohman, W Brian Gibler, Charles V. Pollack, Christopher P. Cannon, and Christopher P. CRUSADE Investigators. “Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement Initiative..” Am J Cardiol 99, no. 11 (June 1, 2007): 1496–99. https://doi.org/10.1016/j.amjcard.2007.01.021.Full Text Link to Item
-
Akhter, Nausheen, Sarah Milford-Beland, Matthew T. Roe, Robert Piana, and Adhir Shroff. “Are we meeting the goals? Gender analysis of evidence-based medical therapies among patients presenting with an acute coronary syndrome (ACS) who undergo post-percutaneous coronary intervention (PCI): Results from the ACC-NCDR cath/PCI registry.” Circulation 115, no. 21 (May 29, 2007): E596–E596.Link to Item
-
Kraschnewski, Jennifer L., Li Liang, Shannon M. Dunlay, Chiara Melloni, Deborah B. Diercks, W Brian Gibler, Matthew T. Roe, E Magnus Ohman, Eric D. Peterson, and Karen P. Alexander. “Age, presentation, and emergency department diagnosis of acute coronary syndromes: Results from CRUSADE.” Circulation 115, no. 21 (May 29, 2007): E584–E584.Link to Item
-
Shah, Bimal R., Anita Y. Chen, Eric D. Peterson, Kenneth W. Mahaffey, Elizabeth R. DeLong, E Magnus Ohman, Charles V. Pollack, W Brian Gibler, and Matthew T. Roe. “Influence of clinical trial participation on anti-thrombin use for patients with non-ST-segment elevation acute coronary syndromes: Patterns of enoxaparin vs. unfractionated heparin use in the CRUSADE initiative.” Circulation 115, no. 21 (May 29, 2007): E583–E583.Link to Item
-
Bennett, Kyla M., Adrian F. Hernandez, Anita Y. Chen, Jyotsna Mulgund, L Kristin Newby, John S. Rumsfeld, Judith S. Hochman, et al. “Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes..” Am J Cardiol 99, no. 10 (May 15, 2007): 1351–56. https://doi.org/10.1016/j.amjcard.2006.12.057.Full Text Link to Item
-
Tricoci, Pierluigi, Eric D. Peterson, Anita Y. Chen, L Kristin Newby, Robert A. Harrington, Adam B. Greenbaum, Chistopher P. Cannon, et al. “Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE)..” Am J Cardiol 99, no. 10 (May 15, 2007): 1389–93. https://doi.org/10.1016/j.amjcard.2006.12.066.Full Text Link to Item
-
Gogo, Prospero B., Harold L. Dauerman, Jyotsna Mulgund, E Magnus Ohman, Manesh R. Patel, David J. Cohen, Jorge F. Saucedo, et al. “Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative)..” Am J Cardiol 99, no. 9 (May 1, 2007): 1222–26. https://doi.org/10.1016/j.amjcard.2006.12.037.Full Text Link to Item
-
Skolnick, Adam H., Karen P. Alexander, Anita Y. Chen, Matthew T. Roe, Charles V. Pollack, E Magnus Ohman, John S. Rumsfeld, W Brian Gibler, Eric D. Peterson, and David J. Cohen. “Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative..” J Am Coll Cardiol 49, no. 17 (May 1, 2007): 1790–97. https://doi.org/10.1016/j.jacc.2007.01.066.Full Text Link to Item
-
Roe, Matthew T., Abdul R. Halabi, Rajendra H. Mehta, Anita Y. Chen, L Kristin Newby, Robert A. Harrington, Sidney C. Smith, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction..” Am Heart J 153, no. 4 (April 2007): 507–14. https://doi.org/10.1016/j.ahj.2006.12.018.Full Text Link to Item
-
Mehta, Rajendra H., Sarah Milford-Beland, Eric D. Peterson, Deepak L. Bhatt, Michael E. Farkouh, Gerald X. Brogan, W Brian Gibler, E Magnus Ohman, and Matthew T. Roe. “Characterizing young patients with diabetes and non-ST-segment elevation acute coronary syndromes..” Diabetes Care 30, no. 3 (March 2007): 731–33. https://doi.org/10.2337/dc06-1367.Full Text
-
Mahaffey, Kenneth W., Matthew T. Roe, Rakhi Kilaru, John H. Alexander, Frans Van de Werf, Robert M. Califf, Maarten L. Simoons, Eric J. Topol, and Robert A. Harrington. “Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials..” Eur Heart J 28, no. 4 (February 2007): 425–32. https://doi.org/10.1093/eurheartj/ehl483.Full Text Link to Item
-
Patel, Manesh R., Anita Y. Chen, Matthew T. Roe, E Magnus Ohman, L Kristin Newby, Robert A. Harrington, Sydney C. Smith, W Brian Gibler, James E. Calvin, and Eric D. Peterson. “A comparison of acute coronary syndrome care at academic and nonacademic hospitals..” Am J Med 120, no. 1 (January 2007): 40–46. https://doi.org/10.1016/j.amjmed.2006.10.008.Full Text Link to Item
-
Steinhubl, Steven, and Matthew T. Roe. “Optimizing platelet P2Y12 inhibition for patients undergoing PCI..” Cardiovasc Drug Rev 25, no. 2 (2007): 188–203. https://doi.org/10.1111/j.1527-3466.2007.00013.x.Full Text Link to Item
-
Tricoci, Pierluigi, Eric D. Peterson, Matthew T. Roe, and Matthew T. CRUSADE Quality Improvement Initiative. “Patterns of guideline adherence and care delivery for patients with unstable angina and non-ST-segment elevation myocardial infarction (from the CRUSADE Quality Improvement Initiative)..” Am J Cardiol 98, no. 12A (December 18, 2006): 30Q-35Q. https://doi.org/10.1016/j.amjcard.2006.09.022.Full Text Link to Item
-
Peterson, Eric D., and Mathew T. Roe. “Continued improvements in quality improvement research..” Am Heart J 152, no. 6 (December 2006): 1005–6. https://doi.org/10.1016/j.ahj.2006.09.001.Full Text Link to Item
-
Calvin, James E., Matthew T. Roe, Anita Y. Chen, Rajendra H. Mehta, Gerard X. Brogan, Elizabeth R. Delong, Dan J. Fintel, et al. “Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromes..” Ann Intern Med 145, no. 10 (November 21, 2006): 739–48. https://doi.org/10.7326/0003-4819-145-10-200611210-00006.Full Text Link to Item
-
Tricoci, P., M. T. Roe, and E. D. Peterson. “In reply [16].” Archives of Internal Medicine 166, no. 20 (November 13, 2006). https://doi.org/10.1001/archinte.166.20.2293.Full Text
-
Tricoci, Pierluigi, Eric D. Peterson, Jyotsna Mulgund, L Kristin Newby, Jorge F. Saucedo, Neil S. Kleiman, Deepak L. Bhatt, et al. “Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE)..” Am J Cardiol 98, no. 9 (November 1, 2006): 1172–76. https://doi.org/10.1016/j.amjcard.2006.05.047.Full Text Link to Item
-
Alexander, Karen P., Anita Y. Chen, L Kristin Newby, Nancy M Allen LaPointe, E Magnus Ohman, Matthew T. Roe, William E. Boden, and Eric D. Peterson. “Blood transfusion and mortality among patients with non-ST-segment elevation acute coronary syndromes: Results from CRUSADE.” Circulation 114, no. 18 (October 31, 2006): 701–701.Link to Item
-
Bangalore, Sripal, Fang-Shu Ou, Jacqueline Tamis-Holland, Matthew T. Roe, Franz H. Messerli, and Eric D. Peterson. “Relationship between heart rate, blood pressure and in-hospital mortality in patients with Non-ST-segment elevation acute coronary syndromes: Results in 139,194 patients.” Circulation 114, no. 18 (October 31, 2006): 513–513.Link to Item
-
Linefsky, Jason P., Kenneth W. Mahaffey, Karen S. Pieper, Annie Lin, Craig J. Reist, Elliott Antman, Shaun G. Goodman, et al. “Differences between site-reported and core laboratory creatine kinase-MB values in an international clinical trial: Results from the SYNERGY trial.” Circulation 114, no. 18 (October 31, 2006): 421–421.Link to Item
-
Mellori, Chiara, Eric D. Peterson, Anita Y. Chen, Lynda A. Szczech, L Kristin Newby, Robert A. Harrington, W Brian Gibler, et al. “Importance of glomerular filtration rate formula for determining chronic kidney disease and clinical care in patients with acute coronary syndromes.” Circulation 114, no. 18 (October 31, 2006): 406–406.Link to Item
-
Petersen, John L., Matthew T. Roe, Jyotsna Mulgund, Michael A. Blazing, JoAnne M. Foody, Sidney C. Smith, Robert M. Califf, et al. “Impact of the national cholesterol education program third adult treatment panel lipid-lowering recommendations on the management of patients with non-ST-segment elevation acute coronary syndromes.” Circulation 114, no. 18 (October 31, 2006): 899–899.Link to Item
-
Mehta, Rajendra H., Matthew T. Roe, Anita Y. Chen, Barbara L. Lytle, Charles V. Pollack, Ralph G. Brindis, Sidney C. Smith, et al. “Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative..” Arch Intern Med 166, no. 18 (October 9, 2006): 2027–34. https://doi.org/10.1001/archinte.166.18.2027.Full Text Link to Item
-
Mehta, Rajendra H., L Kristin Newby, Yogin Patel, James W. Hoekstra, Chadwick D. Miller, Anita Y. Chen, Barbara L. Lytle, et al. “The impact of emergency department structure and care processes in delivering care for non-ST-segment elevation acute coronary syndromes..” Am Heart J 152, no. 4 (October 2006): 648–60. https://doi.org/10.1016/j.ahj.2006.04.015.Full Text Link to Item
-
Patel, Manesh R., Anita Y. Chen, Eric D. Peterson, L Kristin Newby, Charles V. Pollack, Ralph G. Brindis, C Michael Gibson, et al. “Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative..” Am Heart J 152, no. 4 (October 2006): 641–47. https://doi.org/10.1016/j.ahj.2006.02.035.Full Text Link to Item
-
Rokos, Ivan C., David M. Larson, Timothy D. Henry, William J. Koenig, Marc Eckstein, William J. French, Christopher B. Granger, and Matthew T. Roe. “Rationale for establishing regional ST-elevation myocardial infarction receiving center (SRC) networks..” Am Heart J 152, no. 4 (October 2006): 661–67. https://doi.org/10.1016/j.ahj.2006.06.001.Full Text Link to Item
-
Alexander, Karen P., Anita Y. Chen, L Kristin Newby, Janice B. Schwartz, Rita F. Redberg, Judith S. Hochman, Matthew T. Roe, et al. “Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative..” Circulation 114, no. 13 (September 26, 2006): 1380–87. https://doi.org/10.1161/CIRCULATIONAHA.106.620815.Full Text Link to Item
-
Mehta, Rajendra H., Anita Y. Chen, Charles V. Pollack, Matthew T. Roe, Robert J. Zalenski, Elizabeth A. Clements, W Brian Gibler, E Magnus Ohman, Robert A. Harrington, and Eric D. Peterson. “Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes..” Am J Cardiol 98, no. 5 (September 1, 2006): 624–27. https://doi.org/10.1016/j.amjcard.2006.03.040.Full Text Link to Item
-
Singh, Kanwar P., and Matthew T. Roe. “ASSENT-4 PCI: should facilitated percutaneous coronary intervention be used in clinical practice?.” Nat Clin Pract Cardiovasc Med 3, no. 8 (August 2006): 420–21. https://doi.org/10.1038/ncpcardio0626.Full Text Link to Item
-
Mehta, Rajendra H., Matthew T. Roe, Jyotsna Mulgund, E Magnus Ohman, Christopher P. Cannon, W Brian Gibler, Charles V. Pollack, Sidney C. Smith, T Bruce Ferguson, and Eric D. Peterson. “Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery..” J Am Coll Cardiol 48, no. 2 (July 18, 2006): 281–86. https://doi.org/10.1016/j.jacc.2006.04.029.Full Text Link to Item
-
Cohen, Mauricio G., Matthew T. Roe, Jyotsna Mulgund, Eric D. Peterson, Ali F. Sonel, Venu Menon, Sidney C. Smith, et al. “Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE)..” American Heart Journal 152, no. 1 (July 2006): 110–17. https://doi.org/10.1016/j.ahj.2005.09.003.Full Text
-
Diercks, Deborah B., Matthew T. Roe, Jyotsna Mulgund, Charles V. Pollack, J Douglas Kirk, W Brian Gibler, E Magnus Ohman, Sidney C. Smith, William E. Boden, and Eric D. Peterson. “The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative..” Am Heart J 152, no. 1 (July 2006): 140–48. https://doi.org/10.1016/j.ahj.2005.09.024.Full Text Link to Item
-
Menon, Venu, John S. Rumsfeld, Matthew T. Roe, Mauricio G. Cohen, Eric D. Peterson, Ralph G. Brindis, Anita Y. Chen, et al. “Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromes..” Am J Med 119, no. 7 (July 2006): 584–90. https://doi.org/10.1016/j.amjmed.2006.01.018.Full Text Link to Item
-
Roe, Matthew T., Anita Y. Chen, Arthur L. Riba, Raj Gopal Goswami, W Frank Peacock, Charles V. Pollack, Sean P. Collins, et al. “Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes..” Am J Cardiol 97, no. 12 (June 15, 2006): 1707–12. https://doi.org/10.1016/j.amjcard.2005.12.068.Full Text Link to Item
-
Roe, Matthew T., Eric D. Peterson, L Kristin Newby, Anita Y. Chen, Charles V. Pollack, Ralph G. Brindis, Robert A. Harrington, et al. “The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes..” Am Heart J 151, no. 6 (June 2006): 1205–13. https://doi.org/10.1016/j.ahj.2005.08.006.Full Text Link to Item
-
Singh, Kanwar P., Matthew T. Roe, Eric D. Peterson, Anita Y. Chen, Kenneth W. Mahaffey, Shaun G. Goodman, Robert A. Harrington, et al. “Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiative..” Journal of Thrombosis and Thrombolysis 21, no. 3 (June 2006): 211–20. https://doi.org/10.1007/s11239-006-5708-0.Full Text
-
Peterson, Eric D., Matthew T. Roe, Jyotsna Mulgund, Elizabeth R. DeLong, Barbara L. Lytle, Ralph G. Brindis, Sidney C. Smith, et al. “Association between hospital process performance and outcomes among patients with acute coronary syndromes..” Jama 295, no. 16 (April 26, 2006): 1912–20. https://doi.org/10.1001/jama.295.16.1912.Full Text Link to Item
-
Tricoci, Pierluigi, Matthew T. Roe, Jyotsna Mulgund, L Kristin Newby, Sidney C. Smith, Charles V. Pollack, Dan J. Fintel, et al. “Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge..” Arch Intern Med 166, no. 7 (April 10, 2006): 806–11. https://doi.org/10.1001/archinte.166.7.806.Full Text Link to Item
-
Han, Jin H., Abhinav Chandra, Jyotsna Mulgund, Matthew T. Roe, Eric D. Peterson, Lynda A. Szczech, Uptal Patel, E Magnus Ohman, Christopher J. Lindsell, and W Brian Gibler. “Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes..” The American Journal of Medicine 119, no. 3 (March 2006): 248–54. https://doi.org/10.1016/j.amjmed.2005.08.057.Full Text
-
Diercks, Deborah B., W Frank Peacock, Brian C. Hiestand, Anita Y. Chen, Charles V. Pollack, J Douglas Kirk, Sidney C. Smith, et al. “Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative)..” Am J Cardiol 97, no. 4 (February 15, 2006): 437–42. https://doi.org/10.1016/j.amjcard.2005.09.073.Full Text Link to Item
-
Newby, L Kristin, Matthew T. Roe, Anita Y. Chen, E Magnus Ohman, Robert H. Christenson, Charles V. Pollack, James W. Hoekstra, et al. “Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes..” J Am Coll Cardiol 47, no. 2 (January 17, 2006): 312–18. https://doi.org/10.1016/j.jacc.2005.08.062.Full Text Link to Item
-
Brogan, Gerard X., Eric D. Peterson, Jyotsna Mulgund, Deepak L. Bhatt, E Magnus Ohman, W Brian Gibler, Charles V. Pollack, Michael E. Farkouh, and Matthew T. Roe. “Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes..” Diabetes Care 29, no. 1 (January 2006): 9–14.Link to Item
-
Galla, John M., Kenneth W. Mahaffey, Shelly K. Sapp, John H. Alexander, Matthew T. Roe, E Magnus Ohman, Christopher B. Granger, et al. “Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials..” Am Heart J 151, no. 1 (January 2006): 16–24. https://doi.org/10.1016/j.ahj.2005.01.045.Full Text Link to Item
-
Alexander, Karen P., Anita Y. Chen, Matthew T. Roe, L Kristin Newby, C Michael Gibson, Nancy M. Allen-LaPointe, Charles Pollack, et al. “Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes..” Jama 294, no. 24 (December 28, 2005): 3108–16. https://doi.org/10.1001/jama.294.24.3108.Full Text Link to Item
-
Ryan, Jason W., Eric D. Peterson, Anita Y. Chen, Matthew T. Roe, E Magnus Ohman, Christopher P. Cannon, Peter B. Berger, et al. “Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry..” Circulation 112, no. 20 (November 15, 2005): 3049–57. https://doi.org/10.1161/CIRCULATIONAHA.105.582346.Full Text Link to Item
-
Alexander, Karen P., Matthew T. Roe, Anita Y. Chen, Barbara L. Lytle, Charles V. Pollack, Joanne M. Foody, William E. Boden, et al. “Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative..” J Am Coll Cardiol 46, no. 8 (October 18, 2005): 1479–87. https://doi.org/10.1016/j.jacc.2005.05.084.Full Text Link to Item
-
Yang, Xin, Karen P. Alexander, Anita Y. Chen, Matthew T. Roe, Ralph G. Brindis, Sunil V. Rao, W Brian Gibler, E Magnus Ohman, Eric D. Peterson, and Eric D. CRUSADE Investigators. “The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative..” J Am Coll Cardiol 46, no. 8 (October 18, 2005): 1490–95. https://doi.org/10.1016/j.jacc.2005.06.072.Full Text Link to Item
-
Kandzari, David E., Matthew T. Roe, E Magnus Ohman, Sarah Milford-Beland, Anita Y. Chen, Barbara L. Lytle, David J. Cohen, et al. “Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes..” The American Journal of Cardiology 96, no. 6 (September 2005): 750–55. https://doi.org/10.1016/j.amjcard.2005.05.015.Full Text
-
Roe, Matthew T., Eric D. Peterson, Yun Li, Charles V. Pollack, Robert H. Christenson, W Frank Peacock, Francis M. Fesmire, et al. “Relationship between risk stratification by cardiac troponin level and adherence to guidelines for non-ST-segment elevation acute coronary syndromes..” Archives of Internal Medicine 165, no. 16 (September 2005): 1870–76. https://doi.org/10.1001/archinte.165.16.1870.Full Text
-
Roe, Matthew T., Lori S. Parsons, Charles V. Pollack, John G. Canto, Hal V. Barron, Nathan R. Every, William J. Rogers, Eric D. Peterson, and Eric D. National Registry of Myocardial Infarction Investigators. “Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction..” Arch Intern Med 165, no. 14 (July 25, 2005): 1630–36. https://doi.org/10.1001/archinte.165.14.1630.Full Text Link to Item
-
ADVANCE MI Investigators, A. H. “Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial..” Am Heart J 150, no. 1 (July 2005): 116–22. https://doi.org/10.1016/j.ahj.2005.04.005.Full Text Link to Item
-
Mahaffey, Kenneth W., Matthew T. Roe, Rakhi Kilaru, John K. French, John H. Alexander, Lisa G. Berdan, Frans Van De Werf, et al. “Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes..” Am J Cardiol 95, no. 12 (June 15, 2005): 1404–8. https://doi.org/10.1016/j.amjcard.2005.02.005.Full Text Link to Item
-
Gurjeva, O. S., M. T. Roe, S. A. Murphy, D. J. Moliterno, and C. P. Cannon. “Unfortunate impact of age on the management and outcomes of unstable angina and non-ST elevation myocardial infarction (the GUARANTEE registry).” Critical Pathways in Cardiology 4, no. 2 (June 1, 2005): 81–87. https://doi.org/10.1097/01.hpc.0000164658.06135.a2.Full Text
-
Meine, Trip J., Matthew T. Roe, Anita Y. Chen, Manesh R. Patel, Jeffrey B. Washam, E Magnus Ohman, W Frank Peacock, et al. “Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative..” Am Heart J 149, no. 6 (June 2005): 1043–49. https://doi.org/10.1016/j.ahj.2005.02.010.Full Text Link to Item
-
Hoekstra, James W., Matthew T. Roe, Eric D. Peterson, Venu Menon, Jyotsna Mulgund, Charles V. Pollack, Chadwick Miller, et al. “Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns..” Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine 12, no. 5 (May 2005): 431–38. https://doi.org/10.1197/j.aem.2004.11.029.Full Text
-
Roe, Matthew T., and Eric D. Peterson. “Improvements in quality improvement..” Am Heart J 149, no. 5 (May 2005): 751–52. https://doi.org/10.1016/j.ahj.2004.08.032.Full Text Link to Item
-
Pollack, Charles V., Deborah B. Diercks, Matthew T. Roe, Eric D. Peterson, Eric D. American College of Cardiology, and Eric D. American Heart Association. “2004 American College of Cardiology/American Heart Association guidelines for the management of patients with ST-elevation myocardial infarction: implications for emergency department practice..” Ann Emerg Med 45, no. 4 (April 2005): 363–76. https://doi.org/10.1016/j.annemergmed.2004.11.003.Full Text Link to Item
-
Roe, Matthew T., Eric D. Peterson, Charles V. Pollack, L Kristin Newby, Yun Li, Robert H. Christenson, W Frank Peacock, et al. “Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes..” Annals of Emergency Medicine 45, no. 4 (April 2005): 355–62. https://doi.org/10.1016/j.annemergmed.2004.10.016.Full Text
-
Blomkalns, Andra L., Anita Y. Chen, Judith S. Hochman, Eric D. Peterson, Kelly Trynosky, Deborah B. Diercks, Gerard X. Brogan, et al. “Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative..” J Am Coll Cardiol 45, no. 6 (March 15, 2005): 832–37. https://doi.org/10.1016/j.jacc.2004.11.055.Full Text Link to Item
-
Kandzari, David E., Matthew T. Roe, Anita Y. Chen, Barbara L. Lytle, Charles V. Pollack, Robert A. Harrington, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes..” American Heart Journal 149, no. 3 (March 2005): 474–81. https://doi.org/10.1016/j.ahj.2004.11.014.Full Text
-
Rebeiz, Abdallah G., Per Johanson, Cindy L. Green, Suzanne W. Crater, Matthew T. Roe, Anatoly Langer, Robert P. Giugliano, et al. “Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)..” Am J Cardiol 95, no. 5 (March 1, 2005): 611–14. https://doi.org/10.1016/j.amjcard.2004.10.038.Full Text Link to Item
-
Sonel, Ali F., Chester B. Good, Jyotsna Mulgund, Matthew T. Roe, W Brian Gibler, Sidney C. Smith, Mauricio G. Cohen, et al. “Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?)..” Circulation 111, no. 10 (March 2005): 1225–32. https://doi.org/10.1161/01.cir.0000157732.03358.64.Full Text
-
Foody, JoAnne M., Matthew T. Roe, Anita Y. Chen, Sidney C. Smith, Ralph G. Brindis, Eric D. Peterson, W Brian Gibler, E Magnus Ohman, and E Magnus CRUSADE Investigators. “Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE)..” The American Journal of Cardiology 95, no. 4 (February 2005): 483–85. https://doi.org/10.1016/j.amjcard.2004.09.060.Full Text
-
Atwater, Brett D., Matthew T. Roe, and Kenneth W. Mahaffey. “Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selection..” Drugs 65, no. 3 (2005): 313–24. https://doi.org/10.2165/00003495-200565030-00002.Full Text Link to Item
-
Kirtane, Ajay J., Aaron Weisbord, Dimitrios Karmpaliotis, Sabina A. Murphy, Robert P. Giugliano, Christopher P. Cannon, Elliott M. Antman, et al. “Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction..” The American Journal of Cardiology 95, no. 2 (January 2005): 224–27. https://doi.org/10.1016/j.amjcard.2004.09.007.Full Text
-
Kirtane, Ajay J., Pedro Martinezclark, Aref M. Rahman, Kausik K. Ray, Dimitrios Karmpaliotis, Sabina A. Murphy, Robert P. Giugliano, et al. “Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction..” Journal of the American College of Cardiology 45, no. 2 (January 2005): 321–23. https://doi.org/10.1016/j.jacc.2004.10.018.Full Text
-
Yan, Andrew T., Philip Jong, Raymond T. Yan, Mary Tan, David Fitchett, Chi-Ming Chow, Matthew T. Roe, et al. “Clinical trial--derived risk model may not generalize to real-world patients with acute coronary syndrome..” Am Heart J 148, no. 6 (December 2004): 1020–27. https://doi.org/10.1016/j.ahj.2004.02.014.Full Text Link to Item
-
Bhatt, Deepak L., Matthew T. Roe, Eric D. Peterson, Yun Li, Anita Y. Chen, Robert A. Harrington, Adam B. Greenbaum, et al. “Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative..” Jama 292, no. 17 (November 3, 2004): 2096–2104. https://doi.org/10.1001/jama.292.17.2096.Full Text Link to Item
-
Ohman, E Magnus, Matthew T. Roe, Sidney C. Smith, Ralph G. Brindis, Robert H. Christenson, Robert A. Harrington, W Brian Gibler, Eric D. Peterson, and Eric D. CRUSADE Investigators. “Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative..” American Heart Journal 148, no. 5 Suppl (November 2004): S34–39. https://doi.org/10.1016/j.ahj.2004.09.013.Full Text
-
Roe, Matthew T. “Success stories: how hospitals are improving care..” Am Heart J 148, no. 5 Suppl (November 2004): S52–55. https://doi.org/10.1016/j.ahj.2004.09.017.Full Text Link to Item
-
Roe, Matthew T., Eric D. Peterson, E Magnus Ohman, Sidney C. Smith, and W Brian Gibler. “Overcoming the challenges facing quality-improvement strategies for non-ST-segment elevation acute coronary syndromes..” American Family Physician 70, no. 10 (November 2004): 1868–76.
-
Yan, Andrew T., Mary Tan, David Fitchett, Chi-Ming Chow, Ronald A. Fowlis, Thomas G. McAvinue, Matthew T. Roe, et al. “One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry)..” Am J Cardiol 94, no. 1 (July 1, 2004): 25–29. https://doi.org/10.1016/j.amjcard.2004.03.024.Full Text Link to Item
-
Waters, Richard E., Kanwar P. Singh, Matthew T. Roe, Mat Lotfi, Michael H. Sketch, Kenneth W. Mahaffey, L Kristin Newby, et al. “Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction..” J Am Coll Cardiol 43, no. 12 (June 16, 2004): 2153–59. https://doi.org/10.1016/j.jacc.2003.12.057.Full Text Link to Item
-
Giugliano, Robert P., Marc S. Sabatine, C Michael Gibson, Matthew T. Roe, Robert A. Harrington, Sabina A. Murphy, David A. Morrow, Elliott M. Antman, and Eugene Braunwald. “Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion..” Am J Cardiol 93, no. 11 (June 1, 2004): 1362-A6. https://doi.org/10.1016/j.amjcard.2004.02.031.Full Text Link to Item
-
Aghababian, Richard V. “Building evidence for early initiation of clopidogrel loading in non-ST-segment elevation acute coronary syndromes: going past the American College of Cardiology/American Heart Association guidelines..” Ann Emerg Med 43, no. 5 (May 2004): 666–68. https://doi.org/10.1016/j.annemergmed.2003.10.054.Full Text Link to Item
-
Gibson, C Michael, Juhana Karha, Robert P. Giugliano, Mathew T. Roe, Sabina A. Murphy, Robert A. Harrington, Cindy L. Green, et al. “Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction..” Am Heart J 147, no. 5 (May 2004): 847–52. https://doi.org/10.1016/j.ahj.2003.11.015.Full Text Link to Item
-
Trichon, Benjamin H., and Matthew T. Roe. “Acute coronary syndromes and diabetes mellitus..” Diabetes & Vascular Disease Research 1, no. 1 (May 2004): 23–32. https://doi.org/10.3132/dvdr.2004.003.Full Text
-
Gibson, C Michael, Juhana Karha, Sabina A. Murphy, James A. de Lemos, David A. Morrow, Robert P. Giugliano, Mathew T. Roe, et al. “Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction..” J Am Coll Cardiol 43, no. 7 (April 7, 2004): 1170–76. https://doi.org/10.1016/j.jacc.2003.11.035.Full Text Link to Item
-
Roe, Matthew T., Cynthia L. Green, Robert P. Giugliano, C Michael Gibson, Kenneth Baran, Mark Greenberg, Sebastian T. Palmeri, et al. “Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction..” J Am Coll Cardiol 43, no. 4 (February 18, 2004): 549–56. https://doi.org/10.1016/j.jacc.2003.09.039.Full Text Link to Item
-
Roe, M. T., K. W. Mahaffey, R. Kilaru, J. H. Alexander, K. M. Akkerhuis, M. L. Simoons, R. A. Harrington, et al. “Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes..” Eur Heart J 25, no. 4 (February 2004): 313–21. https://doi.org/10.1016/j.ehj.2003.12.009.Full Text Link to Item
-
Rebeiz, Abdallah G., Matthew T. Roe, John H. Alexander, Kenneth W. Mahaffey, Christopher B. Granger, Eric D. Peterson, Robert M. Califf, and Robert A. Harrington. “Integrating antithrombin and antiplatelet therapies with early invasive management for non-ST-segment elevation acute coronary syndromes..” Am J Med 116, no. 2 (January 15, 2004): 119–29. https://doi.org/10.1016/j.amjmed.2003.09.028.Full Text Link to Item
-
Bastani, Aveh, and Brian J. O’Neil. “The lack of science behind the standard of care..” Ann Emerg Med 42, no. 6 (December 2003): 847–48. https://doi.org/10.1016/j.annemergmed.2003.05.003.Full Text Link to Item
-
Roe, Matthew T., Robert H. Christenson, E Magnus Ohman, Raymond Bahr, Francis M. Fesmire, Alan Storrow, Michael Mollod, et al. “A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes..” Am Heart J 146, no. 6 (December 2003): 993–98. https://doi.org/10.1016/S0002-8703(03)00517-9.Full Text Link to Item
-
Waters, Richard E., Kenneth W. Mahaffey, Christopher B. Granger, and Matthew T. Roe. “Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies..” Am Heart J 146, no. 6 (December 2003): 958–68. https://doi.org/10.1016/S0002-8703(03)00439-3.Full Text Link to Item
-
Roe, Matthew T., E Magnus Ohman, Charles V. Pollack, Eric D. Peterson, Ralph G. Brindis, Robert A. Harrington, Robert H. Christenson, Sidney C. Smith, Robert M. Califf, and W Brian Gibler. “Changing the model of care for patients with acute coronary syndromes..” Am Heart J 146, no. 4 (October 2003): 605–12. https://doi.org/10.1016/S0002-8703(03)00388-0.Full Text Link to Item
-
Peterson, Eric D., Charles V. Pollack, Matthew T. Roe, Lori S. Parsons, Katherine A. Littrell, John G. Canto, Hal V. Barron, and Hal V. National Registry of Myocardial Infarction (NRMI) 4 Investigators. “Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4..” J Am Coll Cardiol 42, no. 1 (July 2, 2003): 45–53. https://doi.org/10.1016/s0735-1097(03)00514-x.Full Text Link to Item
-
Fesmire, Francis M., Eric D. Peterson, Matthew T. Roe, and James F. Wojcik. “Early use of glycoprotein IIb/IIIa inhibitors in the ED treatment of non-ST-segment elevation acute coronary syndromes: a local quality improvement initiative..” Am J Emerg Med 21, no. 4 (July 2003): 302–8. https://doi.org/10.1016/s0735-6757(03)00027-5.Full Text Link to Item
-
Gibson, C Michael, Ajay J. Kirtane, Sabina A. Murphy, Juhana Karha, Christopher P. Cannon, Robert P. Giugliano, Mathew T. Roe, Robert A. Harrington, E Magnus Ohman, and Elliott M. Antman. “Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture..” Journal of Thrombosis and Thrombolysis 15, no. 3 (June 2003): 189–96. https://doi.org/10.1023/b:thro.0000011374.60110.bc.Full Text
-
Giugliano, Robert P., Matthew T. Roe, Robert A. Harrington, C Michael Gibson, Uwe Zeymer, Frans Van de Werf, Kenneth W. Baran, et al. “Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial..” J Am Coll Cardiol 41, no. 8 (April 16, 2003): 1251–60. https://doi.org/10.1016/s0735-1097(03)00123-2.Full Text Link to Item
-
Pollack, Charles V., Matthew T. Roe, and Eric D. Peterson. “2002 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice..” Ann Emerg Med 41, no. 3 (March 2003): 355–69. https://doi.org/10.1067/mem.2003.88.Full Text Link to Item
-
Rebeiz, A. G., and M. T. Roe. “Rationale for the early use of platelet glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes.” Cardiovascular Reviews and Reports 24, no. 3 (March 1, 2003): 128–34.
-
Staman, Karen L., Matthew T. Roe, Elizabeth S. Fraulo, Barbara L. Lytle, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Quality improvement tools designed to improve adherence to the ACC/AHA Guidelines for the care of patients with non-ST-segment acute coronary syndromes: the CRUSADE quality improvement initiative..” Crit Pathw Cardiol 2, no. 1 (March 2003): 34–40. https://doi.org/10.1097/01.HPC.0000053684.59325.88.Full Text Link to Item
-
Gurbel, Paul A., Brian Galbut, Kevin P. Bliden, Raymond D. Bahr, Matthew T. Roe, Victor L. Serebruany, W Brian Gibler, Robert H. Christenson, E Magnus Ohman, and E Magnus EARLY Platelet Substudy. “Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy)..” J Thromb Thrombolysis 14, no. 3 (December 2002): 213–19. https://doi.org/10.1023/a:1025048726396.Full Text Link to Item
-
Mukherjee, Debabrata, Kenneth W. Mahaffey, David J. Moliterno, Robert A. Harrington, Jay S. Yadav, Karen S. Pieper, Dianne Gallup, et al. “Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B)..” Am Heart J 144, no. 6 (December 2002): 995–1002. https://doi.org/10.1067/mhj.2002.126118.Full Text Link to Item
-
Hoekstra, James W., Charles V. Pollack, Matthew T. Roe, Eric D. Peterson, Ralph Brindis, Robert A. Harrington, Robert H. Christenson, Sidney C. Smith, E Magnus Ohman, and W Brian Gibler. “Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative..” Acad Emerg Med 9, no. 11 (November 2002): 1146–55. https://doi.org/10.1111/j.1553-2712.2002.tb01569.x.Full Text Link to Item
-
Kandzari, David E., and Matthew T. Roe. “Integrating GP IIb/IIIa inhibition into treatment strategies for acute ST-elevation myocardial infarction..” The Journal of Invasive Cardiology 14, no. 9 (September 2002): 565–74.
-
Roe, Matthew T., Karen L. Staman, Charles Pollack, Rebecca Teaff, Patricia A. French, and Eric D. Peterson. “A practical guide to understanding the 2002 ACC/AHA guidelines for the management of patients with non-ST segment elevation acute coronary syndromes..” Crit Pathw Cardiol 1, no. 3 (September 2002): 129–49.Link to Item
-
Bahr, Raymond D., Paul A. Gurbel, Alex I. Malinin, Charlyn Wentz, Robert H. Christenson, Matthew T. Roe, W Brian Gibler, Michael M. Kitt, E Magnus Ohman, and Victor L. Serebruany. “Relation of platelet activation and myocardial ischemia biomarkers dependent on type of chest pain (abrupt onset versus intermittent) in patients with angina pectoris or non-Q-wave acute myocardial infarction..” Am J Cardiol 90, no. 3 (August 1, 2002): 310–12. https://doi.org/10.1016/s0002-9149(02)02470-0.Full Text Link to Item
-
Mahaffey, Kenneth W., Matthew T. Roe, Christopher K. Dyke, L Kristin Newby, Neal S. Kleiman, Patty Connolly, Lisa G. Berdan, et al. “Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial..” Am Heart J 143, no. 2 (February 2002): 242–48. https://doi.org/10.1067/mhj.2002.120145.Full Text Link to Item
-
Patel, Manesh R., and Matthew T. Roe. “Pharmacological treatment of elderly patients with acute coronary syndromes without persistent ST segment elevation..” Drugs Aging 19, no. 9 (2002): 633–46. https://doi.org/10.2165/00002512-200219090-00002.Full Text Link to Item
-
Aronow, H. D., E. J. Topol, M. T. Roe, P. L. Houghtaling, K. E. Wolski, and A. M. Lincoff. “Lipid-lowering drugs prescription of lipid-lowering drugs at hospital discharge following an acute coronary syndrome was associated with reduced short-term mortality.” Evidence Based Cardiovascular Medicine 5, no. 2 (December 17, 2001): 44–45.
-
Roe, M. T., C. B. Granger, J. A. Puma, A. S. Hellkamp, J. S. Hochman, E. M. Ohman, H. D. White, et al. “Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention..” Am J Cardiol 88, no. 12 (December 15, 2001): 1403-A6. https://doi.org/10.1016/s0002-9149(01)02119-1.Full Text Link to Item
-
Roe, M. T., R. P. Giugliano, R. A. Harrington, C. M. Gibson, J. Strony, M. M. Kitt, R. M. Califf, and E. Braunwald. “Combination reperfusion therapy with eptifibatide and tenecteplase for acute myocardial infarction: Design and methodology of the INTEGRITI (Integrilin and Tenecteplase for Acute Myocardial Infarction) Trial.” Heartdrug 1, no. 1 (December 1, 2001): 5–13. https://doi.org/10.1159/000022704.Full Text
-
Roe, M. T., F. A. Cura, P. S. Joski, E. Garcia, V. Guetta, D. J. Kereiakes, F. Zijlstra, B. R. Brodie, C. L. Grines, and S. G. Ellis. “Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction..” Am J Cardiol 88, no. 2 (July 15, 2001): 170-A6. https://doi.org/10.1016/s0002-9149(01)01615-0.Full Text Link to Item
-
Mukherjee, D., K. Comella, D. L. Bhatt, M. T. Roe, V. Patel, and S. G. Ellis. “Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularization..” Am Heart J 142, no. 1 (July 2001): 72–74. https://doi.org/10.1067/mhj.2001.115786.Full Text Link to Item
-
Aronow, H. D., E. J. Topol, M. T. Roe, P. L. Houghtaling, K. E. Wolski, A. M. Lincoff, R. A. Harrington, et al. “Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study..” Lancet 357, no. 9262 (April 7, 2001): 1063–68. https://doi.org/10.1016/S0140-6736(00)04257-4.Full Text Link to Item
-
Peterson, J. G., E. J. Topol, M. T. Roe, S. K. Sapp, A. M. Lincoff, J. W. Deckers, E. H. Blackstone, R. A. Harrington, R. M. Califf, and M. S. Lauer. “Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy..” Am J Cardiol 87, no. 5 (March 1, 2001): 532–36. https://doi.org/10.1016/s0002-9149(00)01426-0.Full Text Link to Item
-
Christenson, R. H., S. H. Duh, M. T. Roe, and E. M. Ohman. “Determination of the falloff constant (k(f)) from modeling biochemical marker release: a new variable for discriminating therapies..” Cardiovasc Toxicol 1, no. 2 (2001): 171–76. https://doi.org/10.1385/ct:1:2:171.Full Text Link to Item
-
Roe, M. T., E. M. Ohman, A. C. Maas, R. H. Christenson, K. W. Mahaffey, C. B. Granger, R. A. Harrington, R. M. Califf, and M. W. Krucoff. “Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion..” J Am Coll Cardiol 37, no. 1 (January 2001): 9–18. https://doi.org/10.1016/s0735-1097(00)01101-3.Full Text Link to Item
-
Marso, S. P., D. L. Bhatt, M. T. Roe, P. L. Houghtaling, M. Labinaz, N. S. Kleiman, C. Dyke, et al. “Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators..” Circulation 102, no. 24 (December 12, 2000): 2952–58. https://doi.org/10.1161/01.cir.102.24.2952.Full Text Link to Item
-
Roe, M. T., R. A. Harrington, D. M. Prosper, K. S. Pieper, D. L. Bhatt, A. M. Lincoff, M. L. Simoons, et al. “Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators..” Circulation 102, no. 10 (September 5, 2000): 1101–6. https://doi.org/10.1161/01.cir.102.10.1101.Full Text Link to Item
-
Roe, M. T. “Treatment strategies for microvascular dysfunction following acute myocardial infarction..” Curr Cardiol Rep 2, no. 5 (September 2000): 405–10. https://doi.org/10.1007/s11886-000-0053-y.Full Text Link to Item
-
Roe, M. T., M. A. Abramson, J. Li, S. K. Heinle, J. Kisslo, G. R. Corey, and D. J. Sexton. “Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the duke criteria..” Am Heart J 139, no. 6 (June 2000): 945–51. https://doi.org/10.1067/mhj.2000.104762.Full Text Link to Item
-
Roe, M. T., S. K. Sapp, and A. M. Lincoff. “Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes..” Cleve Clin J Med 67, no. 2 (February 2000): 131–40. https://doi.org/10.3949/ccjm.67.2.131.Full Text Link to Item
-
Mukherjee, D., D. L. Bhatt, M. T. Roe, V. Patel, and S. G. Ellis. “Direct myocardial revascularization and angiogenesis--how many patients might be eligible?.” Am J Cardiol 84, no. 5 (September 1, 1999): 598-A8. https://doi.org/10.1016/s0002-9149(99)00387-2.Full Text Link to Item
-
Roe, M. T., and D. J. Moliterno. “Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors..” J Thromb Thrombolysis 7, no. 3 (June 1999): 247–57. https://doi.org/10.1023/a:1008927025962.Full Text Link to Item
-
Roe, M. T., and D. J. Moliterno. “Treatment of non-ST-segment-elevation acute coronary syndromes with platelet glycoprotein IIb/IIIa inhibitors: an emergency department perspective..” J Emerg Med 17, no. 3 (May 1999): 581–88. https://doi.org/10.1016/s0736-4679(99)00023-2.Full Text Link to Item
-
Bedell, S. E., T. B. Graboys, and S. Ravid. “Management of non-Q-wave myocardial infarction..” N Engl J Med 339, no. 19 (November 5, 1998): 1395–96.Link to Item
-
Roe, M. T., and D. J. Moliterno. “The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade..” Cleve Clin J Med 65, no. 5 (May 1998): 267–72. https://doi.org/10.3949/ccjm.65.5.267.Full Text Link to Item
-
Gopal, A. K., and M. T. Roe. “Calcified cardiac lesion..” Chest 110, no. 4 (October 1996): 1097–98. https://doi.org/10.1378/chest.110.4.1097.Full Text Link to Item
-
Roe, M. T., D. V. Dawson, C. M. Hulette, G. Einstein, and B. J. Crain. “Microglia are not exclusively associated with plaque-rich regions of the dentate gyrus in Alzheimer's disease..” J Neuropathol Exp Neurol 55, no. 3 (March 1996): 366–71. https://doi.org/10.1097/00005072-199603000-00012.Full Text Link to Item
-
Weinstein, J. W., M. Roe, M. Towns, L. Sanders, J. J. Thorpe, G. R. Corey, and D. J. Sexton. “Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital..” Infect Control Hosp Epidemiol 17, no. 1 (January 1996): 36–41. https://doi.org/10.1086/647186.Full Text Link to Item
-
-
Book Sections
-
Kang, H. J., and M. T. Roe. “Secondary prevention in ACS: The role of novel oral anticoagulants.” In Pharmacological Treatment of Acute Coronary Syndromes, 123–38, 2014. https://doi.org/10.1007/978-1-4471-5424-2_4.Full Text
-
Kuijt, W. J., J. Williams, C. B. Granger, M. W. Krucoff, and M. T. Roe. “Current approaches to prevention and management of reperfusion injury.” In Management of Myocardial Reperfusion Injury, 9781849960199:215–38, 2012. https://doi.org/10.1007/978-1-84996-019-9_10.Full Text
-
Singh, K., M. Roe, and R. Harrington. “Design and overview of contemporary studies of pharmacoinvasive therapy.” In Pharmacoinvasive Therapy in Acute Myocardial Infarction, 183–207, 2005.
-
-
Conference Papers
-
Povsic, Thomas J., E Magnus Ohman, Matthew T. Roe, Jennifer White, Frank W. Rockhold, Gilles Montalescot, Jan H. Cornel, et al. “P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes..” In Jama Cardiol, 4:680–84, 2019. https://doi.org/10.1001/jamacardio.2019.1510.Full Text Open Access Copy Link to Item
-
Bhatt, Deepak L., Andrew Briggs, Shelby D. Reed, Lieven Annemans, Michael Szarek, Vera A. Bittner, Rafael Diaz, et al. “Cost-Effectiveness of Alirocumab Based on Evidence From a Large Multinational Outcome Trial: The ODYSSEY OUTCOMES Economics Study.” In Circulation, 138:E753–54. LIPPINCOTT WILLIAMS & WILKINS, 2018.Link to Item
-
Schwartz, Gregory G., Michael M. Szarek, Deepak L. Bhatt, Vera A. Bittner, Marie-France Bregeault, Anthony J. Dalby, Rafael Diaz, et al. “Alirocumab Reduces Risk of Death after Acute Coronary Syndrome in Patients with Persistently Elevated Atherogenic Lipoproteins on Intensive Statin Treatment.” In Circulation, 138:E772–73. LIPPINCOTT WILLIAMS & WILKINS, 2018.Link to Item
-
Bittner, Vera, Michael Szarek, Philip E. Aylward, Deepak L. Bhatt, Rafael Diaz, Zlatko Fras, Shaun Goodman, et al. “Lp(a) and Cardiovascular Outcomes: an Analysis from the ODYSSEY OUTCOMES Trial.” In Atherosclerosis Supplements, 32:24–25. Elsevier BV, 2018. https://doi.org/10.1016/j.atherosclerosissup.2018.04.072.Full Text
-
Ambrosy, Andrew P., Lucasz P. Cerbin, Robert Clare, Yuliya Lokhnygina, Andrew Tershakovec, Matthew T. Roe, and Michael Blazing. “The Natural History of Patients Post-Acute Coronary Syndrome Based on Heart Failure Status - An Analysis of the IMPROVE-IT Trial.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.Link to Item
-
Fanaroff, Alexander C., Pearl Zakroysky, Daniel Wojdyla, Matthew W. Sherwood, Matthew T. Roe, Tracy Y. Wang, Eric D. Peterson, et al. “Association Between Operator PCI Volume and Long-term Outcomes in Older Adults: A Report From The NCDR CathPCI Registry.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.Link to Item
-
Inohara, Taku, Karen Pieper, Daniel Wojdyla, Manesh R. Patel, William S. Jones, Pierluigi Tricoci, Kenneth W. Mahaffey, et al. “Incidence, Timing, and Type of First and Recurrent Ischemic Events in Patients With and Without Peripheral Artery Disease After an Acute Coronary Syndrome.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.Link to Item
-
Melloni, Chiara, Jan H. Cornel, Gail Hafley, Megan L. Neely, Peter Clemmensen, Dmitry Zamoryakhin, Dorairaj Prabhakaran, et al. “Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial..” In Eur Heart J Acute Cardiovasc Care, 5:443–54, 2016. https://doi.org/10.1177/2048872615598631.Full Text Link to Item
-
Curtis, Lesley H., Shelley A. Rusincovitch, Jenny Ibarra, Bradley G. Hammill, Laura G. Qualls, Debra F. Harris, W. S. Jones, Russell Rothman, Matthew T. Roe, and Adrian F. Hernandez. “Design and Architecture of a Distributed Network Pragmatic Clinical Trial: The PCORnet ADAPTABLE Study..” In Cri. AMIA, 2016.
-
Zimerman, Andre, Amanda L. Stebbins, Renato D. Lopes, Patricia O. Guimaraes, Stefan K. James, John H. Alexander, Pierluigi Tricoci, et al. “Adverse Event Reporting in > 48,000 Participants in Four Acute Coronary Syndrome Trials.” In Circulation, Vol. 132. LIPPINCOTT WILLIAMS & WILKINS, 2015.Link to Item
-
Hall, Trygve Sørdahl, Jonas Hallén, Mitchell W. Krucoff, Matthew T. Roe, Danielle M. Brennan, Stefan Agewall, Dan Atar, and A Michael Lincoff. “Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction..” In Am Heart J, 169:257-265.e1, 2015. https://doi.org/10.1016/j.ahj.2014.10.015.Full Text Link to Item
-
Cornel, Jan H., E Magnus Ohman, Benjamin Neely, Peter Clemmensen, Piyamitr Sritara, Dmitry Zamoryakhin, Paul W. Armstrong, et al. “Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial..” In Am Heart J, 168:76-87.e1, 2014. https://doi.org/10.1016/j.ahj.2014.04.011.Full Text Link to Item
-
Bagai, Akshay, Yongfei Wang, Tracy Y. Wang, Jeptha Curtis, Hitinder S. Gurm, Eric D. Peterson, Jorge F. Saucedo, et al. “In-Hospital ADP Receptor Inhibitor Switching in Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry (R).” In Circulation, Vol. 128. LIPPINCOTT WILLIAMS & WILKINS, 2013.Link to Item
-
Clemmensen, Peter, Matthew T. Roe, Judith S. Hochman, Derek D. Cyr, Megan L. Neely, Darren K. McGuire, Jan H. Cornel, et al. “Outcomes in Women Compared With Men in Patients With Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction Managed Without Revascularization: Insights From the TRILOGY ACS Trial.” In Circulation, Vol. 128. LIPPINCOTT WILLIAMS & WILKINS, 2013.Link to Item
-
Lopes, Renato D., Benjamin Neely, E. M. Ohman, Diego Ardissino, Christian Hamm, Shaun G. Goodman, Deepak L. Rhatt, et al. “Timing, Profile, and Predictors of Spontaneous Myocardial Infarction Following a Non-ST-Segment Elevation Acute Coronary Syndrome Event: Insights From the TRILOGY-ACS Trial.” In Circulation, Vol. 128. LIPPINCOTT WILLIAMS & WILKINS, 2013.Link to Item
-
O’Brien, Emily C., Dajuanlca N. Holmes, Matthew T. Roe, Eric D. Peterson, and Karen S. Alexander. “Treatment and Outcomes by LDL-C Level in Statin-Naive Non-ST-Elevation Myocardial Infarction (NSTEMI) Patients: Findings From the CRUSADE Registry.” In Circulation, Vol. 128. LIPPINCOTT WILLIAMS & WILKINS, 2013.Link to Item
-
Shen, Lan, Shuang Li, Laine Thomas, Tracy Y. Wang, Karen P. Alexander, Bimal Shah, Eric Peterson, and Matthew T. Roe. “The Association of Transfer-out Rates from Hospitals Without Revascularization Capabilities and Long-term Mortality Risk Among Older Nstemi Patients.” In Circulation, Vol. 128. LIPPINCOTT WILLIAMS & WILKINS, 2013.Link to Item
-
Yeh, Robert W., Matthew J. Czarny, Sunghee Kim, Matthew T. Roe, David R. Holmes, Ralph G. Brindis, W. D. Weaver, Sharon-Lise T. Normand, Dean Kereiakes, and Laura Mauri. “Are "All-Comer" Clinical Trials Representative of Contemporary Clinical Practice: A Linked Analysis of the Dual Antiplatelet Therapy (DAPT) Study and the National Cardiovascular Data Registry (R).” In Circulation, Vol. 128. LIPPINCOTT WILLIAMS & WILKINS, 2013.Link to Item
-
Gurbel, Paul A., David Erlinge, E. M. Ohman, Joseph A. Jakubowski, Shaun G. Goodman, Kurt Huber, Mark Y. Chan, et al. “First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial - The TRILOGY ACS Platelet Function Sub-Study Abstracts.” In Circulation, 126:2777–78. LIPPINCOTT WILLIAMS & WILKINS, 2012.Link to Item
-
Brilakis, Emmanouil S., Sunil V. Rao, Subhash Banerjee, Steven Goldman, Kendrick Shunk, David R. Holmes, Emily Honeycutt, and Matthew T. Roe. “PERCUTANEOUS CORONARY INTERVENTION IN NATIVE ARTERIES VS. BYPASS GRAFTS IN PRIOR CORONARY BYPASS GRAFTING PATIENTS: A REPORT FROM THE CATHPCI REGISTRY®.” In Journal of the American College of Cardiology, 57:E1960–E1960. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)61960-8.Full Text
-
Chin, Chee Tang, Tracy Y. Wang, Anita Y. Chen, Robin Mathews, Karen P. Alexander, Matthew T. Roe, and Eric D. Peterson. “COMPARISON OF TRENDS IN IN-HOSPITAL AND LONG-TERM OUTCOMES OVER TIME AMONG OLDER PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE CRUSADE QUALITY IMPROVEMENT REGISTRY.” In Journal of the American College of Cardiology, 57:E905–E905. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)60905-4.Full Text
-
Desai, Nihar, Anita Y. Chen, Stephen D. Wiviott, Marc S. Sabatine, Karen P. Alexander, Matthew T. Roe, Eric D. Peterson, and Bimal R. Shah. “CHALLENGES IN THE TREATMENT OF NSTEMI PATIENTS AT HIGH RISK FOR BOTH ISCHEMIC AND BLEEDING EVENTS: INSIGHTS FROM THE ACTION REGISTRY-GWTG.” In Journal of the American College of Cardiology, 57:E913–E913. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)60913-3.Full Text
-
Duffy, Danielle, DaJuanicia N. Holmes, Matthew T. Roe, and Eric D. Peterson. “THE LONG-TERM PROGNOSTIC IMPACT OF LOW HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS IN OLDER ADULTS WITH ACUTE MYOCARDIAL INFARCTION.” In Journal of the American College of Cardiology, 57:E996–E996. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)60996-0.Full Text
-
Fosbøl, Emil L., Tracy Y. Wang, Jonathan Piccini, Renato D. Lopes, Bimal Shah, Karen P. Alexander, Shuang Li, Matthew T. Roe, and Eric D. Peterson. “LONG-TERM SAFETY OF ANTITHROMBOTIC THERAPY IN NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH ATRIAL FIBRILLATION.” In Journal of the American College of Cardiology, 57:E948–E948. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)60948-0.Full Text
-
Kuijt, Wichert J., Matthew T. Roe, Cindy L. Green, Karen S. Pieper, Susanna R. Stevens, Renato D. Lopes, Robert H. Christenson, et al. “PREDICTION OF DEATH AND CONGESTIVE HEART FAILURE USING MULTIPLE CONCOMITANT ANGIOGRAPHIC BIOCHEMICAL AND ELECTROCARDIOGRAPHIC BIOMARKERS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION.” In Journal of the American College of Cardiology, 57:E1074–E1074. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)61074-7.Full Text
-
Subherwal, Sumeet, Shuang Li, Manesh R. Patel, Deepak L. Bhatt, Tracy Y. Wang, Karen P. Alexander, E Magnus Ohman, W Brian Gibler, Eric D. Peterson, and Matthew T. Roe. “IMPACT OF POLYVASCULAR DISEASE ON LONG-TERM MORTALITY IN OLDER PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION.” In Journal of the American College of Cardiology, 57:E992–E992. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)60992-3.Full Text
-
Wang, Tracy, Lisa A. Kaltenbach, Deepak L. Bhatt, Sunil V. Rao, Matthew T. Roe, Frederic S. Resnic, Matthew A. Cavender, John C. Messenger, and Eric D. Peterson. “LONG-TERM MORTALITY ASSOCIATED WITH MULTIVESSEL VERSUS CULPRIT VESSEL ONLY PERCUTANEOUS CORONARY INTERVENTION FOR PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM THE NATIONAL CARDIOVASCULAR CATHPCI DATA REGISTRY.” In Journal of the American College of Cardiology, 57:E914–E914. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)60914-5.Full Text
-
Michaels, Andrew D., Theophilus E. Owan, David Dai, John C. Messenger, and Matthew T. Roe. “Temporal Trends in the Use of Thrombectomy During Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction in the United States.” In Journal of the American College of Cardiology, 56:B103–B103. ELSEVIER SCIENCE INC, 2010.Link to Item
-
Aggarwal, Atul, Fang-shu Ou, Lloyd W. Klein, John S. Rumsfeld, Matthew T. Roe, and Tracy Y. Wang. “Incidence, Predictors and In-hospital Outcomes of No Reflow Phenomenon During Percutaneous Coronary Intervention for Acute Myocardial Infarction.” In Circulation, 120:S986–S986. LIPPINCOTT WILLIAMS & WILKINS, 2009.Link to Item
-
Glickman, Seth, Charles B. Cairns, Anita Y. Chen, Christopher B. Granger, Christopher P. Cannon, Elizabeth S. Fraulo, Eric D. Peterson, and Matthew T. Roe. “Delays in Fibrinolytic Administration for Acute ST-Segment Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry (ACTION-GWTG).” In Circulation, 120:S423–S423. LIPPINCOTT WILLIAMS & WILKINS, 2009.Link to Item
-
Shah, Bimal R., Matthew T. Roe, Anita Y. Chen, Karen P. Alexander, Tracy Y. Wang, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Association Between Hospital Process Performance and 1-Year Post-discharge Mortality in Patients With Non-ST-elevation Myocardial Infarction: Results From 36,262 Patients.” In Circulation, 120:S1086–S1086. LIPPINCOTT WILLIAMS & WILKINS, 2009.Link to Item
-
Ting, Henry H., Tracy Y. Wang, Shuang Li, Matthew T. Roe, Brahmajee K. Nallamothu, David R. Holmes, Harlan M. Krumholz, and Eric D. Peterson. “Evaluation of Door-In-Door-Out Time as a Clinical Performance Measure for Patients Transferred for Primary Percutaneous Coronary Intervention.” In Circulation, 120:S437–S437. LIPPINCOTT WILLIAMS & WILKINS, 2009.Link to Item
-
Tsai, Thomas T., Thomas M. Maddox, Matthew T. Roe, David Dai, Ivan P. Casserly, P Michael Ho, John C. Messenger, Brahmajee K. Nallamothu, Eric D. Peterson, and John S. Rumsfeld. “Contemporary Risk of In-Hospital Events in Dialysis Patients Undergoing Percutaneous Coronary Interventions: Insights From the NCDR Cath-PCI Registry.” In Circulation, 120:S1101–S1101. LIPPINCOTT WILLIAMS & WILKINS, 2009.Link to Item
-
Tsai, Thomas T., Thomas M. Maddox, Matthew T. Roe, David Dai, Karen P. Alexander, P Michael Ho, John C. Messenger, Brahmajee K. Nallamothu, Eric D. Peterson, and John S. Rumsfeld. “Use of Contraindicated Anti-Thrombotics in Dialysis Patients Undergoing Percutaneous Coronary Interventions: Insights From the NCDR Cath-PCI Registry.” In Circulation, 120:S414–S414. LIPPINCOTT WILLIAMS & WILKINS, 2009.Link to Item
-
Wang, Tracy Y., Anita Y. Chen, Bimal R. Shah, Matthew T. Roe, Karen P. Alexander, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Readmission Rates Among Patients With Non-ST-Segment Elevation Myocardial Infarction: Results in 38,131 Patients From the CRUSADE Quality Improvement Initiative.” In Circulation, 120:S436–37. LIPPINCOTT WILLIAMS & WILKINS, 2009.Link to Item
-
Alexander, Karen P., Chiara Melloni, A. Pappas, L Kristin Newby, Nancy M Allen LaPointe, E Magnus Ohman, W Brian Gibler, Matthew T. Roe, and Eric D. Peterson. “Potency of statins track with intensity of overall secondary prevention.” In Circulation, 117:E453–E453. LIPPINCOTT WILLIAMS & WILKINS, 2008.Link to Item
-
Melloni, Chiara, Karen P. Alexander, Fang-Shu Ou, Nancy M Allen LaPointe, Matthew T. Roe, and Eric D. Peterson. “Factors associated with patient reported self-discontinuation of prescribed medicine after non-ST-segment elevation acute coronary syndromes.” In Circulation, 117:E418–E418. LIPPINCOTT WILLIAMS & WILKINS, 2008.Link to Item
-
Alexander, Karen P., Richard G. Bach, Anita Y. Chen, Sumeet Subherwal, Brian F. Gage, Sunil V. Rao, W Brian Gibler, et al. “Bleeding and ischemic events run parallel in NSTEMI patients.” In Journal of the American College of Cardiology, 51:A207–8. ELSEVIER SCIENCE INC, 2008.Link to Item
-
Cavender, Matthew A., Sarah Milford-Beland, William S. Weintraub, Matthew T. Roe, Eric D. Peterson, and Sunil V. Rao. “Prevalence and in-hospital outcomes of multivessel PCI during primary PCI for ST-segment elevation myocardial infarction: Results from the American college of cardiology national cardiovascular data registry (ACC-NCDR).” In Journal of the American College of Cardiology, 51:A236–A236. ELSEVIER SCIENCE INC, 2008.Link to Item
-
Diercks, Deborah B., Joseph Lynch, Michael C. Kontos, John S. Rumsfeld, Anita Y. Chen, W Brian Gibler, Christopher P. Cannon, et al. “Pre-hospital electrocardiograms: Potential answer to the time to reperfusion challenge.” In Journal of the American College of Cardiology, 51:A209–10. ELSEVIER SCIENCE INC, 2008.Link to Item
-
Peterson, Eric D., David Dai, Elizabeth R. DeLong, Sunil V. Rao, Matthew T. Roe, Kalon L. Ho, Mandeep Singh, et al. “Contemporary predictors of procedural mortality among patients undergoing percutaneous coronary intervention (PCI): Results from the ACC-NCDR.” In Journal of the American College of Cardiology, 51:A270–A270. ELSEVIER SCIENCE INC, 2008.Link to Item
-
Roe, Matthew T., Christopher P. Cannon, Anita Y. Chen, Sunil V. Rao, John S. Rumsfeld, Lloyd W. Klein, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Decline in the use of drug-eluting stents for patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Results from the CRUSADE and ACTION registries.” In Journal of the American College of Cardiology, 51:A211–A211. ELSEVIER SCIENCE INC, 2008.Link to Item
-
Subherwal, Sumeet, Richard G. Bach, Anita Y. Chen, Brian F. Gage, Sunil V. Rao, Tracy Y. Wang, W Brian Gibler, et al. “The CRUSADE bleeding score to assess baseline risk of major bleeding in non-ST-segment elevation myocardial infarction.” In Journal of the American College of Cardiology, 51:A212–A212. ELSEVIER SCIENCE INC, 2008.Link to Item
-
Tamis-Holland, Jacqueline E., Anita Y. Chen, Matthew T. Roe, Angela M. Palazzo, Amy Chorzempa, Eric D. Peterson, W Brian Gibler, E Magnus Ohman, and Judith S. Hochman. “Sex, age and outcome of non-ST elevation acute coronary syndrome: An analysis of the CRUSADE initiative.” In Journal of the American College of Cardiology, 51:A378–A378. ELSEVIER SCIENCE INC, 2008.Link to Item
-
Wang, Tracy Y., Anita Y. Chen, Eric D. Peterson, Karen P. Alexander, E Magnus Ohman, W Brian Gibler, and Matthew T. Roe. “Incidence and bleeding outcomes of excess unfractionated heparin dosing among patients with ST-Segment elevation myocardial infarction undergoing fibrinolysis.” In Journal of the American College of Cardiology, 51:A203–A203. ELSEVIER SCIENCE INC, 2008.Link to Item
-
Wang, Tracy Y., Fang-Shu Ou, Matthew T. Roe, E Magnus Ohman, W Brian Gibler, Charles V. Pollack, and Eric D. Peterson. “Incidence and impact of acquired thrombocytopenia among patients with acute coronary syndromes.” In Journal of the American College of Cardiology, 51:A217–A217. ELSEVIER SCIENCE INC, 2008.Link to Item
-
Aggarwal, Atul, David Dal, John S. Rumsfeld, LloydW Klein, and Matthew T. Roe. “Characteristics and outcomes of patients taking warfarin prior to percutaneous coronary intervention.” In Circulation, 116:702–702. LIPPINCOTT WILLIAMS & WILKINS, 2007.Link to Item
-
Akhter, Nausheen, Sarah Milford-Beland, Matthew T. Roe, and Adhir R. Shroff. “Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the ACC/NCDR PCI registry.” In Circulation, 116:720–720. LIPPINCOTT WILLIAMS & WILKINS, 2007.Link to Item
-
Alexander, Karen P., Anita Y. Chen, Matthew T. Roe, L Kristin Newby, Brian Gibler, E Magnus Ohman, Charles V. Pollack, and Eric D. Peterson. “Decline in GP 2b3a inhibitor overdosing with site-specific feedback in CRUSADE.” In Circulation, 116:798–99. LIPPINCOTT WILLIAMS & WILKINS, 2007.Link to Item
-
Wang, Tracy Y., David Dai, Eric D. Peterson, Sunil V. Rao, and Matthew T. Roe. “Challenges of using peri-procedural myocardial infarction as a quality measure among patients undergoing percutaneous coronary intervention.” In Circulation, 116:370–370. LIPPINCOTT WILLIAMS & WILKINS, 2007.Link to Item
-
Wang, Tracy Y., Anita Y. Chen, Magnus Ohman, Karen P. Alexander, Charles V. Pollack, Sidney C. Smith, W Brian Gibler, Matthew T. Roe, and Eric D. Peterson. “Contemporary patterns of reperfusion for elderly patients with ST-segment elevation myocardial infarction.” In Circulation, 115:E582–E582. LIPPINCOTT WILLIAMS & WILKINS, 2007.Link to Item
-
Alexander, Deeou, Fang-Shu Ou, Matthew T. Roe, Charles V. Pollack, E. M. Ohman, Christopher P. Cannon, W. B. Giblet, Dan J. Fintel, Eric D. Peterson, and David L. Brown. “Use and outcomes of acute clopiclogrel therapy in non-ST-segment elevation myocardial infarction in community practice: Results from CRUSADE.” In Journal of the American College of Cardiology, 49:207A-208A. ELSEVIER SCIENCE INC, 2007.Link to Item
-
Amsterdam, Ezra A., Eric D. Peterson, Fang-Shu Ou, L Kristin Newby, Charles V. Pollack, W Brian Gibler, E Magnus Ohman, and Matthew T. Roe. “Trends in the treatment and outcomes of patients with non-ST-segment elevation acute coronary syndromes managed medically without cardiac catheterization.” In Journal of the American College of Cardiology, 49:196A-197A. ELSEVIER SCIENCE INC, 2007.Link to Item
-
Patel, Uptal D., Fang-Shu Ou, Matthew T. Roe, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Impact of hospital performance on underuse of therapies, among patients with chronic kidney disease and non-ST-segment elevation acute coronary syndromes.” In Journal of the American College of Cardiology, 49:289A-289A. ELSEVIER SCIENCE INC, 2007.Link to Item
-
Roe, Matthew T., Karen P. Alexander, Fang-Shou Ou, L Kristin Newby, W Brian Gibler, Charles V. Pollack, E Magnus Ohman, Sidney C. Smith, and Eric D. Peterson. “Patterns of HDL levels in patients with non-ST-segment elevation acute coronary syndromes and association with clinical outcomes.” In Journal of the American College of Cardiology, 49:366A-366A. ELSEVIER SCIENCE INC, 2007.Link to Item
-
Roe, Matthew T., Kevin Grimes, Eric Bates, Neal Kleiman, Christoph Bode, Kurt Huber, Christopher B. Granger, et al. “Inhibition of 8 delta-protein kinase C to ameliorate reperfusion injury during primary percutaneous coronary intervention for acute ST-elevation myocardial infarction - Preliminary results from the DELTA MI trial.” In Journal of the American College of Cardiology, 49:215A-215A. ELSEVIER SCIENCE INC, 2007.Link to Item
-
Wang, Tracy Y., Anita Y. Chen, Eric D. Peterson, Richard C. Becker, Magnus Ohman, W Brian Gibler, and Matthew T. Roe. “Non-ST-segment elevation acute coronary syndrome patients on chronic warfarin anticoagulation: Care and outcomes.” In Journal of the American College of Cardiology, 49:213A-213A. ELSEVIER SCIENCE INC, 2007.Link to Item
-
Wang, Tracy Y., Anita Y. Chen, Matthew T. Roe, Karen P. Alexander, L Kristin Newby, Sidney C. Smith, Sripal Bangalore, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Increased bleeding risk among Asians with non-ST-segment elevation acute coronary syndromes: Insights from the CRUSADE quality improvement initiative.” In Journal of the American College of Cardiology, 49:208A-208A. ELSEVIER SCIENCE INC, 2007.Link to Item
-
Wang, Tracy Y., Lee A. Robinson, Matthew T. Roe, Fang-Shu Ou, Eric D. Peterson, E Magnus Ohman, W Brian Gibler, Sidney C. Smith, and Richard C. Becker. “Continuation of warfarin at hospital discharge in patients with acute coronary syndromes on chronic warfarin anticoagulation.” In Journal of the American College of Cardiology, 49:251A-251A. ELSEVIER SCIENCE INC, 2007.Link to Item
-
Glickman, Seth W., Jyotsna Mulgund, Barbara L. Lytle, John S. Rumsfeld, Matthew T. Roe, W Brian Gibler, E Magnus Ohman, Dan Fintel, Kevin A. Schulman, and Eric D. Peterson. “The impact of pay for performance (P4P) on quality of care in acute coronary syndromes: Initial external evaluation of the center for medicare and medicaid services P4P pilot.” In Circulation, 114:835–835. LIPPINCOTT WILLIAMS & WILKINS, 2006.Link to Item
-
Dunlay, Shannon M., Li Liang, Chiara Melloni, Jennifer L. Kraschnewski, Karen P. Alexander, W Brian Gibler, Matthew T. Roe, E Magnus Ohman, and Eric D. Peterson. “Quality of medical record documentation in an acute coronary syndrome population: Results from CRUSADE.” In Circulation, 113:E802–3. LIPPINCOTT WILLIAMS & WILKINS, 2006.Link to Item
-
Leder, David M., Eric D Peterson, Matthew T. Roe, Elizabeth R. DeLong, Anita Y. Chen, E Magnus Ohman, W Brian Gibler, Barbara L. Lytle, and David J. Cohen. “The "July Phenomenon" revisited: Is the quality of care for patients presenting with acute coronary syndromes affected by house officer inexperience? Insights from CRUSADE.” In Circulation, 113:E818–19. LIPPINCOTT WILLIAMS & WILKINS, 2006.Link to Item
-
Blomkalns, Andra L., L Kristin Newby, Anita Chen, Eric D. Peterson, Kelly Trynosky, Deborah Diercks, William E. Boden, et al. “869-4 Sex disparities in the treatment of non-ST-segment elevation acute coronary syndromes.” In Journal of the American College of Cardiology, 43:A304–A304. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)91286-7.Full Text
-
Calvin, James E., Matthew T. Roe, Anita Chen, Gerard X. Brogan, Elizabeth R. DeLong, W Brian Gibler, E. Magnus Ohman, Dan Fintel, Sidney C. Smith, and Eric D. Peterson. “1135-72 Higher mortality and less evidence-based therapies among medicaid-insured patients with high-risk acute coronary syndromes: Results from CRUSADE.” In Journal of the American College of Cardiology, 43:A413–A413. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)91745-7.Full Text
-
Newby, L Kristin, Eric D. Peterson, Anita Chen, Robert A. Harrington, Charles V. Pollack, James W. Hoekstra, Robert H. Christenson, et al. “884-3 Clinical implications of discordant creatine kinase-MB and troponin results in patients with acute coronary syndromes.” In Journal of the American College of Cardiology, 43:A306–A306. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)91295-8.Full Text
-
Peterson, Eric D., Matthew T. Roe, Barbara L. Lytle, L. Kristin Newby, Elizabeth S. Fraulo, W Brian Gibler, and E Magnus Ohman. “1077-71 The association between care and outcomes in patients with acute coronary syndrome: National results from CRUSADE.” In Journal of the American College of Cardiology, 43:A406–A406. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)91714-7.Full Text
-
Roe, Matthew T., L Kristin Newby, Eric D. Paterson, Yun Li, Robert H. Christenson, Raymond D. Bahr, Charles V. Pollack, et al. “1154-90 Suboptimal treatment of patients with non-ST elevation acute coronary syndromes presenting with positive baseline troponin values.” In Journal of the American College of Cardiology, 43:A300–A300. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)91270-3.Full Text
-
Roe, Matthew T., William E. Boden, Anita Chen, James E. Calvin, Sidney C. Smith, E Magnus Ohman, W Brian Gibler, et al. “1001-2 Is the “hub-and-spoke” model working? Patterns of transfer for high-risk acute coronary syndromes patients from community hospitals without revascularization capacity.” In Journal of the American College of Cardiology, 43:A1–A1. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)90001-0.Full Text
-
Ryan, Jason W., Eric D. Peterson, Anita Chen, Matthew T. Roe, E. Magnus Ohman, Christopher P. Cannon, Peter B. Berger, et al. “1097-94 Early versus delayed intervention in non-ST-elevation acute coronary syndromes: A natural experiment from the CRUSADE initiative.” In Journal of the American College of Cardiology, 43:A276–A276. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)91173-4.Full Text
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.